0001437749-17-015699.txt : 20170907 0001437749-17-015699.hdr.sgml : 20170907 20170907162459 ACCESSION NUMBER: 0001437749-17-015699 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 63 CONFORMED PERIOD OF REPORT: 20170731 FILED AS OF DATE: 20170907 DATE AS OF CHANGE: 20170907 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ocean Power Technologies, Inc. CENTRAL INDEX KEY: 0001378140 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRIC SERVICES [4911] IRS NUMBER: 222535818 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33417 FILM NUMBER: 171074125 BUSINESS ADDRESS: STREET 1: 1590 REED ROAD CITY: PENNINGTON STATE: NJ ZIP: 08534 BUSINESS PHONE: 609-730-0400 MAIL ADDRESS: STREET 1: 1590 REED ROAD CITY: PENNINGTON STATE: NJ ZIP: 08534 FORMER COMPANY: FORMER CONFORMED NAME: Ocean Power Technologies, INc. DATE OF NAME CHANGE: 20061012 10-Q 1 optt20170731_10q.htm FORM 10-Q optt20170731_10q.htm Table of Contents

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q     

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended July 31, 2017

 

Or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period From                     to                    

 

Commission file number: 001-33417

 

OCEAN POWER TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

22-2535818

(State or Other Jurisdiction of Incorporation or Organization)

 

(I.R.S. Employer Identification No.)

 

1590 REED ROAD, PENNINGTON, NJ 08534

(Address of Principal Executive Offices, Including Zip Code)

 

(609) 730-0400

(Registrant's Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

  

Large accelerated filer

 

Accelerated filer

 

Non-accelerated filer

 

Smaller reporting company

 

 

 

 

 

 

 

 

 

 

 

(Do not check if a smaller

reporting company)

 

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

 

As of August 30, 2017 the number of outstanding shares of common stock of the registrant was 12,526,124

 

 

 

 

 

OCEAN POWER TECHNOLOGIES, INC.

INDEX TO FORM 10-Q

   

 

Page

 

Number

PART I — FINANCIAL INFORMATION

 

 

Item 1. Financial Statements:

 

 

Consolidated Balance Sheets as of July 31, 2017 (unaudited) and April 30, 2017

3

 

Unaudited Consolidated Statements of Operations for the three months ended July 31, 2017 and 2016

4

 

Unaudited Consolidated Statements of Comprehensive Loss for the three months ended July 31, 2017 and 2016

5

 

Unaudited Consolidated Statement of Stockholders' Equity for the three months ended July 31, 2017

6

 

Unaudited Consolidated Statements of Cash Flows for the three months ended July 31, 2017 and 2016

7

 

Notes to Unaudited Consolidated Financial Statements

8

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

23

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 34

 

Item 4. Controls and Procedures

34

 

PART II — OTHER INFORMATION

 

 

Item 1. Legal Proceedings

35

 

Item 1A. Risk Factors

 36

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 38

 

Item 3. Defaults Upon Senior Securities

 38

 

Item 4. Mine Safety Disclosures

 38

 

Item 5. Other Information

 38

 

Item 6. Exhibits

39

 

 

 

 

 

PowerBuoy and the Ocean Power Technologies logo are trademarks of Ocean Power Technologies, Inc. All other trademarks appearing in this report are the property of their respective holders.

  

 

Special Note Regarding Forward-Looking Statements

 

We have made statements in this Quarterly Report on Form 10-Q that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements convey our current expectations or forecasts of future events. Forward-looking statements include statements regarding our future financial position, business strategy, pending, threatened, and current litigation, liquidity, budgets, projected costs, plans and objectives of management for future operations. The words "may," "continue," "estimate," "intend," "plan," "will," "believe," "project," "expect," "anticipate", and similar expressions may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking.

 

The forward-looking statements contained in or incorporated by reference are largely based on our expectations, which reflect estimates and assumptions made by our management. These estimates and assumptions reflect our best judgment based on currently known market conditions and other factors. Although we believe such estimates and assumptions to be reasonable, they are inherently uncertain and involve a number of risks and uncertainties that are beyond our control, including:

 

 

our ability to commercialize our PowerBuoys, and achieve and sustain profitability;

 

 

our continued development of our proprietary technologies, and expected continued use of cash from operating activities unless or until we achieve positive cash flow from the commercialization of our products and services;

 

 

our ability to obtain additional funding, as and if needed which will be subject to a number of factors, including market conditions, and our operating performance;

 

 

our estimates regarding expenses, future revenues and capital requirements;

 

 

the adequacy of our cash balances and our need for additional financings;

 

 

our ability to develop and manufacture a commercially viable PowerBuoy product;

 

 

that we will be successful in our efforts to commercialize our PowerBuoy or the timetable upon which commercialization can be achieved, if at all;

 

 

our ability to identify and penetrate markets for our PowerBuoys and our wave energy technology;

 

 

our ability to implement our commercialization strategy as planned, or at all;

 

 

our ability to maintain the listing of our common stock on the NASDAQ Capital Market;

 

 

the reliability of our technology and our PowerBuoys;

 

 

our ability to improve the power output, survivability and reliability of our PowerBuoys;

 

 

the impact of pending and threatened litigation on our business, financial condition and liquidity;

 

 

changes in current legislation, regulations and economic conditions that affect the demand for renewable energy;

 

 

our ability to compete effectively in our target markets;

 

 

our limited operating history and history of operating losses;

 

 

our sales and marketing capabilities and strategy in the United States and internationally; and

 

 

our ability to protect our intellectual property portfolio.

  

 

Any or all of our forward-looking statements in this report may turn out to be inaccurate. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. They may be affected by inaccurate assumptions we might make or unknown risks and uncertainties, including the risks, uncertainties and assumptions described in Item 1A "Risk Factors" of our Annual Report on Form 10-K for the year ended April 30, 2017, and elsewhere in this report. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report may not occur as contemplated and actual results could differ materially from those anticipated or implied by the forward-looking statements.

 

Many of these factors are beyond our ability to control or predict. These factors are not intended to represent a complete list of the general or specific factors that may affect us. You should not unduly rely on these forward-looking statements, which speak only as of the date of this filing. Unless required by law, we undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise.

  

 

PART I — FINANCIAL INFORMATION

 

Item 1.      Financial Statements

 

Ocean Power Technologies, Inc. and Subsidiaries

Consolidated Balance Sheets

(in $000’s, except share data)

 

   

July 31, 2017

   

April 30, 2017

 
   

(Unaudited)

         

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 11,414     $ 8,421  

Marketable securities

    25       25  

Restricted cash- short-term

    361       334  

Accounts Receivable

    86       48  

Unbilled receivables

    163       296  

Litigation receivable

    350       -  

Other current assets

    383       622  

Total current assets

    12,782       9,746  

Property and equipment, net

    146       170  

Restricted cash- long-term

    154       154  

Other noncurrent assets

    3       3  

Total assets

  $ 13,085     $ 10,073  

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current liabilities:

               

Accounts payable

  $ 183     $ 586  

Accrued expenses

    1,530       3,059  

Litigation payable

    350       -  

Warrant liabilities

    286       323  

Current portion of capital lease obligations

    36       35  

Deferred credits payable current

    600       600  

Total current liabilities

    2,985       4,603  

Long-term portion of capital lease obligations

    14       23  

Total liabilities

    2,999       4,626  

Commitments and contingencies

               

Ocean Power Technologies, Inc. stockholders’ equity:

               

Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding

    -       -  

Common stock, $0.001 par value; authorized 50,000,000 shares, issued 12,621,205 and 6,313,996 shares, respectively

    13       6  

Treasury stock, at cost; 70,081 and 48,065 shares, respectively

    (295 )     (263 )

Additional paid-in capital

    200,549       193,234  

Accumulated deficit

    (190,043 )     (187,370 )

Accumulated other comprehensive loss

    (138 )     (160 )

Total stockholders' equity

    10,086       5,447  

Total liabilities and stockholders’ equity

  $ 13,085     $ 10,073  

 

See accompanying notes to unaudited consolidated financial statements.

 

 

Ocean Power Technologies, Inc. and Subsidiaries

Unaudited Consolidated Statements of Operations

(in $000’s, except per share data)

  
   

Three months ended July 31,

 
   

2017

   

2016

 
                 

Revenues

  $ 195     $ 202  

Cost of revenues

    217       127  

Gross profit (loss)

    (22 )     75  
                 

Operating expenses:

               

Product development costs

    1,102       1,636  

Selling, general and administrative costs

    1,641       1,519  

Total operating expenses

    2,743       3,155  

Operating loss

    (2,765 )     (3,080 )
                 

Change in fair value of warrant liabilities

    37       (752 )

Interest income, net

    3       -  

Foreign exchange gain

    62       5  

Net loss

  $ (2,663 )   $ (3,827 )

Basic and diluted net loss per share

  $ (0.22 )   $ (1.72 )

Weighted average shares used to compute basic and diluted net loss per share

    12,268,683       2,228,585  

 

See accompanying notes to unaudited consolidated financial statements.

 

 

 

Ocean Power Technologies, Inc. and Subsidiaries

Unaudited Consolidated Statements of Comprehensive Loss

(in $000’s)

   

   

Three months ended July 31,

 
   

2017

   

2016

 
                 

Net loss

  $ (2,663 )   $ (3,827 )

Foreign currency translation adjustment

    22       (31 )

Total comprehensive loss

  $ (2,641 )   $ (3,858 )

 

See accompanying notes to unaudited consolidated financial statements.

 

 

 

Ocean Power Technologies, Inc. and Subsidiaries

Unaudited Consolidated Statement of Stockholders' Equity

(in $000’s, except share data) 

   

                                                   

Accumulated

         
                                   

Additional

           

Other

   

Total

 
   

Common Shares

   

Treasury Shares

   

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Loss

   

Equity

 
                                                                 

Balances, April 30, 2017

    6,313,996     $ 6       (48,065 )   $ (263 )   $ 193,234     $ (187,370 )   $ (160 )   $ 5,447  

Net loss

                                            (2,663 )             (2,663 )

Stock based compensation

                                    91                       91  

Issuance of restricted stock, net

    114,459                                                       -  

Sale of stock, net of financing costs

    6,192,750       7                       7,214                       7,221  

Acquisition of treasury stock

                    (22,016 )     (32 )                             (32 )

Adoption of accounting standard update related to stock compensation accounting (ASU 2016-09)

                                    10       (10 )             -  
Other comprehensive loss                                                     22       22  

Balances, July 31, 2017

    12,621,205     $ 13       (70,081 )   $ (295 )   $ 200,549     $ (190,043 )   $ (138 )   $ 10,086  

 

 See accompanying notes to unaudited consolidated financial statements.

 

 

Ocean Power Technologies, Inc. and Subsidiaries

Unaudited Consolidated Statements of Cash Flows

(in $000’s) 

 

   

Three months ended July 31,

 
   

2017

   

2016

 
                 

Cash flows from operating activities:

               

Net loss

  $ (2,663 )   $ (3,827 )

Adjustments to reconcile net loss to net cash used in operating activities:

               

Foreign exchange gain

    (62 )     (5 )

Depreciation and amortization

    31       34  

Loss on disposal of property, plant and equipment

    4       -  

Compensation expense related to stock option grants and restricted stock

    91       218  

Change in fair value of warrant liabilities

    (37 )     752  

Changes in operating assets and liabilities:

               

Accounts receivable

    (38 )     (150 )

Unbilled receivable

    133       (13 )

Other assets

    239       (370 )

Accounts payable

    (405 )     264  

Accrued expenses

    (1,531 )     215  

Unearned revenues

    -       (39 )

Net cash used in operating activities

    (4,238 )     (2,921 )

Cash flows from investing activities:

               

Purchases of marketable securities

    -       (25 )

Purchases of equipment

    (12 )     (5 )

Net cash used in investing activities

    (12 )     (30 )

Cash flows from financing activities:

               

Proceeds from issuance of common stock, net of costs

    7,221       -  

Proceeds from issuance of common stock and related warrants, net of costs

    -       5,261  

Payment of capital lease obligations

    (9 )     -  

Payment of debt

    -       (32 )

Acquisition of treasury stock

    (32 )     (4 )

Net cash provided by financing activities

    7,180       5,225  

Effect of exchange rate changes on cash and cash equivalents

    90       (13 )

Net increase in cash, cash equivalents and restricted cash

    3,020       2,261  

Cash, cash equivalents and restricted cash, beginning of period

    8,909       7,030  

Cash, cash equivalents and restricted cash, end of period

  $ 11,929     $ 9,291  
                 

Supplemental schedule of cash flows information:

               

Cash paid for interest

  $ 1     $ 2  

 

See accompanying notes to unaudited consolidated financial statements.

 

 

 

Ocean Power Technologies, Inc. and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

 

(1) Background, Basis of Presentation and Liquidity

 

a)

Background

 

Ocean Power Technologies, Inc. (the “Company”) was founded in 1984 in New Jersey, commenced business operations in 1994 and re-incorporated in Delaware in 2007. The Company is developing and commercializing its proprietary systems that generate electricity by harnessing the renewable energy of ocean waves. The Company uses proprietary technologies that convert the mechanical energy created by the heaving motion of ocean waves into electricity. The Company has designed and continues to develop the PowerBuoy product line which is based on modular, ocean-going buoys, which the Company has been periodically ocean testing since 1997. The Company markets its PowerBuoys in the United States and internationally. Since fiscal 2002, government agencies have accounted for a significant portion of the Company’s revenues.  These revenues were largely for the support of product development efforts. The Company’s goal is that an increased portion of its revenues be from the sale or lease of products and maintenance services, as compared to revenue to support its product development efforts. As the Company continues to advance its proprietary technologies, it expects to continue to have a net decrease in cash from operating activities unless and until it achieves positive cash flow from the planned commercialization of products and services.

 

b)

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are not necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form 10-K for the year ended April 30, 2017 filed with the Securities and Exchange Commission (“SEC”) and elsewhere in this Form 10-Q.

 

c)

Liquidity/Going Concern

 

The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of $190.0 million as of July 31, 2017. As of July 31, 2017, the Company had approximately $11.4 million in cash and cash equivalents on hand. The Company generated revenues of $0.2 million during each of the three months ended July 31, 2017 and 2016. Based on the Company’s cash and cash equivalents and marketable securities as of July 31, 2017, the Company believes that it will be able to finance its capital requirements and operations into the quarter ending July 31, 2018. The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.

 

Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies may include, but are not limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company’s equity or debt securities; partnerships and/or collaborations. There can be no assurance that any of these future-funding efforts will be successful.

 

 

In fiscal 2017 and the three months ended July 31, 2017, the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company’s future results of operations involve significant risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys, its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed four equity financing arrangements during the year ended April 30, 2017 and three months ended July 31, 2017. The Company does not currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is not obtained when needed, the Company may be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and may cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.

 

On June 2, 2016, the Company entered into a securities purchase agreement, which was amended on June 7, 2016 (as amended, the “Purchase Agreement”) with certain institutional purchasers (the “June Purchasers”). Pursuant to the terms of the June Purchase Agreement, the Company sold an aggregate of 417,000 shares of Common Stock together with warrants to purchase up to an aggregate of 145,952 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.35 of a share of Common Stock at a combined purchase price of $4.60. The net proceeds to the Company from the offering were approximately $1.7 million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of $6.08 per share, became exercisable on December 3, 2016 (“Initial Exercise Date”), and will expire five years following the Initial Exercise Date. The Company paid the placement agents approximately $0.1 million as placement agent fees in connection with the sale of securities in the offering. The Company also reimbursed the placement agents $35,000 for their out of pocket and legal expenses in connection with the offering.  

 

On July 22, 2016, the Company entered into the Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain purchasers (the “July Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of 595,000 shares of Common Stock together with warrants to purchase up to an aggregate of 178,500 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.30 of a share of Common Stock at a combined purchase price of $6.75. The net proceeds to the Company from the offering were approximately $3.6 million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of $9.36 per share. The Warrants will expire on the fifth (5th) anniversary of the initial date of issuance.

 

On October 19, 2016, the Company sold 2,760,000 shares of common stock at a price of $2.75 per share, which includes the sale of 360,000 shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately $6.9 million, after deducting underwriter fees and offering expenses payable by the Company.

 

On May 2, 2017, the Company sold 6,192,750 shares of common stock at a price of $1.30 per share, which includes the sale of 807,750 shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately $7.2 million, after deducting underwriter fees and offering expenses payable by the Company.

 

The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company’s Common Stock and could contain covenants that would restrict its operations. Financing may not be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it may be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it may be forced to cease operations.

 

(2) Summary of Significant Accounting Policies

 

(a) Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

 

  

(b) Use of Estimates

 

The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates. The current economic environment, particularly the macroeconomic pressures in certain European countries, has increased the degree of uncertainty inherent in those estimates and assumptions.

 

(c) Revenue Recognition

 

The Company’s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.

 

The Company has two types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of zero. The Company’s share of the costs is recorded as product development expense.

 

Generally, revenue under fixed price or cost plus contracts is recognized using the cost to cost percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria may be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.

 

In addition, recognition of revenue (and the related costs) may be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management may make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects may have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.

 

Unbilled receivables represent expenditures on contracts, plus applicable profit margin, not yet billed. Unbilled receivables are normally billed and collected within one year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.

  

(d) Cash, Cash Equivalents, Restricted Cash and Security Agreements

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does not take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least 100% of the bank’s total obligations under the agreement.

 

 

 

   

July 31, 2017

   

April 30, 2017

 
   

(in thousands)

 
                 

Checking and savings accounts

  $ 4,400     $ 4,241  

Overnight repurchase account

    7,014       4,180  
    $ 11,414     $ 8,421  

 

 Restricted Cash and Security Agreements

 

A portion of the Company’s cash is restricted under the terms of two security agreements.

 

One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD, one of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility is approximately €0.3 million ($0.3 million) and carries a fee of 1% per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does not have an expiration date, but is cancelable at the discretion of the bank. As of July 31, 2017, there was €0.3 million ($0.3 million) in letters of credit outstanding under this agreement.

 

The second agreement is between the Company and Santander Bank. Under this agreement, the cash is on deposit at Santander Bank and serves as security for letter of credit issued by Santander Bank for the lease of new warehouse/office space in Monroe Township, New Jersey. The agreement cannot be extended beyond January 31, 2025, and is cancelable at the discretion of the bank. Restricted cash includes the following:

 

   

July 31, 2017

   

April 30, 2017

 
   

(in thousands)

 
                 

Barclay's Bank Agreement

  $ 361     $ 334  

Santander Bank

    154       154  
    $ 515     $ 488  

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.

 

   

July 31, 2017

   

April 30, 2017

 
   

(in thousands)

 
                 

Cash and cash equivalents

  $ 11,414     $ 8,421  

Restricted cash- short term

    361       334  

Restricted cash- long term

    154       154  
    $ 11,929     $ 8,909  

 

(e) Marketable Securities

 

Marketable securities with original maturities longer than three months but that mature in less than one year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of July 31, 2017 and April 30, 2017, all of the Company’s investments were classified as held-to-maturity.

  

 

(f) Foreign Exchange Gains and Losses

 

The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions may result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in “Foreign exchange gain/(loss)” in the accompanying consolidated statements of operations.

 

(g) Property and Equipment

 

Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives (three to seven years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.

 

(h) Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does not believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.

 

The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least 10% of the Company's consolidated revenues for at least one of the periods indicated:

 

   

Three months ended July 31,

 

Customer

 

2017

   

2016

 
                 

Mitsui Engineering & Shipbuilding

    67 %     100 %

U.S. Department of Defense Office of  Naval Research

    33 %     -  
      100 %     100 %

 

The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does not require its customers to maintain collateral.

 

(i) Warrant Liabilities

 

The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within “Change in fair value of warrant liabilities.” The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to “Additional paid-in capital”, a component of “Stockholders' equity” on the consolidated balance sheets.

 

 

(j) Net Loss per Common Share

 

Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.

 

In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling 701,977 for the three months ended July 31, 2017 and 711,453 for the three months ended July 31, 2016, were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.  

 

(k) Share-Based Compensation

 

Costs resulting from all share-based payment transactions are recognized in the consolidated financial statements at their fair values. The aggregate share-based compensation expense recorded in the consolidated statements of operations for the three months ended July 31, 2017 and 2016 was approximately $0.1 million and $0.2 million, respectively. The following table summarizes share-based compensation related to the Company’s share-based plans by expense category for the three months ended July 31, 2017 and 2016:

 

   

Three months ended July 31,

 
   

2017

   

2016

 
   

(in thousands)

 
                 

Product development

  $ 13     $ 53  

Selling, general and administratvie

    78       165  

Total share-based compensation expense

  $ 91     $ 218  

 

(l) Recently Issued Accounting Standards

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The FASB subsequently issued additional clarifying standards to address issues arising from implementation of the new revenue standard, including a one-year deferral of the effective date for the new revenue standard. Public companies should now apply the guidance in ASU 2014-09 to annual reporting periods beginning after December 15, 2017 and interim periods within those annual periods. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim periods within that annual period. As such, the Company is required to adopt this standard effective in fiscal 2019, which begins May 1, 2018. Companies may use either a full retrospective or a modified retrospective approach to adopt ASU 2014-09. The Company has not yet completed its final review of the impact of this guidance; however the Company anticipates applying the modified retrospective method upon adoption of ASU 2014-09 on May 1, 2018. The impact to the Company could be affected by the nature and terms of potential future contracts with customers, as those contracts may have terms that differ from the Company’s current contracts.

 

In August 2014, the FASB issued ASU 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the first annual period ending after December 15, 2016, and interim periods thereafter. Early application is permitted. The Company adopted ASU 2014-15 for the fiscal year 2017. The Company’s addition of the standard did not have a material impact on its disclosures. See section (c) “Liquidity/Going Concern” within Note (1) “Background and Liquidity” of the consolidated financial statements included in this Quarterly Report on Form 10-Q for further discussion on the Company’s ability to continue as a going concern.

 

 

In January 2016, the FASB issued ASU No. 2016-01, “Recognition and Measurement of Financial Assets and Financial Liabilities”, which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company will evaluate the effect of ASU 2016-01 for future periods as applicable.

 

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842).” The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for annual periods beginning after December 15, 2018, including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU 2016-02 will have on its consolidated financial statements and disclosures and has not yet determined the effect of the standard on its ongoing financial reporting at this time.

 

In March 2016, the FASB issued ASU No. 2016-09, “Compensation - Stock Compensation (Topic 718). The amendments of ASU No. 2016-09 were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity may be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including accounting for forfeitures, income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU No. 2016-09 is effective for fiscal years beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted ASU 2016-09 on May 1, 2017. Certain of the amendments are applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of May 1, 2017, while other amendments are applied retrospectively, prospectively or using either a prospective or a retrospective transition method. Upon adoption, the Company is beginning to account for forfeitures as they occur rather than estimate a forfeiture rate and has recorded a cumulative-effect adjustment in equity of approximately $10,000 on the date of initial adoption. In periods subsequent to adoption, a higher expense will be recognized earlier during the respective vesting periods of stock-based awards that are not forfeited. The Company expects that the income tax amendments within ASU 2016-09 will have no impact on its results of operations or cash flows because it is in a net operating loss position with a full valuation allowance.

 

In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments”, providing additional guidance on eight specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years and early adoption is permitted. The Company has evaluated the effect ASU 2016-13 will have on its consolidated financial statements and disclosures and has determined the standard will have no impact on its ongoing financial reporting at this time.

 

In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash”, which amends guidance and presentation related to restricted cash in the statement of cash flows, including stating that amounts generally described as restricted cash and restricted cash equivalents should be included within cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. An entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years and early adoption is permitted. The Company has early adopted ASU 2016-18 effective May 1, 2017. In connection with the adoption of the standard the Company has used a retrospective transition method for each period presented in the statement of cash flows. The Company reclassified $488,000 and $300,000 of restricted cash to cash, cash equivalents and restricted cash, beginning of period for the period April 30, 2017 and April 30, 2016 in the statement of cash flows. The Company reclassified $266,000 of restricted cash to cash, cash equivalents and restricted cash, end of period for the period ended July 31, 2016 in the statement of cash flows.

 

 

(3) Marketable Securities

 

Marketable securities with initial maturities greater than three months but that mature within one year from the balance sheet date are classified as current assets and are summarized as follows:

 

   

July 31, 2017

   

April 30, 2017

 
   

(in thousands)

 
                 

Certificate of Deposit

  $ 25     $ 25  

 

  (4) Accrued Expenses

 

Accrued expenses consist of the following at July 31, 2017 and April 30, 2017.

 

   

July 31, 2017

   

April 30, 2017

 
   

(in thousands)

 
                 

Project costs

  $ 46     $ 898  

Contract loss reserve

    298       238  

Employee incentive payments

    142       643  

Accrued salary and benefits

    420       484  

Legal and accounting fees

    358       478  

Accrued taxes payable

    132       132  

Other

    134       186  
    $ 1,530     $ 3,059  

 

 (5) Deferred Credits Payable

 

During the year ended April 30, 2001, in connection with the sale of common stock to an investor, the Company received $0.6 million from the investor in exchange for an option to purchase up to 500,000 metric tons of carbon emissions credits generated by the Company during the years 2008 through 2012, at a 30% discount from the then-prevailing market rate. If the Company received emission credits under applicable laws and failed to sell to the investor the credits up to the full amount of emission credits covered by the option, the investor was entitled to liquidated damages equal to 30% of the aggregate market value of the shortfall in emission credits (subject to a limit on the market price of emission credits).  Under the terms of the agreement, if the Company did not become entitled under applicable laws to the full amount of emission credits covered by the option by December 31, 2012, the Company was obligated to return the option fee of $0.6 million, less the aggregate discount on any emission credits sold to the investor prior to such date. In December 2012, the Company and the investor agreed to extend the period for the sale of emission credits until December 31, 2017. As of July 31, 2017, the Company has not generated any emissions credits eligible for purchase under the agreement. As a result, the Company anticipates returning the option fee of $0.6 million. Therefore, the $0.6 million is reflected in the consolidated balance sheets within “Deferred credits payable current” as of July 31, 2017 and April 30, 2017, respectively.

   

(6) Warrants

 

On June 2, 2016, the Company entered into a securities purchase agreement, which was amended on June 7, 2016 (as amended, the “June Purchase Agreement”) with certain institutional purchasers (the “June Purchasers”). Pursuant to the terms of the June Purchase Agreement, the Company sold an aggregate of 417,000 shares of Common Stock together with warrants to purchase up to an aggregate of 145,952 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.35 of a share of Common Stock at a combined purchase price of $4.60. The warrants have an exercise price of $6.08 per share, became exercisable on December 3, 2016 (“Initial Exercise Date”), and will expire five years following the Initial Exercise Date. 

 

 

On July 22, 2016, the Company entered into a Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain institutional purchasers (the “July Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of 595,000 shares of Common Stock together with warrants to purchase up to an aggregate of 178,500 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.30 of a share of Common Stock at a combined purchase price of $6.75. The Warrants were exercisable immediately at an exercise price of $9.36 per share. The Warrants will expire on the fifth (5th) anniversary of the initial date of issuance.

  

Both sets of warrants contain a feature whereby they could require the transfer of assets and therefore are classified as a liability in accordance with ASC 480. As such, the warrants with a value of $0.3 million and $0.3 million at July 31, 2017 and April 30, 2017, respectively, are reflected within “Warrant liabilities” in the unaudited consolidated balance sheets.

 

An unrealized gain and unrealized loss of approximately $37,000 and $752,000, respectively, were included within “Change in fair value of warrant liability” in the consolidated statements of operations for the three months ended July 31, 2017 and 2016, respectively. The Company determined the fair value using the Black-Scholes option pricing model with the following assumptions:

 

   

July 31, 2017

   

July 31, 2016

 
                     

Dividend rate

    0.0%         0.0%    

Risk-free rate

    1.68%         1.00%    

Expected life (years)

  4.0 - 4.4     5.0 - 5.4  

Expected volatility

    140.3%         125.4%    

 

(7) Stock-Based Compensation

 

(a) Stock Options

 

Valuation Assumptions for Options Granted during the three months ended July 31, 2017 and 2016

 

The fair value of each stock option granted, for both service-based and performance-based vesting requirements during the three months ended July 31, 2017 and 2016, was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends, and using the weighted average valuation assumptions noted in the following table. The risk-free rate is based on the US Treasury yield curve in effect at the time of grant. The expected life (estimated period of time outstanding) of the stock options granted was estimated using the "simplified" method as permitted by the SEC's Staff Accounting Bulletin No. 110, Share-Based Payment. Expected volatility was based on the Company’s historical volatility during the three months ended July 31, 2017 and 2016. The below assumptions were used to determine the weighted average per share fair value of $1.10 for stock options granted during the three months ended July 31, 2016. No options were granted during the three months ended July 31, 2017.

 

   

Three months ended July 31,

 
   

2017

   

2016

 
                 

Risk-free interest rate

    N/A       1.3 %

Expected dividend yield

    N/A       0.0 %

Expected life (in years)

    N/A       5.5  

Expected volatility

    N/A       85.6 %

    

 

A summary of stock options under our stock incentive plans is detailed in the following table. 

 

                   

Weighted

 
                   

Average

 
           

Weighted

   

Remaining

 
   

Shares

   

Average

   

Contractual

 
   

Underlying

   

Exercise

   

Term

 
   

Options

   

Price

   

(In Years)

 

Outstanding as of April 30, 2017

    237,214     $ 14.64       7.6  

Granted

    -     $ -          

Exercised

    -     $ -          

Cancelled/forfeited

    (6,910 )   $ 161.18          

Outstanding as of July 31, 2017

    230,304     $ 10.24       7.6  

Exercisable as of July 31, 2017

    128,641     $ 16.10       6.3  

 

As of July 31, 2017, the total intrinsic value of outstanding and exercisable options was approximately $5,000 and $4,000, respectively. As of July 31, 2017, approximately 100,323 additional options were unvested, which had no intrinsic value and a weighted average remaining contractual term of 9.2 years. There was approximately $69,000 and $83,000 of total recognized compensation cost related to stock options during each of the three months ended July 31, 2017 and 2016, respectively. As of July 31, 2017, there was approximately $0.1 million of total unrecognized compensation cost related to non-vested stock options granted under the plans. This cost is expected to be recognized over a weighted-average period of 0.4 years. The Company typically issues newly authorized but unissued shares to satisfy option exercises under these plans.

 

(b) Restricted Stock

 

Compensation expense for non-vested restricted stock is generally recorded based on its market value on the date of grant and recognized ratably over the associated service and performance period. During the three months ended July 31, 2017, the Company granted 114,584 shares subject to service-based vesting requirements and no shares subject to performance-based vesting requirements. The achievement or vesting requirement of the performance-based grants is tied to the Company’s total shareholder return (“TSR”) relative to the total shareholder return of three alternative energy Exchange Traded Funds as measured over a specific performance period. No vesting of the relevant shares will occur in instances where the Company’s TSR for the relevant period is below 80% of the peer group. However, additional opportunities to vest some or all of a portion of the shares in a subsequent period may occur. Compensation expense for these awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.

 

Restricted stock issued and unvested as of July 31, 2017 included 12,000 shares of unvested restricted stock subjected to performance-based vesting requirements.

 

A summary of non-vested restricted stock under our stock incentive plans is as follows:

 

           

Weighted

 
   

Number

   

Average Price per

 
   

of Shares

   

Share

 
                 

Issued and unvested at April 30, 2017

    103,412     $ 3.99  

Granted

    114,584     $ 1.40  

Vested

    (70,650 )   $ 4.55  

Cancelled/forfeited

    (125 )   $ 1.40  

Issued and unvested at July 31, 2017

    147,221     $ 2.04  

 

There was approximately $22,000 and $0.1 million of total recognized compensation cost related to restricted stock for the three months ended July 31, 2017 and 2016, respectively. As of July 31, 2017, there was approximately $0.2 million of total unrecognized compensation cost related to unvested restricted stock granted under our plans. This cost is expected to be recognized over a weighted average period of 1.5 years.

   

 

(c) Treasury Stock

 

During the three months ended July 31, 2017 and 2016, 22,016 and 447 shares, respectively, of common stock were purchased by the Company from employees to pay taxes related to the vesting of restricted stock.

 

(8) Fair Value Measurements

 

The Company measures and reports certain financial and non-financial assets and liabilities on a fair value basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP specifies a three-level hierarchy that is used when measuring and disclosing fair value. The fair value hierarchy gives the highest priority to quoted prices available in active markets (i.e., observable inputs) and the lowest priority to data lacking transparency (i.e., unobservable inputs). An instrument’s categorization within the fair value hierarchy is based on the lowest level of significant input to its valuation. The following is a description of the three hierarchy levels.

 

Level 1

Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Active markets are considered to be those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.

 

 

Level 2

Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in inactive markets.

 

 

Level 3   

Unobservable inputs are not corroborated by market data. This category is comprised of financial and non-financial assets and liabilities whose fair value is estimated based on internally developed models or methodologies using significant inputs that are generally less readily observable from objective sources.

 

Transfers into or out of any hierarchy level are recognized at the end of the reporting period in which the transfers occurred. There were no transfers between any levels during the three months ended July 31, 2017 and 2016.

 

The following information is provided to help readers gain an understanding of the relationship between amounts reported in the accompanying consolidated financial statements and the related market or fair value. The disclosures include financial instruments and derivative financial instruments, other than investment in affiliates.

 

Following are descriptions of the valuation methodologies used to measure material assets and liabilities at fair value and details of the valuation models, key inputs to those models and significant assumptions utilized.

 

Warrant Liabilities

 

The fair value of the Company's warrant liabilities (refer to Note 6) recorded in the Company's financial statements is determined using the Black-Scholes option pricing model and the quoted price of the Company's common stock in an active market, volatility and expected life, is a Level 3 measurement. Volatility is based on the actual market activity of the Company's stock. The expected life is based on the remaining contractual term of the warrants and the risk free interest rate is based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrants' expected life.  

 

 

The following table presents financial assets and liabilities measured at fair value on a recurring basis as of July 31, 2017.

 

   

Total Carrying Value in Consolidated Balance Sheet

   

Quoted prices in active markets for identical assts or liabilities

(Level 1)

   

Significant other observable inputs

(Level 2)

   

Significant unobservable inputs

(Level 3)

 
   

(in thousands)

 
                                 

Warrant liabilities

  $ 286     $ -     $ -     $ 286  

 

 The following table presents financial assets and liabilities measured at fair value on a recurring basis as of April 30, 2017.

 

   

Total Carrying Value in Consolidated Balance Sheet

   

Quoted prices in active markets for identical assts or liabilities

(Level 1)

   

Significant other observable inputs

(Level 2)

   

Significant unobservable inputs

(Level 3)

 
   

(in thousands)

 
                                 

Warrant liabilities

  $ 323     $ -     $ -     $ 323  

 

The following table provides a summary of changes in fair value of the Company’s warrant liabilities held at July 31, 2017.

  

Fair Value Measurement Using Significant Unobservable Inputs ( Level 3)  
       
   

Total

 
   

Warrant

 
   

Liability

 
   

(in thousands)

 
         

Fair value – April 30, 2016

  $ -  

Issuance

    1,814  

Transfers

    -  

Change in fair value

    (1,491 )

Fair value – April 30, 2017

  $ 323  
         

Change in fair value

    (37 )

Fair value – July 31, 2017

  $ 286  

 

There were no re-measured assets or liabilities at fair value on a non-recurring basis during the three months ended July 31, 2017 and 2016, respectively.

 

 

(9) Commitments and Contingencies

 

(a) Litigation

 

Shareholder Litigation and Demands 

 

The Company and certain of its current and former directors and officers are defendants in a derivative lawsuit filed on March 18, 2015 in the United States District Court for the District of New Jersey captioned Labare v. Dunleavy, et. al., Case No. 3:15-cv-01980-FLW-LHG. The derivative complaint alleges claims for breach of fiduciary duty, abuse of control, gross mismanagement and unjust enrichment relating to the now terminated agreement between Victorian Wave Partners Pty. Ltd. (VWP) and the Australian Renewable Energy Agency (ARENA) for the development of a wave power station. The derivative complaint seeks unspecified monetary damages and other relief.

 

On July 10, 2015, a second derivative lawsuit, captioned Rywolt v. Dunleavy, et al., Case No. 3:15-cv-05469, was filed by another shareholder against the same defendants in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, gross mismanagement, abuse of control, and unjust enrichment relating to the now terminated agreement between VWP and ARENA. The Rywolt complaint also seeks unspecified monetary damages and other relief. On February 8, 2016, the Court issued an order consolidating the Labare and Rywolt actions, appointing co-lead plaintiffs and lead counsel, and ordering a consolidated amended complaint to be filed within 30 days of the order. On March 9, 2016, the co-lead plaintiffs filed an amended complaint consolidating their claims and seeking unspecified monetary damages and other relief.

 

On April 21, 2016, a third derivative lawsuit, captioned LaCalamito v. Dunleavy, et al., Case No. 3:16-cv-02249, was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty relating to the now terminated agreement between VWP and ARENA. The LaCalamito complaint seeks unspecified monetary damages and other relief. The Company has not been formally served and has not yet responded to the complaint.

 

On June 9, 2016, a fourth derivative lawsuit, captioned Pucillo v. Dunleavy, et al., was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, unjust enrichment, and abuse of control relating to the now terminated agreement between VWP and ARENA. The Pucillo complaint seeks unspecified monetary damages and other relief. On August 2, 2016, the parties in the Pucillo lawsuit filed a Stipulation and Proposed Order pursuant to which: (i) the defendants agreed to accept service of the Pucillo complaint; (ii) the parties agreed to stay the Pucillo action pending the filing and resolution of a motion to consolidate the Pucillo action with the Labare and Rywolt actions; and (iii) the parties agreed that the defendants shall not be required to respond to the Pucillo complaint during the pendency of the stay. The Court approved the Stipulation on August 3, 2016.

 

On October 25, 2016, the Court approved and entered a Stipulation and Order that, among other things, (i) consolidated the four derivative actions; (ii) identified plaintiff Pucillo as the lead plaintiff in the consolidated actions; and (iii) stayed the consolidated actions pending the settlement hearing scheduled for November 14, 2016 in the securities class action and further order of the Court. During the month of August, 2017, the Company tentatively reached a settlement with the plaintiff subject to final documentation. The settlement, once finalized and if approved by the court, provides, among other things, for a settlement payment by or on behalf of the Company of $350,000, of which the Company’s insurer would pay the complete amount of $350,000. As a result, the Company has accrued $350,000 related to this matter as a probable and reasonably estimable loss contingency during the three months ended July 31, 2017. The Company also recorded a receivable of $350,000 from its insurance carrier with the offset to the statement of operations.

 

On May 26, 2017, an attorney claiming to represent two stockholders sent the Company’s Board of Directors a Stockholder Litigation Demand letter (“Stockholder Demand”). The Stockholder Demand alleges that the voting of shares for the 1-for-10 reverse stock split at the 2015 annual meeting of stockholders held on October 22, 2015 was not properly counted, and further alleges that, although the Company reported the reverse stock split as having been passed, if the vote was properly counted the reverse stock split would not have been approved. The Stockholder Demand requests the Board of Directors either to deem the reverse stock split as ineffective and disclose the same or to seek a proper and effective stockholder ratification of the reverse stock split. In addition, the Stockholder Demand requests the Board of Directors to adopt and implement adequate internal controls and systems to prevent the alleged improper voting from recurring. On June 23, 2017, the Company responded to the Stockholder Demand, explained the procedures that were followed for the 2015 annual meeting of stockholders and provided the Oath of the Inspector of Elections and the Certificate of the Inspector of Elections that certified as accurate the results of the voting at the meeting including voting on the reverse stock split proposal. On June 26, 2017, the attorney representing the alleged stockholders replied to the Company’s response, further alleged that the proxy statement underlying the 2015 annual meeting provided voting instructions that misled the stockholders regarding whether their brokers could vote on the reverse stock split proposal, and renewed their requests of the Board. On July 24, 2017, the Company provided an additional response to the Stockholders Demand, denied the allegations, and declined to take any of the actions requested.

 

 

Employment Litigation 

 

On June 10, 2014, the Company announced that it had terminated Charles Dunleavy as its Chief Executive Officer and as an employee of the Company for cause, effective June 9, 2014, and that Mr. Dunleavy had also been removed from his position as Chairman of the Board of Directors. On June 17, 2014, Mr. Dunleavy wrote to the Company stating that he had retained counsel to represent him in connection with an alleged wrongful termination of his employment. On July 28, 2014, Mr. Dunleavy resigned from the Board and the boards of directors of the Company's subsidiaries. The Company and Mr. Dunleavy have agreed to suspend his alleged employment claims pending resolution of the shareholder litigation, and have since agreed to continue to the suspension pending resolution of the derivatives litigation.

 

Except for the pending settlement noted previously, we have not established any provision for losses relating to these claims and pending litigation. Due to the stages of these proceedings, and considering the inherent uncertainty of these claims and litigation, at this time we are not able to predict or reasonably estimate whether we have any possible loss exposure or the ultimate outcome of these claims.

 

(b) Regulatory Matters

 

SEC Investigation

 

On February 4, 2015, the Company received a subpoena from the SEC requesting information related to the VWP Project. The Company has provided information to the SEC in response to that subpoena. As part of the same investigation, on July 12, 2016, the SEC issued second subpoena requesting information related to the Company’s April 4, 2014 public offering. The Company has provided information to the SEC in response to that subpoena. The SEC investigation is ongoing and the Company continues to cooperate with the SEC in its investigation. We are unable to predict what action, if any, might be taken by the SEC or its staff as a result of this investigation or what impact, if any, the cost of responding to the SEC’s investigation or its ultimate outcome might have on our financial position, results of operations or liquidity. We have not established any provision for losses relating to this matter.

 

Spain IVA (sales tax)

 

In June 2012, the Company received notice that the Spanish tax authorities are inquiring into its 2010 IVA (value-added tax) filing for which the Company benefitted from the offset of approximately $0.3 million of input tax. The Company believes that the inquiry will find that the tax credit was properly claimed and, therefore, no liability has been recorded. The Company issued two letters of credit totaling €0.3 million ($0.3 million) at the request of the Spanish tax authorities. On January 31, 2017 the Company has received $0.2 million from the Spanish tax authorities as a result of the conclusion of the inquiry. In addition, during February 2017, the Spanish tax authorities approved of the release of the two outstanding letters of credit.

    

Spain Income Tax Audit

 

The Company is currently undergoing an income tax audit in Spain for the period from 2008 to 2014, when its Spanish branch was closed. The branch reported net operating losses for each of the years reported. It is anticipated that the Company will be assessed a penalty relating to these tax years for these losses. The Company has estimated this penalty to be $132,000, and as such, for the period ended April 30, 2017 and July 31, 2017, the Company has recorded $132,000 for this penalty to Accrued expenses in its balance sheet.

 

(10) Income Taxes

 

 The Company did not recognize any consolidated income tax benefit (expense) during the three month periods ended July 31, 2017 and 2016. The Company has recorded a valuation allowance to reduce its net deferred tax asset to an amount that is more likely than not to be realized in future years. Accordingly, the benefit of the net operating loss that would have been recognized was offset by changes in the valuation allowance.

 

 

The Company applies the guidance issued by the FASB for the accounting and reporting of uncertain tax positions. The guidance requires the Company to recognize in its consolidated financial statements the impact of a tax position if that position is more likely than not to be sustained upon examination, based on the technical merits of the position. We are currently undergoing an income tax audit in Spain for the period from 2008 to 2014, when our Spanish branch was closed. The branch reported net operating losses for each of the years reported. It is anticipated that we will be assessed a penalty relating to these tax years for these losses. We have estimated this penalty to be $132,000, and as such, for the period ended April 30, 2017 and July 31, 2017, we have recorded $132,000 for this penalty to Accrued expenses in the Balance Sheet. At July 31, 2017 the Company had no other unrecognized tax positions. The Company does not expect any material increase or decrease in its income tax expense in the next twelve months, related to examinations or uncertain tax positions. U.S. federal and state income tax returns were audited through fiscal 2014 and fiscal 2010 respectively. Net operating loss and credit carry forwards since inception remain open to examination by taxing authorities, and will continue to remain open for a period of time after utilization.  

  

 (11) Operating Segments and Geographic Information

 

The Company's business consists of one segment as this represents management's view of the Company's operations. The Company operates on a worldwide basis with one operating company in the US and operating subsidiaries in the UK and in Australia. Revenues and expenses are generally attributed to the operating unit that bills the customers. During the three months ended July 31, 2017 and 2016, the Company’s primary business operations were in North America.

  

 

Item 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with the accompanying unaudited consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q. Some of the information contained in this management’s discussion and analysis or set forth elsewhere in this Form 10-Q, including information with respect to our plans and strategy for our business, pending and threatened litigation and our liquidity includes forward-looking statements that involve risks and uncertainties. You should review the "Risk Factors" section of our Annual Report on Form 10-K for the year ended April 30, 2017 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. References to a fiscal year in this Form 10-Q refer to the year ended April 30 of that year (e.g., fiscal 2017 refers to the year ended April 30, 2017).

 

Overview

 

Nearly 70% of the earth’s surface is covered by water, with over 40% of the world’s population living within approximately 150 miles of a coast. Thousands of information gathering and/or power systems are deployed in the oceans today to increase our understanding of weather, climate change, biological processes, and marine mammal patterns and to support exploration and operations for industries such as oil and gas. Most of these systems are powered by battery, solar, wind, fuel cell, or fossil fuel generators that may be unreliable and expensive to operate while they also may be limited in their ability to deliver ample electric power. These current systems often necessitate significant tradeoffs in sensor accuracy, data processing and communications bandwidth and frequency in order to operate given limited available power. More persistent power systems requiring less maintenance, such as our systems, may have the ability to save costs over these current systems. Just as importantly, increases in available power may allow for better sensors, faster data sampling and higher frequency communication intervals up to real-time which could as a result improve scientific and economic returns.

 

Founded in 1984 and headquartered in Pennington, New Jersey, we believe we are the leader in ocean wave power conversion technology. Our PB3 PowerBuoy is our first fully commercial product which generates electricity by harnessing the renewable energy of ocean waves. In addition to our PB3 PowerBuoy, we continue to develop our PowerBuoy product line based on modular, ocean-going buoys, which we have been periodically ocean testing since 1997.

 

The PB3 PowerBuoy generates power for use in remote offshore locations, independent of a conventional power grid, and it incorporates a unique onboard power take-off (“PTO”) system, which incorporates both energy storage and energy management and control systems. The PB3 generates up to 3 kilowatts (“kW”) of peak power during recharging of the onboard batteries. Power generation is deployment-site dependent whereby average power generated can increase substantially at very active sites. Our standard energy storage system (“ESS”) has an energy capacity of up to a nominal 150 kilowatt-hours (“kWh”) to meet specific application requirements. We continue to develop and test our new PowerBuoys, with the objective to incrementally scale up power production. We believe there is a substantial addressable market for the current capabilities of our PB3, which we believe could be utilized in a variety of applications.

 

In addition to leveraging earlier design aspects of our autonomous PowerBuoy, the PB3 has undergone extensive factory and in-ocean design validation testing. Currently, our engineering efforts are focused primarily on cost reductions and life extensions of the PB3, while also scaling our technologies to increase the energy output. Our marketing efforts are focused on applications in remote offshore locations that require reliable and persistent power and communications, either by supplying electric power to payloads that are integrated directly in or on our PowerBuoy or located in its vicinity, such as on the seabed and in the water column.

 

Based on our market research and publicly available data, we believe that multiple markets have a direct need for our PowerBuoys including oil and gas, ocean observing, defense and security, and communications. Depending on payload power requirements, sensor types and other considerations, we have found that our PowerBuoy could satisfy several application requirements within these markets. We believe that the PB3 persistently generates sufficient power to meet the requirements of many potential customer applications within our target markets.

 

Since fiscal 2002, government agencies have accounted for a significant portion of our revenues. These revenues were largely for the support of our development efforts relating to our technology. Today our goal is to generate the majority of our revenue from the sale or lease of our products, and sales of services to support our business operations. As we continue to develop and commercialize our products, we expect to have a net loss of cash from operating activities unless and until we achieve positive cash flow from the commercialization of our products and services. During fiscal 2017 and the first quarter of fiscal year 2018, we continued work on projects with the U.S. Department of Defense (“DOD”) and Mitsui Engineering and Shipbuilding Co., Ltd. (“MES”), while we continued to validate the reliability and power output of our PB3 PowerBuoy.

 

 

Product Development

 

The development of our technology has been funded by revenue generating projects, capital we raised, and by development engineering contracts we received starting in fiscal 1995, including projects with the DOE, the U.S. Navy, the Department of Homeland Security and MES.

 

Through these historic projects, we also continued development of our PowerBuoy technologies. We are continuing to focus on marketing and developing our PowerBuoy products and services for use in autonomous power applications. 

 

During fiscal 2017, we continued to focus on the commercialization of our PowerBuoy technology and our PB3 product in autonomous application markets. We completed our work under our DOE contract that focused on further optimization of our modular PTO technology and delivered the project final report to the DOE in the prior year. In the prior year, we successfully completed the final stage and associated review with the DOE of the contract deliverables during which the DOE reviewed advancements related to PTO design aspects such as reliability, cost take out, manufacturability and scalability. As we continued to focus on the development and validation of our PB3 PowerBuoy commercial product, our activities concentrated mainly on implementing all of our lessons learned during our efforts in the prior fiscal year from our ocean deployments and accelerated life testing (“ALT”). The resulting improved PB3 PowerBuoy was deployed off the coast of New Jersey in July of 2016 and was retrieved early December 2016 upon completing all intended testing and validation. Inspection and refurbishment of the PB3 PowerBuoy were completed and this PB3 was shipped for delivery to MES in Japan to fulfill the requirements of our lease with MES, including a deployment off of Kozushima Island in the Pacific Ocean. ALT of the PB3 commercial PTO is ongoing with no failures to date. In addition to the deployment of the PB3 PowerBuoy, the prior generation pre-commercial PB3 (“PB3-A1”), was fitted with a sensor that collects tagged marine mammal migration information as well as with a Self-Contained Ocean Observing Payload (“SCOOP”). The marine mammal migration detection sensor was attached to the PB3-A1 PowerBuoy as part of an agreed scope of work with the Wildlife Conservation Society (“WCS”) through a memorandum of agreement between WCS and OPT. The SCOOP payload was integrated into PB3-A1 to complete the Phase 1 work scope of a Cooperative Research and Development Agreement (“CRADA”) between the National Data Buoy Center (“NDBC”) and OPT. The PB3-A1, deployed off the coast of New Jersey in May 2016, was retrieved in October 2016. From July 2016 through October 2016, both PB3-A1 and PB3 were concurrently deployed generating valuable performance validation data. Both the NDBC SCOOP as well as the WCS tagged mammal migration detection sensor met all of their performance requirements. This pre-commercial PowerBuoy, referred to as “PB3-A1” has now undergone a full upgrade and has achieved full commercial status by retrofitting it with the final commercial PTO including our modular energy storage system, and to make it available to support our on-going commercialization efforts. In addition to the PB3 commercial product validation activities, a concerted effort has been underway which focuses on proactively implementing additional features driven by extensive and direct discussions with potential users and customers in our target markets. Such features include:

 

 

The design, development and implementation of a versatile mooring interface that allows the PB3 to accommodate various types of mooring configurations depending on the specifics and the needs of the customer, eliminating the need for a redesign to the device.

 

The design, development and implementation of a flexible power transmission system intended to support delivery of power and communication capabilities to customer payloads which are external to the PowerBuoy, and which may reside in the water column or on the seabed.

 

Additionally, and building upon our initial success in implementing an auto-ballast system in our commercial PB3, we further enhanced this feature in order to achieve faster and more cost effective PB3 deployments and retrievals.

 

Further, we are continuing the development of our PB15, the next scale-up of our autonomous PowerBuoy, which will provide higher peak power than our PB3. We completed the preliminary design of our PB15 in fiscal 2017. We are continuing to obtain market feedback on the value proposition of this design while at the same time advancing the commercialization of our PB3. While this scale-up leverages every aspect of the product development and validation of the PB3, it may also strategically position the product to allow OPT to respond to higher power needs as expressed by potential end-users and customers in our target markets.

 

As previously stated, the PB3 has achieved commercial status through a series of design iterations which focused on improving its reliability and survivability in the ocean environment. Though the PB3 will continue to undergo further enhancements through customary product life cycle management, we believe the PB3 has achieved a maturity level for immediate commercial use. We believe that the PB3 will generate and store sufficient power to address various application requirements in our target markets. Our product development and engineering efforts are focused, in part, on increasing the energy output and efficiency of our PowerBuoys and, if we are able to do so, we believe the PowerBuoy would be useful for additional applications where cost savings and additional power are required by our potential customers. We continue to explore opportunities in these target markets, and we have not yet finalized any product offerings in these potential markets. We believe that by increasing the energy output of our PowerBuoys we may be able to address larger segments of our target markets. By improving our design and manufacturing, we also seek to reduce the cost of our PowerBuoys through further design iterations and manufacturing ramp-up. In so doing, we seek to improve customer value, displace additional incumbent solutions, and become a viable power source for new applications in our target markets.

 

 

We also are continuing to work to develop solutions seeking to improve our products’ durability and reliability and to reduce their cost. For example, the redesigned PB3 leverages our knowledge base from past designs to incorporate new design features which we believe will improve its reliability and efficiency, including a redesigned PTO and a higher efficiency and higher voltage ESS. In July 2016, we deployed our first commercial PB3 PowerBuoy, off of the coast of New Jersey. This deployment was the final validation of the PB3 prior to the March 2017 six-month lease of the PB3 PowerBuoy under a previously announced customer agreement. In March 2017, our commercial PB3 was deployed off the coast of Kozushima Island in Japan as part of this lease, and continues to operate meeting all project requirements.

 

Commercial Activities

 

We are seeking to build strategic relationships with other companies that have developed or are developing in-ocean applications requiring a persistent source of power that is also capable of real time data collection, processing and communication, to address potential customer needs.

 

 

In 2016, we entered into a cooperative research and development agreement (“CRADA”) with the NDBC to conduct ocean demonstrations of its innovative Self-Contained Ocean Observing Payload (“SCOOP”) monitoring system integrated into our PB3-A1 PowerBuoy. NDBC operates a large network of buoys and stations which provide critical meteorological and oceanic observations that are utilized by government, industry, and academia throughout the world. Under the CRADA, an initial ocean demonstration was to be conducted off the coast of New Jersey. We integrated the SCOOP onto our PB3 PowerBuoy and in June 2016 we deployed the system off of the coast of New Jersey. Site-specific measurements of meteorological and ocean conditions, as well as system performance and maintenance data collection, were carried out. The SCOOP was powered by the PB3, and provided metocean data to OPT and to NDBC. The deployment proceeded for approximately three months and met all project objectives. We are continuing discussions with the NDBC around next steps.

 

 

In May 2016, we entered into a Memorandum of Agreement (“MOA”) with WCS to explore the use of our PowerBuoys in conjunction with ocean life monitoring sensors to collect ocean mammal migration data. The MOA includes the exploration and assessment of the use of the PB3 as an integration platform to provide power and communications to sensors that monitor marine life migrations. An initial effort consisting of a battery powered sensor mounted to the PB3-A1 was deployed off of the coast of New Jersey which sought to establish a baseline acoustic survey. The deployment proceeded for approximately three months and met all project objectives. We are continuing discussions with WCS around next steps.

 

 

In May, 2016 we entered into a contract with MES totaling nearly $1.0 million, a portion of which was performed in fiscal 2016 as agreed under a letter of intent signed in March 2016. The contract with MES includes certain engineering and other services, and a six-month lease of our PB3 PowerBuoy off the coast of Japan, which commenced in March 2017. This six-month lease has been extended an additional month, that will now go through September 2017, at which time this PB3 Powerbuoy will be recovered.

 

 

In September 2016, we entered into a contract with the U.S. Department of Defense Office of Naval Research (“ONR”) totaling approximately $0.2 million to carry out the first phase of a project which focuses on the initial concept design and development of a mass-on-spring PTO-based PowerBuoy leveraging a number of OPT patents covering such a technology. If successful, this device is expected to be able to respond to the unique set of requirements expected in various military marine applications. Overall, progress was made on the project whereby design and analysis tasks as well as a portion of the test were completed and documented. The Company requested two no-cost extensions to ONR in order to address some “infant mortality” findings on the life test portion of the testing effort associated with implementing improved sealing elements and improving test fixture alignment and the completion of the actual test.

 

 

In December 2016, we entered into a Joint Marketing Agreement with Sonalysts, Inc. to explore and pursue mutual opportunities in defense and oil and gas applications. The agreement includes the exploration and assessment of the use of the PB3 as a platform to provide power and communications for these markets. Founded in 1973, Sonalysts is a multi-disciplinary engineering and technical services firm with tremendous competency and expertise as systems integrator developing and supporting mission critical systems for the U.S. Navy Submarine Force.  Such applications include real-world mission and tactical analyses and electronic warfare, imaging and combat control systems.  Sonalysts’ core strengths also include developing and delivering interactive, computer-based training solutions, operations analysis, human systems integration solutions, and weather and aviation information processing and streaming systems.  Additionally, Sonalysts maintains core technology and expertise in undersea wireless communications and in autonomous undersea systems analysis which are available to a variety of defense and commercial customers. We believe that bringing the unique capabilities and expertise of our two companies together will enable the autonomous undersea vehicle infrastructure in these two critically important business sectors.

  

 

 

In February 2017, we entered into a Joint Application Development and Marketing Agreement with HAI Technologies to pursue mutual opportunities. The initial focus of the agreement is on offshore oil and gas subsea chemical injection systems where persistent power and real-time data communications are critical. HAI has experience in a variety of technologies and applications in the offshore oil and gas industry including subsea chemical systems.  Chemical injection techniques are used to mitigate the diminishing effects of buildup in piping and pumping systems used in subsea oil production operations. HAI has developed an innovative, compact and modular concept which moves the chemical injection system closer to the production field. We believe HAI Technologies’ advanced chemical injection solutions, combined with OPT’s PB3 PowerBuoy, creates a unique opportunity to pair two distinctive offshore technologies creating new methods to deal with long distance and remote offshore field developments. 

 

Capital Raises

 

On June 2, 2016, we entered into a securities purchase agreement, which was amended on June 7, 2016 (as amended, the “Purchase Agreement”) with certain institutional purchasers (the “June Purchasers”). Pursuant to the terms of the Purchase Agreement, we sold an aggregate of 417,000 shares of common stock together with warrants to purchase up to an aggregate of 145,952 shares of common stock. Each share of common stock was sold together with a warrant to purchase 0.35 of a share of common stock at a combined purchase price of $4.60. The net proceeds from the offering to us were approximately $1.7 million, after deducting placement agent fees and estimated offering expenses payable by us, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of $6.08 per share, will be exercisable on December 3, 2016, and will expire five years following the date of issuance.

 

On July 22, 2016, the Company entered into the Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain purchasers (the “July Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of 595,000 shares of Common Stock together with warrants to purchase up to an aggregate of 178,500 shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase 0.30 of a share of Common Stock at a combined purchase price of $6.75. The net proceeds to the Company from the offering were approximately $3.6 million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of $9.36 per share. The Warrants will expire on the fifth (5th) anniversary of the initial date of issuance.

 

On October 19, 2016, the Company sold 2,760,000 shares of common stock at a price of $2.75 per share, which includes the sale of 360,000 shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately $6.9 million, after deducting underwriter fees and offering expenses payable by the Company.

 

On May 2, 2017, the Company sold 6,192,750 shares of common stock at a price of $1.30 per share, which includes the sale of 807,750 shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately $7.2 million, after deducting underwriter fees and offering expenses payable by the Company.

 

The sale of additional equity or convertible securities could result in dilution to our stockholders. If additional funds are raised through the issuance of debt securities or preferred stock, these securities could have rights senior to those associated with our common stock and could contain covenants that would restrict our operations. We do not have any committed sources of debt or equity financing and we cannot assure you that financing will be available in amounts or on terms acceptable to us when needed, or at all. If we are unable to obtain required financing when needed, we may be required to reduce the scope of our operations, including our planned product development and marketing efforts, which could materially and adversely affect our financial condition and operating results. If we are unable to secure additional financing, we may be forced to cease our operations.  

 

 

Backlog

 

As of July 31, 2017, our negotiated backlog was $0.1 million. As of April 30, 2017, our negotiated backlog was $0.3 million. Our backlog can include both funded amounts, which are unfilled firm orders for our products and services for which funding has been both authorized and appropriated by the customer (U.S. Congress, in the case of U.S. Government agencies), and unfunded amounts, which are unfilled firm orders for which funding has not been appropriated. If any of our contracts were to be terminated, our backlog would be reduced by the expected value of the remaining terms of such contract. Our backlog was fully funded at July 31, 2017.

 

The amount of contract backlog is not necessarily indicative of future revenue because modifications to, or terminations of present contracts and production delays can provide additional revenue or reduce anticipated revenue. A substantial portion of our revenue has been for the support of our product development efforts. These revenues are recognized using the percentage-of-completion method, and changes in estimates from time to time may have a significant effect on revenue and backlog. Our backlog is also typically subject to large variations from time to time due to the timing of new awards.

 

Business Strategy 

 

We continue to commercialize our PB3 PowerBuoy for use in remote offshore power and real-time data communications applications, and in order to achieve this goal, we are pursuing the following business objectives:

 

 

Sell and/or lease PB3 PowerBuoys. We believe our PB3 PowerBuoy is well suited for many remote offshore applications. We have observed potential market demand for both PowerBuoy sales and leases within our selected markets, and we intend to sell and lease PB3 PowerBuoys to these markets. Additionally, we intend to provide services associated with product sales and leases such as maintenance, remote monitoring and diagnostic, application engineering, planning, training, and logistics support required for the PB3 PowerBuoy life-cycle. We continue to increase our commercial capabilities through new hires in marketing, sales, and application support, and through engagement of expert market consultants in various geographies.

 

 

Concentrate sales and marketing efforts in specific geographic markets. We are currently focusing our marketing efforts in North America, Europe, Australia, and parts of Asia, including Japan. We believe that each of these areas has sizable end market opportunities, political and economic stability, and high levels of industrialization and economic development.

 

 

Expand our relationships in key market areas through strategic partnerships and collaborations.  We believe that strategic partners are an important part of commercializing a new product. Partnerships and collaborations can be used to improve the development of overall integrated solutions, to create new market channels, to expand commercial know-how and geographic footprint, and to bolster our product delivery capabilities.

       
   

Commercial collaborations. We believe that an important element of our business strategy is to collaborate with other organizations to leverage our combined expertise, market presence and access, and core competences across key markets. We have formed such a relationship with several well-known groups, including MES in Japan, the National Data Buoy Center (“NDBC”), the Wildlife Conservation Society (“WCS”), Gardline Environmental (an international and multi-disciplinary marine service company), Sonalysts (with expertise in subsea and surface communications, systems integration, and big-data management), and HAI Technologies (an innovative company focusing on bringing new capabilities to the oil and gas industry). We continue to seek other opportunities to collaborate with application experts from within our selected markets.

       
    Outsourcing of fabrication, deployment and service support. We outsource all fabrication, anchoring, mooring, cabling supply, and in most cases deployment of our PowerBuoy in order to minimize our capital requirements as we scale our business. Our PTO is a proprietary subsystem and is assembled and tested at our facility. We believe this distributed manufacturing and assembly approach enables us to focus on our core competencies ensure a cost-effective product by leveraging a larger more established supply base. We also continue to seek strategic partnerships with regards to servicing of our PB3 PowerBuoy.

 

 

PB3 cost reduction and PowerBuoy product development.  Our engineering efforts are focused on customer application development for PB3 sales, cost reduction of our PB3 PowerBuoy and improving the energy output, reliability, maintenance interval and expected operating life of our PowerBuoys. We continue to optimize manufacturability of our designs with a focus on cost competitiveness, and we believe that we will be able to address new and different applications by developing new products that increase energy output.

  

 

Going Concern 

 

Our financial statements have been prepared assuming we will continue as a going concern. We have experienced substantial and recurring losses from operations, which losses have caused an accumulated deficit of $190.0 million at July 31, 2017. Based on the Company’s cash and cash equivalents and marketable securities balances as of July 31, 2017 the Company believes that it will be able to finance its capital requirements and operations into the quarter ending July 31, 2018.

 

The report of our independent registered public accounting firm on our consolidated financial statements filed with our Annual Report on Form 10-K for the year ended April 30, 2017, contains an explanatory paragraph regarding our ability to continue as a going concern, based on, among other factors, that our ability to continue as a going concern is dependent upon our ability to raise additional external capital and increase revenues. These factors, among others, raise substantial doubt about our ability to continue as a going concern. Our consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. We cannot assure you that we will be successful in our efforts to generate revenues, become profitable, raise additional outside capital or to continue as a going concern. If we are not successful in our efforts to raise additional capital sufficient to support our operations, we would be forced to cease operations, in which event investors would lose their entire investment in our company.

 

 Critical Accounting Policies and Estimates

 

To understand our financial statements, it is important to understand our critical accounting policies and estimates. We prepare our financial statements in accordance with generally accepted accounting principles, or “GAAP”. The preparation of financial statements also requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. We believe that the accounting policies are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.

 

For a discussion of our critical accounting estimates, see the section entitled Item 7.- “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended April 30, 2017. There were no material changes in our critical accounting estimates or accounting policies during the three months ended July 31, 2017.

 

Recently Issued Accounting Standards

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The FASB subsequently issued additional clarifying standards to address issues arising from implementation of the new revenue standard, including a one-year deferral of the effective date for the new revenue standard. Public companies should now apply the guidance in ASU 2014-09 to annual reporting periods beginning after December 15, 2017 and interim periods within those annual periods. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim periods within that annual period. As such, the Company is required to adopt this standard effective in fiscal 2019, which begins May 1, 2018. Companies may use either a full retrospective or a modified retrospective approach to adopt ASU 2014-09. The Company has not yet completed its final review of the impact of this guidance; however the Company anticipates applying the modified retrospective method upon adoption of ASU 2014-09 on May 1, 2018. The impact to the Company could be affected by the nature and terms of potential future contracts with customers, as those contracts may have terms that differ from the Company’s current contracts.

 

In August 2014, the FASB issued ASU 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the first annual period ending after December 15, 2016, and interim periods thereafter. Early application is permitted. The Company adopted ASU 2014-15 for the fiscal year 2017. The Company’s addition of the standard did not have a material impact on its disclosures. See section (c) “Liquidity/Going Concern” within Note (1) “Background and Liquidity” of the consolidated financial statements included in this Quarterly Report on Form 10-Q for further discussion on the Company’s ability to continue as a going concern.

 

 

In January 2016, the FASB issued ASU No. 2016-01, “Recognition and Measurement of Financial Assets and Financial Liabilities”, which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company will evaluate the effect of ASU 2016-01 for future periods as applicable.

 

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842).” The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for annual periods beginning after December 15, 2018, including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU 2016-02 will have on its consolidated financial statements and disclosures and has not yet determined the effect of the standard on its ongoing financial reporting at this time.

 

In March 2016, the FASB issued ASU No. 2016-09, “Compensation - Stock Compensation (Topic 718). The amendments of ASU No. 2016-09 were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity may be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including accounting for forfeitures, income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU No. 2016-09 is effective for fiscal years beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted ASU 2016-09 on May 1, 2017. Certain of the amendments are applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of May 1, 2017, while other amendments are applied retrospectively, prospectively or using either a prospective or a retrospective transition method. Upon adoption, the Company is beginning to account for forfeitures as they occur rather than estimate a forfeiture rate and has recorded a cumulative-effect adjustment in equity of approximately $10,000 on the date of initial adoption. In periods subsequent to adoption, a higher expense will be recognized earlier during the respective vesting periods of stock-based awards that are not forfeited. The Company expects that the income tax amendments within ASU 2016-09 will have no impact on its results of operations or cash flows because it is in a net operating loss position with a full valuation allowance.

 

In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments”, providing additional guidance on eight specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years and early adoption is permitted. The Company has evaluated the effect ASU 2016-13 will have on its consolidated financial statements and disclosures and has determined the standard will have no impact on its ongoing financial reporting at this time.

 

In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash”, which amends guidance and presentation related to restricted cash in the statement of cash flows, including stating that amounts generally described as restricted cash and restricted cash equivalents should be included within cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. An entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years and early adoption is permitted. The Company has early adopted ASU 2016-18 effective May 1, 2017. In connection with the adoption of the standard the Company has used a retrospective transition method for each period presented in the statement of cash flows. The Company reclassified $488,000 and $300,000 of restricted cash to cash, cash equivalents and restricted cash, beginning of period for the period April 30, 2017 and April 30, 2016 in the statement of cash flows. The Company reclassified $266,000 of restricted cash to cash, cash equivalents and restricted cash, end of period for the period ended July 31, 2016 in the statement of cash flows.

 

 

Financial Operations Overview

 

The following describes certain line items in our statement of operations and some of the factors that affect our operating results.

 

Revenues

 

The Company’s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.

 

 

The Company has two types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of zero. The Company’s share of the costs is recorded as product development expense.

 

Generally, revenue under fixed price or cost plus contracts is recognized using the percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria may be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.

 

In addition, recognition of revenue (and the related costs) may be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management may make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects may have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.

 

The following table provides information regarding the breakdown of our revenues by customer for the three months ended July 31, 2017 and 2016. 

 

   

Three months ended July 31,

 
   

2017

   

2016

 
   

(in thousands)

 
                 

Mitsui Engineering & Shipbuilding

  $ 131     $ 202  

U.S. Department of Defense Office of Naval Research

    64       -  
    $ 195     $ 202  

 

We currently focus our sales and marketing efforts on North America, Europe, Australia and Japan. The following table shows the percentage of our revenues by geographical location of our customers for the three months ended July 31, 2017 and 2016.

 

   

Three months ended July 31,

 

Customer Location

 

2017

   

2016

 
                 

Asia and Australia

    67 %     100 %

United States

    33 %     -  
      100 %     100 %

 

  Cost of revenues

 

Our cost of revenues consists primarily of incurred material, labor and manufacturing overhead expenses, such as engineering expense, equipment depreciation and maintenance and facility related expenses, and includes the cost of PowerBuoy parts and services supplied by third-party suppliers. Cost of revenues also includes PowerBuoy system delivery and deployment expenses and may include anticipated losses at completion on certain contracts.

 

Our ability to generate a gross profit will depend on the nature of future contracts, our success at generating revenues through sales or leases of our PowerBuoy systems, the nature of our contracts generating revenues to fund our product development efforts, and our ability to manage costs incurred on fixed price commercial contracts.

 

 

Product development costs

 

Our product development costs consist of salaries and other personnel-related costs and the costs of products, materials and outside services used in our product development and unfunded research activities. Our product development costs relate primarily to our efforts to increase the power output and reliability of our PowerBuoy system, and to the development of new products, product applications and complementary technologies. We expense all of our product development costs as incurred.

 

Selling, general and administrative costs

 

Our selling, general and administrative costs consist primarily of professional fees, salaries and other personnel-related costs for employees and consultants engaged in sales and marketing and support of our PowerBuoy systems and costs for executive, accounting and administrative personnel, professional fees and other general corporate expenses.

 

Fair Value of Financial Instruments

 

The fair value of our financial instruments reflects the amounts that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value of our warrant liabilities are subject to remeasurement each financial statement reporting period, as such, changes in this fair value are reflected in the statement of operations.

 

Our financial instruments not required to be adjusted to fair value on a recurring basis consist principally of cash and restricted cash, accounts receivable, accounts payable, and accrued expenses. We believe the carrying amount of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to their relatively short maturities.

 

Interest income, net

 

Interest income, net consists of interest received on cash and cash equivalents, investments in commercial bank-issued certificates of deposit and US Treasury bills and notes and interest expense paid on certain obligations to third parties.  

 

Foreign exchange gain (loss)

 

We transact business in various countries and have exposure to fluctuations in foreign currency exchange rates. Foreign exchange gains and losses arise in the translation of foreign-denominated assets and liabilities, which may result in realized and unrealized gains or losses from exchange rate fluctuations. Since we conduct our business in US dollars and our functional currency is the US dollar, our main foreign exchange exposure, if any, results from changes in the exchange rate between the US dollar and the British pound sterling, the Euro and the Australian dollar. Due to the macroeconomic pressures in certain European countries, foreign exchange rates may become more volatile in the future.

 

We may invest our foreign cash reserves in certificates of deposit and we maintain cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These foreign-denominated certificates of deposit and cash accounts had a balance of $1.2 million as of July 31, 2017 and $1.2 million as of July 31, 2016, compared to our total cash, cash equivalents, restricted cash, and marketable securities balances of $12.0 million as of July 31, 2017 and $9.4 million as of July 31, 2016. These foreign currency balances are translated at each month and to our functional currency, the US dollar, and any resulting gain or loss is recognized in our results of operations.

 

In addition, a portion of our operations is conducted through our subsidiaries in countries other than the United States, specifically Ocean Power Technologies Ltd. in the United Kingdom, the functional currency of which is the British pound sterling, and Ocean Power Technologies (Australasia) Pty Ltd. in Australia, the functional currency of which is the Australian dollar. Both of these subsidiaries have foreign exchange exposure that results from changes in the exchange rate between their functional currency and other foreign currencies in which they conduct business. All of our international revenues during the three months ended July 31, 2017 and 2016 were recorded in Euros or British pounds sterling.

 

We currently do not hedge our exchange rate exposure. However, we assess the anticipated foreign currency working capital requirements and capital asset acquisitions of our foreign operations and attempt to maintain a portion of our cash, cash equivalents and marketable securities denominated in foreign currencies sufficient to satisfy these anticipated requirements. We also assess the need and cost to utilize financial instruments to hedge currency exposures on an ongoing basis and may hedge against exchange rate exposure in the future.

 

 

Results of Operations

 

This section should be read in conjunction with the discussion below under “Liquidity and Capital Resources.”

 

Three months ended July 31, 2017 compared to the three months ended July 31, 2016

 

The following table contains selected statement of operations information, which serves as the basis of the discussion of our results of operations for the three months ended July 31, 2017 and 2016.

  

                   

% change

 
   

Three months ended July 31,

   

2017 period to

 
   

2017

   

2016

   

2016 period

 
   

(in thousands)

         
                         

Revenues

  $ 195     $ 202       -3 %

Cost of revenues

    217       127       71 %

Gross profit (loss)

    (22 )     75          

Operating expenses:

                       

Product development costs

    1,102       1,636       -33 %

Selling, general and administrative costs

    1,641       1,519       8 %

Total operating expenses

    2,743       3,155          

Operating loss

    (2,765 )     (3,080 )        

Change in fair value of warrant liabilities

    37       (752 )     -105 %

Interest income, net

    3       -       100 %

Foreign exchange gain

    62       5       1140 %

Net loss

  $ (2,663 )   $ (3,827 )     -30 %

 

Revenues

 

Revenues during the three months ended July 31, 2017 were relatively flat as compared to the three months ended July 31, 2016. Revenue for the first quarter of fiscal year 2018 came from contracts with MES and ONR, while revenue for first quarter of fiscal year 2017 came from the contract with MES.

 

Cost of revenues

 

Cost of revenues for the three months ended July 31, 2017 and 2016 were $0.2 million and $0.1 million, respectively. The increase of approximately $0.1 million, or 71%, over 2016 is due to the $0.1 million increase in the reserve for future project costs on the ONR project.

  

Product development costs

 

Product development costs during the three months ended July 31, 2017 were $1.1 million and $1.6 million, respectively. The decrease of approximately $0.5 million, or 33%, over 2016 is due to a delayed start of new projects in 2017.

 

Selling, general and administrative costs

 

Selling, general and administrative costs during the three months ended July 31, 2017 and 2016 were $1.6 million and $1.5 million, respectively. The increase of $0.1 million, or 8%, over 2016, is due to higher employee costs and consulting fees of $0.1 million.

  

Change in fair value of warrant liabilities

 

The change in fair value of warrant liabilities during the three months ended July 31, 2017 was an unrealized gain of $37,000 versus an unrealized loss of $752,000 for the three months ended July 31, 2016.The change between periods is due to a higher risk-free rate, lower expected life and higher expected volatility assumptions for the three months ended July 31, 2017.

  

Interest income, net

 

Interest income, net during the three months ended July 31, 2017 was $3,000, an increase of $3,000 as compared to the three months ended July 31, 2016.

 

Foreign exchange gain

 

Foreign exchange gain during the three months ended July 31, 2017 was $62,000, an increase of $57,000 as compared to a gain of $5,000 during the three months ended July 31, 2016. The difference was attributable primarily to the relative change in value of the British pound sterling, Euro and Australian dollar compared to the US dollar during the two periods.

 

 Liquidity and Capital Resources

 

Since our inception, the cash flows from customer revenues have not been sufficient to fund our operations and provide the capital resources for the planned growth of our business. For the two years ended April 30, 2017, our aggregate revenues were $1.5 million, our aggregate net losses were $22.6 million and our aggregate net cash used in operating activities was $21.0 million. Refer to “Liquidity Outlook” below for additional information. 

 

 

Net cash used in operating activities

 

Net cash flows used in operating activities during the three months ended July 31, 2017 were $4.2 million, an increase of $1.3 million compared to $2.9 million during the three months ended July 31, 2016. The increase was primarily related to a reduction of $2.4 million in accounts payable and accrued expenses balances partially offset by a lower net loss of $1.2 million for the three months ended July 31, 2017 compared to the same period in 2016.

 

Net cash used in investing activities

 

Net cash used in investing activities during the three months ended July 31, 2017 and 2016 was $12,000 and $30,000, respectively. The improvement in net cash used in investing activities was primarily due to the decrease in the balance of marketable securities in 2017. 

 

Net cash provided by financing activities

 

Net cash provided by financing activities during the three months ended July 31, 2017 and 2016 was $7.2 million and $5.2 million, respectively, due to the fact that the capital raise in 2017 exceeded the 2016 capital raises by $2.0 million.

 

Effect of exchange rates on cash and cash equivalents

 

The effect of exchange rates on cash and cash equivalents was an increase of $90,000 in the three months ended July 31, 2017 and a decrease of $13,000 in the three months ended for July 31, 2016. The effect of exchange rates on cash and cash equivalents results primarily from gains or losses on consolidation of foreign subsidiaries and foreign denominated cash and cash equivalents.

 

Liquidity Outlook

 

Our financial statements have been prepared assuming we will continue as a going concern. We have experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of $190.0 million at July 31, 2017. As of July 31, 2017, we had approximately $11.4 million in cash on hand. In addition, as of July 31, 2017, our restricted cash balance was approximately $0.5 million. The Company generated revenues of $0.2 million during each of the three months ended July 31, 2017 and 2016. Based on the Company’s cash and cash equivalents and marketable securities balances as of July 31, 2017, the Company believes that it will be able to finance its capital requirements and operations into the quarter ending July 31, 2018. These conditions raise substantial doubt about our ability to continue as a going concern.

 

We expect to devote substantial resources to continue our development efforts for our PowerBuoys and to expand our sales, marketing and manufacturing programs associated with the planned commercialization of the PowerBuoys. Our future capital requirements will depend on a number of factors, including but not limited to:

 

 

our ability to commercialize our PowerBuoys, and achieve and sustain profitability;

 

 

our continued development of our proprietary technologies, and expected continued use of cash from operating activities unless or until we achieve positive cash flow from the commercialization of our products and services;

 

 

our ability to obtain additional funding, as and if needed which will be subject to a number of factors, including market conditions, and our operating performance;

 

 

our estimates regarding expenses, future revenues and capital requirements;

 

 

the adequacy of our cash balances and our need for additional financings;

 

 

our ability to develop and manufacture a commercially viable PowerBuoy product;

 

 

that we will be successful in our efforts to commercialize our PowerBuoy or the timetable upon which commercialization can be achieved, if at all;

 

 

our ability to identify and penetrate markets for our PowerBuoys and our wave energy technology;

 

 

our ability to implement our commercialization strategy as planned, or at all;

  

 

 

our ability to maintain the listing of our common stock on the NASDAQ Capital Market;

 

 

the reliability of our technology and our PowerBuoys;

 

 

our ability to improve the power output, survivability and reliability of our PowerBuoys;

 

 

the impact of pending and threatened litigation on our business, financial condition and liquidity;

 

 

changes in current legislation, regulations and economic conditions that affect the demand for renewable energy;

 

 

our ability to compete effectively in our target markets;

 

 

 

our limited operating history and history of operating losses;

 

 

our sales and marketing capabilities and strategy in the United States and internationally; and

 

 

our ability to protect our intellectual property portfolio.

 

Our business is capital intensive and, to date, we have been funding our business principally through sales of our securities, and we expect to continue to fund our business with sales of our securities and, to a limited extent, with our revenues until, if ever, we generate sufficient cash flow to internally fund our business. This is largely a result of the high product development costs associated with our product development. We may choose to reduce our operating expenses through personnel reductions, and reductions in our research and development and other operating costs during the remainder of fiscal year 2018, if we are not successful in our efforts to raise additional capital. We cannot assure you that we will be able to increase our revenues and cash flow to a level which would support our operations and provide sufficient funds to pay our obligations for the foreseeable future. Further, we cannot assure you that we will be able to secure additional financing or raise additional capital or, if we are successful in our efforts to raise additional capital, of the terms and conditions upon which any such financing would be extended. If we are unable to raise additional capital when needed or generate positive cash flow, it is unlikely that we will be able to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

 Off-Balance Sheet Arrangements

 

Since inception, we have not engaged in any off-balance sheet financing activities.

 

Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

Item 4.

CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of July 31, 2017 pursuant to Rules 13a-15(b) or 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s (“SEC”) rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Exchange Act is accumulated and communicated to our management, as appropriate, to allow timely decisions regarding required disclosure. Based on such evaluation, management concluded that our disclosure controls and procedures were effective as of July 31, 2017 to ensure that non-financial statement and related disclosure information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.   

 

Changes in Internal Control over Financial Reporting

 

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fiscal quarter ended July 31, 2017 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II — OTHER INFORMATION

 

Item 1.

LEGAL PROCEEDINGS

 

Shareholder Litigation and Demands 

 

The Company and certain of its current and former directors and officers are defendants in a derivative lawsuit filed on March 18, 2015 in the United States District Court for the District of New Jersey captioned Labare v. Dunleavy, et. al., Case No. 3:15-cv-01980-FLW-LHG. The derivative complaint alleges claims for breach of fiduciary duty, abuse of control, gross mismanagement and unjust enrichment relating to the now terminated agreement between Victorian Wave Partners Pty. Ltd. (VWP) and the Australian Renewable Energy Agency (ARENA) for the development of a wave power station. The derivative complaint seeks unspecified monetary damages and other relief.

 

On July 10, 2015, a second derivative lawsuit, captioned Rywolt v. Dunleavy, et al., Case No. 3:15-cv-05469, was filed by another shareholder against the same defendants in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, gross mismanagement, abuse of control, and unjust enrichment relating to the now terminated agreement between VWP and ARENA. The Rywolt complaint also seeks unspecified monetary damages and other relief. On February 8, 2016, the Court issued an order consolidating the Labare and Rywolt actions, appointing co-lead plaintiffs and lead counsel, and ordering a consolidated amended complaint to be filed within 30 days of the order. On March 9, 2016, the co-lead plaintiffs filed an amended complaint consolidating their claims and seeking unspecified monetary damages and other relief.

 

On April 21, 2016, a third derivative lawsuit, captioned LaCalamito v. Dunleavy, et al., Case No. 3:16-cv-02249, was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty relating to the now terminated agreement between VWP and ARENA. The LaCalamito complaint seeks unspecified monetary damages and other relief. The Company has not been formally served and has not yet responded to the complaint.

 

On June 9, 2016, a fourth derivative lawsuit, captioned Pucillo v. Dunleavy, et al., was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, unjust enrichment, and abuse of control relating to the now terminated agreement between VWP and ARENA. The Pucillo complaint seeks unspecified monetary damages and other relief. On August 2, 2016, the parties in the Pucillo lawsuit filed a Stipulation and Proposed Order pursuant to which: (i) the defendants agreed to accept service of the Pucillo complaint; (ii) the parties agreed to stay the Pucillo action pending the filing and resolution of a motion to consolidate the Pucillo action with the Labare and Rywolt actions; and (iii) the parties agreed that the defendants shall not be required to respond to the Pucillo complaint during the pendency of the stay. The Court approved the Stipulation on August 3, 2016.

 

On October 25, 2016, the Court approved and entered a Stipulation and Order that, among other things, (i) consolidated the four derivative actions; (ii) identified plaintiff Pucillo as the lead plaintiff in the consolidated actions; and (iii) stayed the consolidated actions pending the settlement hearing scheduled for November 14, 2016 in the securities class action and further order of the Court. During the month of August, 2017, the Company tentatively reached a settlement with the plaintiff subject to final documentation. The settlement, once finalized and if approved by the court, provides, among other things, for a settlement payment by or on behalf of the Company of $350,000, of which the Company’s insurer would pay the complete amount of $350,000. As a result, the Company has accrued $350,000 related to this matter as a probable and reasonably estimable loss contingency during the three months ended July 31, 2017. The Company also recorded a receivable of $350,000 from its insurance carrier with the offset to the statement of operations.

  

On May 26, 2017, an attorney claiming to represent two stockholders sent the Company’s Board of Directors a Stockholder Litigation Demand letter (“Stockholder Demand”). The Stockholder Demand alleges that the voting of shares for the 1-for-10 reverse stock split at the 2015 annual meeting of stockholders held on October 22, 2015 was not properly counted, and further alleges that, although the Company reported the reverse stock split as having been passed, if the vote was properly counted the reverse stock split would not have been approved. The Stockholder Demand requests the Board of Directors either to deem the reverse stock split as ineffective and disclose the same or to seek a proper and effective stockholder ratification of the reverse stock split. In addition, the Stockholder Demand requests the Board of Directors to adopt and implement adequate internal controls and systems to prevent the alleged improper voting from recurring. On June 23, 2017, the Company responded to the Stockholder Demand, explained the procedures that were followed for the 2015 annual meeting of stockholders and provided the Oath of the Inspector of Elections and the Certificate of the Inspector of Elections that certified as accurate the results of the voting at the meeting including voting on the reverse stock split proposal. On June 26, 2017, the attorney representing the alleged stockholders replied to the Company’s response, further alleged that the proxy statement underlying the 2015 annual meeting provided voting instructions that misled the stockholders regarding whether their brokers could vote on the reverse stock split proposal, and renewed their requests of the Board. On July 24, 2017, the Company provided an additional response to the Stockholders Demand, denied the allegations, and declined to take any of the actions requested.

 

 

Employment Litigation

 

On June 10, 2014, the Company announced that it had terminated Charles Dunleavy as its Chief Executive Officer and as an employee of the Company for cause, effective June 9, 2014, and that Mr. Dunleavy had also been removed from his position as Chairman of the Board of Directors. On June 17, 2014, Mr. Dunleavy wrote to the Company stating that he had retained counsel to represent him in connection with an alleged wrongful termination of his employment. On July 28, 2014, Mr. Dunleavy resigned from the Board and the boards of directors of the Company's subsidiaries. The Company and Mr. Dunleavy have agreed to suspend his alleged employment claims pending resolution of the shareholder litigation, and have since agreed to continue the suspension pending resolution of the derivatives litigation.

 

Except for the pending settlement noted previously, we have not established any provision for losses relating to these claims and pending litigation. Due to the stages of these proceedings, and considering the inherent uncertainty of these claims and litigation, at this time we are not able to predict or reasonably estimate whether we have any possible loss exposure or the ultimate outcome of these claims.

 

(b) Regulatory Matters

 

SEC Investigation

 

On February 4, 2015, the Company received a subpoena from the SEC requesting information related to the VWP Project. The Company has provided information to the SEC in response to that subpoena. As part of the same investigation, on July 12, 2016, the SEC issued second subpoena requesting information related to the Company’s April 4, 2014 public offering. The Company has provided information to the SEC in response to that subpoena. The SEC investigation is ongoing and the Company continues to cooperate with the SEC in its investigation. We are unable to predict what action, if any, might be taken by the SEC or its staff as a result of this investigation or what impact, if any, the cost of responding to the SEC’s investigation or its ultimate outcome might have on our financial position, results of operations or liquidity. We have not established any provision for losses relating to this matter.

 

Spain IVA (sales tax)

 

In June 2012, the Company received notice that the Spanish tax authorities are inquiring into its 2010 IVA (value-added tax) filing for which the Company benefitted from the offset of approximately $0.3 million of input tax. The Company believes that the inquiry will find that the tax credit was properly claimed and, therefore, no liability has been recorded. The Company issued two letters of credit in the amount of €0.3 million ($0.3 million) at the request of the Spanish tax authorities. On January 31, 2017 the Company has received $0.2 million from the Spanish Tax authorities as a result of the conclusion of the inquiry. In addition, during February 2017, the Spanish tax authorities approved of the release of the two outstanding letters of credit.

 

Spain Income Tax Audit

 

The Company is currently undergoing an income tax audit in Spain for the period from 2008 to 2014, when its Spanish branch was closed. The branch reported net operating losses for each of the years reported. It is anticipated that the Company will be assessed a penalty relating to these tax years for these losses. The Company has estimated this penalty to be $132,000, and as such, for the period ended April 30, 2017 and July 31, 2017, has recorded $132,000 for this penalty to Selling, general and administrative costs in its statement of operations.  

  

Item 1A.

RISK FACTORS

 

The discussion of our business and operations should be read together with the risk factors contained in Item 1A of our Annual Report on Form 10-K for the year ended April 30, 2017 and set forth below in this Quarterly Report on Form 10-Q. These risk factors describe various risks and uncertainties to which we are or may become subject. These risks and uncertainties have the potential to affect our business, financial condition, results of operations, cash flows, strategies or prospects in a material and adverse manner. There has been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K filed with the SEC on July 14, 2017.

 

Our auditors have raised substantial doubts as to our ability to continue as a going concern.

 

Our financial statements have been prepared assuming we will continue as a going concern. Due to the significant product development costs associated with our business and operations, we have experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of $190.0 million as of July 31, 2017. As of July 31, 2017, the Company had approximately $11.4 million in cash on hand. The Company generated revenues of $0.2 million during each of the three months ended July 31, 2017 and 2016. Based on the Company’s cash and cash equivalents and marketable securities balances as of July 31, 2017, the Company believes that it will be able to finance its capital requirements and operations into the quarter ending July 31, 2018.

 

 

We continue to experience operating losses and currently have only two revenue producing contracts. We continue to experience operating losses and currently have two revenue producing contracts. The first is an agreement with MES (the “MES Agreement”) to, among other things, lease and deploy our PB3 PowerBuoy off Kozushima Island, Japan and to provide certain engineering and other services. The total value of the lease and other services to be provided by us under the MES Agreement is $1.0 million. The term of the lease commenced in March 2017, and the term of the MES Agreement extends through September 2017. The second contract is with ONR totaling approximately $0.2 million to carry out the first phase of a project which focuses on the initial concept design and development of a mass-on-spring PTO-based PowerBuoy leveraging a number of OPT patents covering such a technology. During fiscal 2017, our net burn rate (cash used in operations less cash generated by operations) including product development spending was approximately $900,000 per month.

 

We have been funding our business principally through sales of our securities, and we expect to continue to fund our business with sales of our securities and, to a limited extent, with our revenues until, if ever, we generate sufficient cash flow to internally fund our business. These factors, among others, raise substantial doubt about our ability to continue as a going concern. Our consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. We anticipate that our operating expenses will be approximately $12.3 million in fiscal 2018 including product development spending of more than $5.5 million. However, we may choose to reduce our operating expenses through personnel reductions, and reductions in our research and development and other operating costs during fiscal year 2018, if we are not successful in our efforts to raise additional capital. We cannot assure you that we will be able to increase our revenues and cash flow to a level which would support our operations and provide sufficient funds to pay our obligations for the foreseeable future. Further, we cannot assure you that we will be able to secure additional financing or raise additional capital or, if we are successful in our efforts to raise additional capital, of the terms and conditions upon which any such financing would be extended. If we are unable to meet our obligations, we would be forced to cease operations, in which event investors would lose their entire investment in our company.

 

We have a history of operating losses and may not achieve or maintain profitability and positive cash flow. 

 

We have incurred net losses since we began operations in 1994, including net losses attributable to Ocean Power Technologies, Inc. of $2.7 million during the three months ended July 31, 2017 and $9.5 million in fiscal 2017. As of July 31, 2017, we had an accumulated deficit of $190.0 million. To date, our activities have consisted primarily of activities related to the development and testing of our technologies and our PowerBuoy. Thus, our losses to date have resulted primarily from costs incurred in our research and development programs and from our selling, general and administrative costs. As we continue to develop our proprietary technologies, we expect to continue to have a net use of cash from operating activities unless or until we achieve positive cash flow from the commercialization of our products and services. 

 

We do not know whether we will be able to successfully commercialize our PowerBuoys, or whether we can achieve profitability. There is significant uncertainty about our ability to successfully commercialize our PowerBuoys in our targeted markets. Even if we do achieve commercialization of our PowerBuoy and become profitable, we may not be able to achieve or, if achieved, sustain profitability on a quarterly or annual basis. 

 

 

Item 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

The following table details the Company’s share repurchases during the quarter:  

 

Period

 

Total Number of

Shares Purchased (1)

   

Average Price

Paid per Share

   

Total Number of

Shares Purchased

as Part of Publicly

Announced Plans

   

Approximate Dollar

Value of Shares

that May Yet Be

Purchased Under

the Plan

 
                                     

May 1 - May 31

    22,016     $ 1.47       -       -  

June 1 - June 30

    -     $ -       -       -  

July 1 - July 31

    -     $ -       -       -  
 

 

(1)

Represents shares delivered back to the Company by employees to pay taxes related to the vesting of restricted shares.

 

Item 3.

DEFAULTS UPON SENIOR SECURITIES

 

None.

 

Item 4.

MINE SAFETY DISCLOSURES

 

Not applicable.

 

Item 5.

OTHER INFORMATION

 

None.

 

 

Item 6.

 

EXHIBITS

 

 

 

31.1

 

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

31.2

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.2

*

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

101

 

The following financial information from Ocean Power Technologies, Inc.'s Quarterly Report on Form 10-Q for the quarter ended July 31, 2017, formatted in eXtensible Business Reporting Language (XBRL): (i) Consolidated Balance Sheets – July 31, 2017 (unaudited) and April 30, 2016, (ii) Consolidated Statements of Operations (unaudited) – Three months ended July 31, 2017 and 2016, (iii) Consolidated Statements of Comprehensive Loss (unaudited) – Three months ended July 31, 2017 and 2016, (iv) Consolidated Statements of Cash Flows (unaudited) –Three months ended July 31, 2017 and 2016, (v) Consolidated Statement of Stockholders’ Equity (unaudited) – Three months ended July 31, 2017 (vi) Notes to Consolidated Financial Statements.**

 

 

 

 

 

* As provided in Item 601(b)(32)(ii) of Regulation S-K, this exhibit shall not be deemed to be “filed” or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liability under those sections. 

 

 

 

 

 

** As provided in Rule 406T of Regulation S-T, this exhibit shall not be deemed “filed” or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liability under those sections.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

  Ocean Power Technologies, Inc.

 

 

  (Registrant)

 

 

 

 

 

 

 

 

 

Date: September 7, 2017

 

/s/ George H. Kirby III

 

 

By:

George H. Kirby III

 

 

 

President and Chief Executive Officer

 

       
       
Date: September 7, 2017   /s/ Matthew T. Shafer  
  By: Matthew T. Shafer  
    Chief Financial Officer  

 

 

40

EX-31.1 2 ex31-1.htm EXHIBIT 31.1 ex31-1.htm

 

Exhibit 31.1 

 

CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT

 

I, George H. Kirby III, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Ocean Power Technologies, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

 

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or other persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Date: September 7, 2017

 

 

 

 

 

 

/s/ George H. Kirby III

 

 

George H. Kirby III

 

 

President and Chief Executive Officer

 

 

EX-31.2 3 ex31-2.htm EXHIBIT 31.2 ex31-2.htm

 

Exhibit 31.2

  

CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT

 

I, Matthew T. Shafer, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Ocean Power Technologies, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

 

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or other persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Date: September 7, 2017

 

 

 

 

 

 

/s/ Matthew T. Shafer

 

 

Matthew T. Shafer

 

 

Chief Financial Officer

 

 

EX-32.1 4 ex32-1.htm EXHIBIT 32.1 ex32-1.htm

 

Exhibit 32.1

  

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Ocean Power Technologies, Inc. (the "Company") for the period ended July 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, George H. Kirby III, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: September 7, 2017

 

 

 

 

 

 

/s/ George H. Kirby III

 

 

George H. Kirby III

 

 

President and Chief Executive Officer

 

  

 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-32.2 5 ex32-2.htm EXHIBIT 32.2 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Ocean Power Technologies, Inc. (the "Company") for the period ended July 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Matthew T. Shafer, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: September 7, 2017

 

 

 

 

 

 

/s/ Matthew T. Shafer

 

 

Matthew T. Shafer

 

 

Chief Financial Officer

 

 

 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-101.INS 6 optt-20170731.xml EXHIBIT 101.INS false --04-30 Q1 2018 2017-07-31 10-Q 0001378140 12526124 Yes Smaller Reporting Company Ocean Power Technologies, Inc. No No optt <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 83%; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="4">Fair Value Measurement Using Significant Unobservable Inputs ( Level 3)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="WIDTH: 81%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 16%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; April 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,814 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transfers</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,491</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; April 30, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="WIDTH: 81%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 16%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(37</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; July 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">286 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> P5Y P5Y <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;<div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>)&nbsp;Deferred Credits Payable</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2001,</div> in connection with the sale of common stock to an investor, the Company received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million from the investor in exchange for an option to purchase up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500,000</div> metric tons of carbon emissions credits generated by the Company during the years <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2008</div> through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> at a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div> discount from the then-prevailing market rate. If the Company received emission credits under applicable laws and failed to sell to the investor the credits up to the full amount of emission credits covered by the option, the investor was entitled to liquidated damages equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div> of the aggregate market value of the shortfall in emission credits (subject to a limit on the market price of emission credits).&nbsp;&nbsp;Under the terms of the agreement, if the Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> become entitled under applicable laws to the full amount of emission credits covered by the option by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> the Company was obligated to return the option fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million, less the aggregate discount on any emission credits sold to the investor prior to such date. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2012, </div>the Company and the investor agreed to extend the period for the sale of emission credits until <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generated any emissions credits eligible for purchase under the agreement. As a result, the Company anticipates returning the option fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million. Therefore, the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million is reflected in the consolidated balance sheets within &#x201c;Deferred credits payable current&#x201d; as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017, </div>respectively.</div></div></div> 0.3 0.3 500000 -200000 300000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"><tr><td style="WIDTH: 4%; VERTICAL-ALIGN: top"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">c)</div></div></div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Liquidity/Going Concern</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$190.0</div> million as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017. </div>As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company had approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11.4</div> million in cash and cash equivalents on hand. The Company generated revenues of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div></div> million during each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Based on the Company&#x2019;s cash and cash equivalents and marketable securities as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company believes that it will be able to finance its capital requirements and operations into the quarter ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2018. </div>The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company&#x2019;s ability to continue as a going concern.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include, but are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company&#x2019;s equity or debt securities; partnerships and/or collaborations. There can be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurance that any of these future-funding efforts will be successful.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company&#x2019;s future results of operations involve significant risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys,</div> <div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div></div> equity financing arrangements during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017. </div>The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> obtained when needed, the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2, 2016, </div>the Company entered into a securities purchase agreement, which was amended on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 7, 2016 (</div>as amended, the &#x201c;Purchase Agreement&#x201d;) with certain institutional purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;June </div>Purchasers&#x201d;). Pursuant to the terms of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June </div>Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">417,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,952</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.35</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.60.</div> The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.7</div> million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.08</div> per share, became exercisable on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 3, 2016 (</div>&#x201c;Initial Exercise Date&#x201d;), and will expire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years following the Initial Exercise Date.&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company paid the placement agents approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million as placement agent fees in connection with the sale of securities in the offering. The Company also reimbursed the placement agents <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$35,000</div> for their out of pocket and legal expenses in connection with the offering. &nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 22, 2016, </div>the Company entered into the Second Amendment to the Purchase Agreement (the &#x201c;Second Amended Purchase Agreement&#x201d;) with certain purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;July </div>Purchasers&#x201d;). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">178,500</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.30</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.75.</div> The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.6</div> million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.36</div> per share. The Warrants will expire on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifth</div> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5th</div>) anniversary of the initial date of issuance.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 19, 2016, </div>the Company sold <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,760,000</div> shares of common stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.75</div> per share, which includes the sale of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">360,000</div> shares of the Company&#x2019;s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.9</div> million, after deducting underwriter fees and offering expenses payable by the Company.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 20.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2, 2017, </div>the Company sold <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,192,750</div> shares of common stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.30</div> per share, which includes the sale of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">807,750</div> shares of the Company&#x2019;s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.2</div> million, after deducting underwriter fees and offering expenses payable by the Company. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company&#x2019;s Common Stock and could contain covenants that would restrict its operations. Financing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be forced to cease operations.</div></div></div></div></div></div> 350000 4 4 4.60 6.75 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash and cash equivalents</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,414 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,421 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Restricted cash- short term</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">361 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">334 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Restricted cash- long term</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,929 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,909 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div>) Warrants</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2, 2016, </div>the Company entered into a securities purchase agreement, which was amended on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 7, 2016 (</div>as amended, the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;June </div>Purchase Agreement&#x201d;) with certain institutional purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;June </div>Purchasers&#x201d;). Pursuant to the terms of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June </div>Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">417,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,952</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.35</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.60.</div> The warrants have an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.08</div> per share, became exercisable on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 3, 2016 (</div>&#x201c;Initial Exercise Date&#x201d;), and will expire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years following the Initial Exercise Date.&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 22, 2016, </div>the Company entered into a Second Amendment to the Purchase Agreement (the &#x201c;Second Amended Purchase Agreement&#x201d;) with certain institutional purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;July </div>Purchasers&#x201d;). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">178,500</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.30</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.75.</div> The Warrants were exercisable immediately at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.36</div> per share. The Warrants will expire on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifth</div> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5th</div>) anniversary of the initial date of issuance.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Both sets of warrants contain a feature whereby they could require the transfer of assets and therefore are classified as a liability in accordance with ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">480.</div> As such, the warrants with a value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017, </div>respectively, are reflected within &#x201c;Warrant liabilities&#x201d; in the unaudited consolidated balance sheets. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">An unrealized gain and unrealized loss of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$37,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$752,000,</div> respectively, were included within &#x201c;Change in fair value of warrant liability&#x201d; in the consolidated statements of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. The Company determined the fair value using the Black-Scholes option pricing model with the following assumptions:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 39.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 8%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="3"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 8%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="3"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="WIDTH: 72%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.68%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.4</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.4</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140.3%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">125.4%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 286000 323000 286000 286000 323000 323000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(i) Warrant Liabilities</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within &#x201c;Change in fair value of warrant liabilities.&#x201d; The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to &#x201c;Additional paid-in capital&#x201d;, a component of &#x201c;Stockholders' equity&#x201d; on the consolidated balance sheets.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 183000 586000 86000 48000 132000 132000 1530000 3059000 358000 478000 420000 484000 -138000 -160000 200549000 193234000 91000 91000 91000 218000 69000 83000 22000 100000 13000 53000 78000 165000 701977 711453 13085000 10073000 12782000 9746000 0 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 4%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">b)</div></div></div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Basis of Presentation</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q and Article&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> of Regulation&nbsp;S-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">X.</div> Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017 </div>filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and elsewhere in this Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>)&nbsp;Background, Basis of Presentation and Liquidity</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 4%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">a)</div></div></div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Background</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Ocean Power Technologies, Inc. (the &#x201c;Company&#x201d;) was founded in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1984</div> in New Jersey, commenced business operations in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1994</div> and re-incorporated in Delaware in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2007.</div> The Company is developing and commercializing its proprietary systems that generate electricity by harnessing the renewable energy of ocean waves. The Company uses proprietary technologies that convert the mechanical energy created by the heaving motion of ocean waves into electricity. The Company has designed and continues to develop the PowerBuoy product line which is based on modular, ocean-going buoys, which the Company has been periodically ocean testing since <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1997.</div> The Company markets its PowerBuoys in the United States and internationally. Since fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2002,</div> government agencies have accounted for a significant portion of the Company&#x2019;s revenues.&nbsp;&nbsp;These revenues were largely for the support of product development efforts. The Company&#x2019;s goal is that an increased portion of its revenues be from the sale or lease of products and maintenance services, as compared to revenue to support its product development efforts. As the Company continues to advance its proprietary technologies, it expects to continue to have a net decrease in cash from operating activities unless and until it achieves positive cash flow from the planned commercialization of products and services.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 4%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">b)</div></div></div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Basis of Presentation</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q and Article&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> of Regulation&nbsp;S-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">X.</div> Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017 </div>filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and elsewhere in this Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 4%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">c)</div></div></div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Liquidity/Going Concern</div></div></div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$190.0</div> million as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017. </div>As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company had approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11.4</div> million in cash and cash equivalents on hand. The Company generated revenues of<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div> million during each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Based on the Company&#x2019;s cash and cash equivalents and marketable securities as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company believes that it will be able to finance its capital requirements and operations into the quarter ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2018. </div>The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company&#x2019;s ability to continue as a going concern.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include, but are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company&#x2019;s equity or debt securities; partnerships and/or collaborations. There can be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurance that any of these future-funding efforts will be successful.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company&#x2019;s future results of operations involve significant risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys,</div> <div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div></div> equity financing arrangements during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017. </div>The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> obtained when needed, the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2, 2016, </div>the Company entered into a securities purchase agreement, which was amended on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 7, 2016 (</div>as amended, the &#x201c;Purchase Agreement&#x201d;) with certain institutional purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;June </div>Purchasers&#x201d;). Pursuant to the terms of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June </div>Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">417,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,952</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.35</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.60.</div> The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.7</div> million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.08</div> per share, became exercisable on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 3, 2016 (</div>&#x201c;Initial Exercise Date&#x201d;), and will expire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years following the Initial Exercise Date.&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company paid the placement agents approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million as placement agent fees in connection with the sale of securities in the offering. The Company also reimbursed the placement agents <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$35,000</div> for their out of pocket and legal expenses in connection with the offering. &nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 22, 2016, </div>the Company entered into the Second Amendment to the Purchase Agreement (the &#x201c;Second Amended Purchase Agreement&#x201d;) with certain purchasers (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;July </div>Purchasers&#x201d;). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595,000</div> shares of Common Stock together with warrants to purchase up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">178,500</div> shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.30</div> of a share of Common Stock at a combined purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.75.</div> The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.6</div> million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.36</div> per share. The Warrants will expire on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifth</div> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5th</div>) anniversary of the initial date of issuance.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 19, 2016, </div>the Company sold <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,760,000</div> shares of common stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.75</div> per share, which includes the sale of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">360,000</div> shares of the Company&#x2019;s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.9</div> million, after deducting underwriter fees and offering expenses payable by the Company.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 20.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2, 2017, </div>the Company sold <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,192,750</div> shares of common stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.30</div> per share, which includes the sale of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">807,750</div> shares of the Company&#x2019;s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.2</div> million, after deducting underwriter fees and offering expenses payable by the Company. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company&#x2019;s Common Stock and could contain covenants that would restrict its operations. Financing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be forced to cease operations.</div></div></div> 36000 35000 14000 23000 11414000 8421000 4400000 4241000 7014000 4180000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(d)&nbsp;Cash, Cash Equivalents, Restricted Cash and Security Agreements</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Cash and Cash Equivalents</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company considers all highly liquid investments with a maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> of the bank&#x2019;s total obligations under the agreement.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Checking and savings accounts</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,400 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,241 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Overnight repurchase account</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,014 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,180 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,414 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,421 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">&nbsp;Restricted Cash and </div><div style="display: inline; font-style: italic;">Security Agreements</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A portion of the Company&#x2019;s cash is restricted under the terms of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> security agreements.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 26.4pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility is approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;0.3</div> million (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million) and carries a fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1%</div> per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have an expiration date, but is cancelable at the discretion of the bank. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;0.3</div> million (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million) in letters of credit outstanding under this agreement.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> agreement is between the Company and Santander Bank. Under this agreement, the cash is on deposit at Santander Bank and serves as security for letter of credit issued by Santander Bank for the lease of new warehouse/office space in Monroe Township, New Jersey. The agreement cannot be extended beyond <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 31, 2025, </div>and is cancelable at the discretion of the bank. Restricted cash includes the following:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Barclay's Bank Agreement</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">361 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">334 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Santander Bank</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">515 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">488 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash and cash equivalents</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,414 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,421 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Restricted cash- short term</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">361 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">334 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Restricted cash- long term</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,929 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,909 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 488000 300000 266000 8909000 7030000 11929000 9291000 3020000 2261000 6.08 9.36 0.35 0.3 145952 178500 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div>)&nbsp;Commitments and Contingencies</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(a) Litigation</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Shareholder Litigation and Demands&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company and certain of its current and former directors and officers are defendants in a derivative lawsuit filed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 18, 2015 </div>in the United States District Court for the District of New Jersey captioned <div style="display: inline; font-style: italic;">Labare v. Dunleavy, et. al.,</div> Case <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:15</div>-cv-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01980</div>-FLW-LHG. The derivative complaint alleges claims for breach of fiduciary duty, abuse of control, gross mismanagement and unjust enrichment relating to the now terminated agreement between Victorian Wave Partners Pty. Ltd. (VWP) and the Australian Renewable Energy Agency (ARENA) for the development of a wave power station. The derivative complaint seeks unspecified monetary damages and other relief.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 10, 2015, </div>a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> derivative lawsuit, captioned <div style="display: inline; font-style: italic;">Rywolt v. Dunleavy, et al.,</div> Case <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:15</div>-cv-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">05469,</div> was filed by another shareholder against the same defendants in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, gross mismanagement, abuse of control, and unjust enrichment relating to the now terminated agreement between VWP and ARENA. The <div style="display: inline; font-style: italic;">Rywolt</div> complaint also seeks unspecified monetary damages and other relief. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 8, 2016, </div>the Court issued an order consolidating the <div style="display: inline; font-style: italic;">Labare</div> and <div style="display: inline; font-style: italic;">Rywolt </div>actions, appointing co-lead plaintiffs and lead counsel, and ordering a consolidated amended complaint to be filed within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div> days of the order. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 9, 2016, </div>the co-lead plaintiffs filed an amended complaint consolidating their claims and seeking unspecified monetary damages and other relief.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 21, 2016, </div>a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> derivative lawsuit, captioned <div style="display: inline; font-style: italic;">LaCalamito v. Dunleavy, et al.,</div> Case <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:16</div>-cv-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02249,</div> was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty relating to the now terminated agreement between VWP and ARENA. The <div style="display: inline; font-style: italic;">LaCalamito </div>complaint seeks unspecified monetary damages and other relief. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been formally served and has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet responded to the complaint.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 9, 2016, </div>a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> derivative lawsuit, captioned <div style="display: inline; font-style: italic;">Pucillo v. Dunleavy, et al.,</div> was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, unjust enrichment, and abuse of control relating to the now terminated agreement between VWP and ARENA. The <div style="display: inline; font-style: italic;">Pucillo</div> complaint seeks unspecified monetary damages and other relief. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2, 2016, </div>the parties in the <div style="display: inline; font-style: italic;">Pucillo</div> lawsuit filed a Stipulation and Proposed Order pursuant to which: (i) the defendants agreed to accept service of the <div style="display: inline; font-style: italic;">Pucillo</div> complaint; (ii) the parties agreed to stay the <div style="display: inline; font-style: italic;">Pucillo</div> action pending the filing and resolution of a motion to consolidate the <div style="display: inline; font-style: italic;">Pucillo</div> action with the <div style="display: inline; font-style: italic;">Labar</div>e and <div style="display: inline; font-style: italic;">Rywolt</div> actions; and (iii) the parties agreed that the defendants shall <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be required to respond to the <div style="display: inline; font-style: italic;">Pucillo</div> complaint during the pendency of the stay. The Court approved the Stipulation on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 3, 2016. </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 25, 2016, </div>the Court approved and entered a Stipulation and Order that, among other things, (i) consolidated the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> derivative actions; (ii) identified plaintiff <div style="display: inline; font-style: italic;">Pucillo</div> as the lead plaintiff in the consolidated actions; and (iii) stayed the consolidated actions pending the settlement hearing scheduled for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 14, 2016 </div>in the securities class action and further order of the Court. During the month of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August, 2017, </div>the Company tentatively reached a settlement with the plaintiff subject to final documentation. The settlement, once finalized and if approved by the court, provides, among other things, for a settlement payment by or on behalf of the Company of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$350,000,</div> of which the Company&#x2019;s insurer would pay the complete amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$350,000.</div> As a result, the Company has accrued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$350,000</div> related to this matter as a probable and reasonably estimable loss contingency during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017. </div>The Company also recorded a receivable of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$350,000</div> from its insurance carrier with the offset to the statement of operations. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 26, 2017, </div>an attorney claiming to represent <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> stockholders sent the Company&#x2019;s Board of Directors a Stockholder Litigation Demand letter (&#x201c;Stockholder Demand&#x201d;). The Stockholder Demand alleges that the voting of shares for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>-for-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> reverse stock split at the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> annual meeting of stockholders held on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 22, 2015 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> properly counted, and further alleges that, although the Company reported the reverse stock split as having been passed, if the vote was properly counted the reverse stock split would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have been approved. The Stockholder Demand requests the Board of Directors either to deem the reverse stock split as ineffective and disclose the same or to seek a proper and effective stockholder ratification of the reverse stock split. In addition, the Stockholder Demand requests the Board of Directors to adopt and implement adequate internal controls and systems to prevent the alleged improper voting from recurring. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 23, 2017, </div>the Company responded to the Stockholder Demand, explained the procedures that were followed for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> annual meeting of stockholders and provided the Oath of the Inspector of Elections and the Certificate of the Inspector of Elections that certified as accurate the results of the voting at the meeting including voting on the reverse stock split proposal. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 26, 2017, </div>the attorney representing the alleged stockholders replied to the Company&#x2019;s response, further alleged that the proxy statement underlying the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> annual meeting provided voting instructions that misled the stockholders regarding whether their brokers could vote on the reverse stock split proposal, and renewed their requests of the Board. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 24, 2017, </div>the Company provided an additional response to the Stockholders Demand, denied the allegations, and declined to take any of the actions requested.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Employment Litigation&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 10, 2014, </div>the Company announced that it had terminated Charles Dunleavy as its Chief Executive Officer and as an employee of the Company for cause, effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 9, 2014, </div>and that Mr. Dunleavy had also been removed from his position as Chairman of the Board of Directors. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 17, 2014, </div>Mr. Dunleavy wrote to the Company stating that he had retained counsel to represent him in connection with an alleged wrongful termination of his employment. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 28, 2014, </div>Mr. Dunleavy resigned from the Board and the boards of directors of the Company's subsidiaries. The Company and Mr. Dunleavy have agreed to suspend his alleged employment claims pending resolution of the shareholder litigation, and have since agreed to continue to the suspension pending resolution of the derivatives litigation.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Except for the pending settlement noted previously, we have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> established any provision for losses relating to these claims and pending litigation. Due to the stages of these proceedings, and considering the inherent uncertainty of these claims and litigation, at this time we are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> able to predict or reasonably estimate whether we have any possible loss exposure or the ultimate outcome of these claims.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(b) Regulatory Matters</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">SEC Investigation</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 4, 2015, </div>the Company received a subpoena from the SEC requesting information related to the VWP Project. The Company has provided information to the SEC in response to that subpoena. As part of the same investigation, on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 12, 2016, </div>the SEC issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> subpoena requesting information related to the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 4, 2014 </div>public offering. The Company has provided information to the SEC in response&nbsp;to that subpoena. The SEC investigation is ongoing and the Company continues to cooperate with the SEC in its investigation. We are unable to predict what action, if any, might be taken by the SEC or its staff as a result of this investigation or what impact, if any, the cost of responding to the SEC&#x2019;s investigation or its ultimate outcome might have on our financial position, results of operations or liquidity. We have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> established any provision for losses relating to this matter.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Spain IVA (sales tax)</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2012, </div>the Company received notice that the Spanish tax authorities are inquiring into its <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010</div> IVA (value-added tax) filing for which the Company benefitted from the offset of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million of input tax. The Company believes that the inquiry will find that the tax credit was properly claimed and, therefore, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> liability has been recorded. The Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> letters of credit totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;0.3</div> million (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million) at the request of the Spanish tax authorities. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 31, 2017 </div>the Company has received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million from the Spanish tax authorities as a result of the conclusion of the inquiry. In addition, during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2017, </div>the Spanish tax authorities approved of the release of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> outstanding letters of credit.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Spain Income Tax Audit</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company is currently undergoing an income tax audit in Spain for the period from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2008</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> when its Spanish branch was closed. The branch reported net operating losses for each of the years reported. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">It is anticipated that the Company will be assessed a penalty relating to these tax years for these losses. The Company has estimated this penalty to be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$132,000</div>,</div> and as such, for the period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company has recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$132,000</div> for this penalty to Accrued expenses in its balance sheet.</div></div></div> 0.001 0.001 50000000 50000000 12621205 6313996 13000 6000 -2641000 -3858000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(h)&nbsp;Concentration of Credit Risk</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company's consolidated revenues for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the periods indicated:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended July 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Customer </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mitsui Engineering &amp; Shipbuilding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; MARGIN-TOP: 0px; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">U.S. Department of Defense Office of&nbsp; Naval Research</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require its customers to maintain collateral.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 0.67 1 0.33 1 1 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(a)&nbsp;Consolidation</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 46000 898000 217000 127000 -10000 10000 -10000 600000 600000 600000 31000 34000 300000 300000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>)&nbsp;Stock-Based Compensation</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(a)&nbsp;Stock Options</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Valuation Assumptions for Options Granted during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of each stock option granted, for both service-based and performance-based vesting requirements during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> was estimated at the date of grant using the Black-Scholes option pricing model, assuming <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> dividends, and using the weighted average valuation assumptions noted in the following table. The risk-free rate is based on the US Treasury yield curve in effect at the time of grant. The expected life (estimated period of time outstanding) of the stock options granted was estimated using the &quot;simplified&quot; method as permitted by the SEC's Staff Accounting Bulletin <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110,</div><div style="display: inline; font-style: italic;"> Share-Based Payment.</div> Expected volatility was based on the Company&#x2019;s historical volatility during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The below assumptions were used to determine the weighted average per share fair value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.10</div> for stock options granted during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2016. </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> options were granted during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended July 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">N/A</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.3</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">N/A</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">N/A</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.5</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">N/A</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">85.6</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A summary of stock options under our stock incentive plans is detailed in the following table.&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Remaining</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Contractual</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Underlying</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Term</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Options</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Price</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In Years)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 49%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding as of April 30, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">237,214 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.64 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.6 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cancelled/forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6,910</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">161.18 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding as of July 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230,304 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.24 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.6 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable as of July 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">128,641 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.10 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.3 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the total intrinsic value of outstanding and exercisable options was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,000,</div> respectively. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,323</div> additional options were unvested, which had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> intrinsic value and a weighted average remaining contractual term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9.2</div> years. There was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$69,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$83,000</div>&nbsp;of total recognized compensation cost related to stock options during each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>there was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million of total unrecognized compensation cost related to non-vested stock options granted under the plans. This cost is expected to be recognized over a weighted-average period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.4</div> years. The Company typically issues newly authorized but unissued shares to satisfy option exercises under these plans.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(b)&nbsp;Restricted Stock</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Compensation expense for non-vested restricted stock is generally recorded based on its market value on the date of grant and recognized ratably over the associated service and performance period. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">114,584</div> shares subject to service-based vesting requirements and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> shares subject to performance-based vesting requirements. The achievement or vesting requirement of the performance-based grants is tied to the Company&#x2019;s total shareholder return (&#x201c;TSR&#x201d;) relative to the total shareholder return of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> alternative energy Exchange Traded Funds as measured over a specific performance period. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> vesting of the relevant shares will occur in instances where the Company&#x2019;s TSR for the relevant period is below <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80%</div> of the peer group. However, additional opportunities to vest some or all of a portion of the shares in a subsequent period <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>occur. Compensation expense for these awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Restricted stock issued and unvested as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>included <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,000</div> shares of unvested restricted stock subjected to performance-based vesting requirements.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A summary of non-vested restricted stock under our stock incentive plans is as follows:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Number</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average Price per</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">of Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Share</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued and unvested at April 30, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">103,412 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.99 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">114,584 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.40 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(70,650</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.55 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cancelled/forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(125</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.40 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued and unvested at July 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">147,221 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.04 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$22,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million of total recognized compensation cost related to restricted stock for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>there was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million of total unrecognized compensation cost related to unvested restricted stock granted under our plans. This cost is expected to be recognized over a weighted average period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.5</div>&nbsp;years.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div>&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(c) Treasury Stock</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">447</div> shares, respectively, of common stock were purchased by the Company from employees to pay taxes related to the vesting of restricted stock.</div></div></div> -0.22 -1.72 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(j)&nbsp;Net Loss per Common Share</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">701,977</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">711,453</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2016, </div>were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.<div style="display: inline; font-weight: bold;"> </div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 90000 -13000 P146D P1Y182D 200000 100000 -37000 752000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 8%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="3"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 8%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="3"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="WIDTH: 72%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 4%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.68%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.4</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.4</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 72%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140.3%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">125.4%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> 0 0 P4Y P4Y146D P5Y P5Y146D 1.403 1.254 0.0168 0.01 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div>) Fair Value Measurements</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company measures and reports certain financial and non-financial assets and liabilities on a fair value basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP specifies a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-level hierarchy that is used when measuring and disclosing fair value. The fair value hierarchy gives the highest priority to quoted prices available in active markets (i.e., observable inputs) and the lowest priority to data lacking transparency (i.e., unobservable inputs). An instrument&#x2019;s categorization within the fair value hierarchy is based on the lowest level of significant input to its valuation. The following is a description of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> hierarchy levels.</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Active markets are considered to be those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</div></div></td> </tr> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div></div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Quoted prices in markets that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in inactive markets.</div></div></td> </tr> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>&nbsp;&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 91%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unobservable inputs are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> corroborated by market data. This category is comprised of financial and non-financial assets and liabilities whose fair value is estimated based on internally developed models or methodologies using significant inputs that are generally less readily observable from objective sources.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transfers into or out of any hierarchy level are recognized at the end of the reporting period in which the transfers occurred. There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> transfers between any levels during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following information is provided to help readers gain an understanding of the relationship between amounts reported in the accompanying consolidated financial statements and the related market or fair value. The disclosures include financial instruments and derivative financial instruments, other than investment in affiliates.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Following are descriptions of the valuation methodologies used to measure material assets and liabilities at fair value and details of the valuation models, key inputs to those models and significant assumptions utilized.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Warrant Liabilities</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of the Company's warrant liabilities (refer to Note&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div>) recorded in the Company's financial statements is determined using the Black-Scholes option pricing model and the quoted price of the Company's common stock in an active market, volatility and expected life, is a Level&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> measurement. Volatility is based on the actual market activity of the Company's stock. The expected life is based on the remaining contractual term of the warrants and the risk free interest rate is based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrants' expected life.&nbsp;&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table presents financial assets and liabilities measured at fair value on a recurring basis as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Total Carrying Value in Consolidated Balance Sheet</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quoted prices in active markets for identical assts or liabilities </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 1)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant other observable inputs </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 2)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant unobservable inputs</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 3)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="14"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="WIDTH: 48%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liabilities</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">286 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">286 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;The following table presents financial assets and liabilities measured at fair value on a recurring basis as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Total Carrying Value in Consolidated Balance Sheet</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quoted prices in active markets for identical assts or liabilities </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 1)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant other observable inputs </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 2)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant unobservable inputs</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 3)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="14"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="WIDTH: 48%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liabilities</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 2pt"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table provides a summary of changes in fair value of the Company&#x2019;s warrant liabilities held at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div>&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 83%; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="4">Fair Value Measurement Using Significant Unobservable Inputs ( Level 3)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="WIDTH: 81%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 16%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; April 30, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,814 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transfers</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,491</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; April 30, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="WIDTH: 81%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 16%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(37</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 81%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value &#x2013; July 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">286 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div></div></div> re-measured assets or liabilities at fair value on a non-recurring basis during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively.</div></div></div> -1491000 -37000 1814000 323000 286000 62000 5000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(f)&nbsp;Foreign Exchange Gains and Losses</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in &#x201c;Foreign exchange gain/(loss)&#x201d;&nbsp;in the accompanying consolidated statements of operations.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> -4000 -22000 75000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>)&nbsp;Income Taxes</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;The Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div></div></div> recognize any consolidated income tax benefit (expense) during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> month periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The Company has recorded a valuation allowance to reduce its net deferred tax asset to an amount that is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to be realized in future years. Accordingly, the benefit of the net operating loss that would have been recognized was offset by changes in the valuation allowance.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company applies the guidance issued by the FASB for the accounting and reporting of uncertain tax positions. The guidance requires the Company to recognize in its consolidated financial statements the impact of a tax position if that position is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to be sustained upon examination, based on the technical merits of the position. We are currently undergoing an income tax audit in Spain for the period from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2008</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> when our Spanish branch was closed. The branch reported net operating losses for each of the years reported. It is anticipated that we will be assessed a penalty relating to these tax years for these losses. We have estimated this penalty to be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$132,000</div>,</div> and as such, for the period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>we have recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$132,000</div> for this penalty to Accrued expenses in the Balance Sheet. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> other unrecognized tax positions. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect any material increase or decrease in its income tax expense in the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months, related to examinations or uncertain tax positions. U.S. federal and state income tax returns were audited through fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> and fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010</div> respectively. Net operating loss and credit carry forwards since inception remain open to examination by taxing authorities, and will continue to remain open for a period of time after utilization.</div></div></div> 132000 132000 0 0 -405000 264000 38000 150000 -1531000 215000 -39000 -239000 370000 -133000 13000 350000 350000 3000 1000 2000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>)&nbsp;Marketable Securities</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Marketable securities with initial maturities greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months but that mature within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the balance sheet date are classified as current assets and are summarized as follows:</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certificate of Deposit</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 300000 300000 2999000 4626000 13085000 10073000 2985000 4603000 0 0 300000 300000 0.01 350000 350000 350000 298000 238000 25000 25000 25000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(e) Marketable Securities</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Marketable securities with original maturities longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months but that mature in less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017, </div>all of the Company&#x2019;s investments were classified as held-to-maturity.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certificate of Deposit</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> 7180000 5225000 -12000 -30000 -4238000 -2921000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(l) Recently Issued Accounting Standards</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>).&#x201d;</div> ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The FASB subsequently issued additional clarifying standards to address issues arising from implementation of the new revenue standard, including a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-year deferral of the effective date for the new revenue standard. Public companies should now apply the guidance in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> to annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and interim periods within those annual periods. Earlier application is permitted only as of annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> including interim periods within that annual period. As such, the Company is required to adopt this standard effective in fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> which begins <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2018. </div>Companies <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>use either a full retrospective or a modified retrospective approach to adopt ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet completed its final review of the impact of this guidance; however the Company anticipates applying the modified retrospective method upon adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2018.</div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> The impact to the Company could be affected by the nature and terms of potential future contracts with customers, as those contracts <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>have terms that differ from the Company&#x2019;s current contracts. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 7.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.5pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2014, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">&#x201c;Disclosure of Uncertainties about an Entity&#x2019;s Ability</div> <div style="display: inline; font-style: italic;">to Continue as a Going Concern&#x201d;,</div> which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> annual period ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>and interim periods thereafter. Early application is permitted. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> for the fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> The Company&#x2019;s addition of the standard did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on its disclosures.</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> See section (c) &#x201c;Liquidity/Going Concern&#x201d; within Note (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>)&nbsp;&#x201c;Background and Liquidity&#x201d; of the consolidated financial statements included in this Quarterly Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q for further discussion on the Company&#x2019;s ability to continue as a going concern.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div><div style="display: inline; font-style: italic;"> &#x201c;Recognition and Measurement of Financial Assets and Financial Liabilities&#x201d;,</div> which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>including interim periods within those fiscal years. The Company will evaluate the effect of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01</div> for future periods as applicable.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: 21.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">&#x201c;Leases (Topic&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div></div>).&#x201d; The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div>&nbsp;months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will have on its consolidated financial statements and disclosures and has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet determined the effect of the standard on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">&#x201c;Compensation - Stock Compensation (Topic</div> <div style="display: inline; font-style: italic;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>)</div><div style="display: inline; font-style: italic;">.</div><div style="display: inline; font-style: italic;">&#x201d;</div> The amendments of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including accounting for forfeitures, income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>and interim periods within those annual periods. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2017. </div>Certain of the amendments are applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2017, </div>while other amendments are applied retrospectively, prospectively or using either a prospective or a retrospective transition method. Upon adoption, the Company is beginning to account for forfeitures as they occur rather than estimate a forfeiture rate and has recorded a cumulative-effect adjustment in equity of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10,000</div> on the date of initial adoption. In periods subsequent to adoption, a higher expense will be recognized earlier during the respective vesting periods of stock-based awards that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> forfeited. The Company expects that the income tax amendments within ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> will have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on its results of operations or cash flows because it is in a net operating loss position with a full valuation allowance. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">&#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Classification</div> <div style="display: inline; font-style: italic;">of Certain Cash Receipts and Cash Payments&#x201d;,</div> providing additional guidance on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within those fiscal years and early adoption is permitted. The Company has evaluated the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> will have on its consolidated financial statements and disclosures and has determined the standard will have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> <div style="display: inline; font-style: italic;">&#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Restricted</div> <div style="display: inline; font-style: italic;">Cash&#x201d;,</div> which amends guidance and presentation related to restricted cash in the statement of cash flows, including stating that amounts generally described as restricted cash and restricted cash equivalents should be included within cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. An entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within those fiscal years and early adoption is permitted. The Company has early adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2017. </div>In connection with the adoption of the standard the Company has used a retrospective transition method for each period presented in the statement of cash flows. The Company reclassified <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$488,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$300,000</div> of restricted cash to cash, cash equivalents and restricted cash, beginning of period for the period <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2016 </div>in the statement of cash flows. The Company reclassified <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$266,000</div> of restricted cash to cash, cash equivalents and restricted cash, end of period for the period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2016 </div>in the statement of cash flows.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 1 2743000 3155000 -2765000 -3080000 134000 186000 383000 622000 3000 3000 22000 -31000 22000 22000 142000 643000 32000 4000 100000 35000 12000 5000 25000 0.001 0.001 5000000 5000000 0 0 0 0 7221000 1700000 3600000 6900000 7.20 5261000 -2663000 -3827000 -2663000 146000 170000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(g)&nbsp;Property and Equipment</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> P3Y P7Y 32000 9000 1102000 1636000 361000 334000 154000 154000 515000 488000 361000 334000 154000 154000 -190043000 -187370000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(c) Revenue Recognition</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of zero. The Company&#x2019;s share of the costs is recorded as product development expense.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Generally, revenue under fixed price or cost plus contracts is recognized using the cost to cost percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition, recognition of revenue (and the related costs) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unbilled receivables represent expenditures on contracts, plus applicable profit margin, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet billed. Unbilled receivables are normally billed and collected within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 195000 202000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Checking and savings accounts</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,400 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,241 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Overnight repurchase account</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,014 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,180 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,414 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,421 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended July 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Product development</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">53 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Selling, general and administratvie</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">78 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">165 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total share-based compensation expense</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">218 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Total Carrying Value in Consolidated Balance Sheet</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quoted prices in active markets for identical assts or liabilities </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 1)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant other observable inputs </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 2)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant unobservable inputs</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 3)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="14"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="WIDTH: 48%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liabilities</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">286 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">286 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Total Carrying Value in Consolidated Balance Sheet</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quoted prices in active markets for identical assts or liabilities </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 1)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant other observable inputs </div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 2)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Significant unobservable inputs</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Level 3)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="14"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%">&nbsp;</td> </tr> <tr> <td style="WIDTH: 48%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> <td style="WIDTH: 10%">&nbsp;</td> <td style="WIDTH: 1%">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liabilities</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Project costs </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">898 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contract loss reserve</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">298 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">238 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Employee incentive payments</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">142 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">643 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued salary and benefits</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">420 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">484 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Legal and accounting fees</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">358 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">478 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued taxes payable</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Other</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">134 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">186 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,530 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,059 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Barclay's Bank Agreement</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">361 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">334 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Santander Bank</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">515 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">488 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended July 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Customer </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mitsui Engineering &amp; Shipbuilding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; MARGIN-TOP: 0px; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">U.S. Department of Defense Office of&nbsp; Naval Research</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Remaining</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Contractual</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Underlying</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Term</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Options</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Price</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In Years)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 49%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding as of April 30, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">237,214 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.64 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.6 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cancelled/forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6,910</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">161.18 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding as of July 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230,304 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.24 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.6 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable as of July 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">128,641 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.10 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.3 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Number</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Average Price per</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">of Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Share</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued and unvested at April 30, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">103,412 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.99 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">114,584 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.40 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(70,650</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.55 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cancelled/forfeited</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(125</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.40 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued and unvested at July 31, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">147,221 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.04 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended July 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">N/A</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.3</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">N/A</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.0</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected life (in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">N/A</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.5</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">N/A</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">85.6</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div>)&nbsp;Operating Segments and Geographic Information</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's business consists of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> segment as this represents management's view of the Company's operations. The Company operates on a worldwide basis with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> operating company in the US and operating subsidiaries in the UK and in Australia. Revenues and expenses are generally attributed to the operating unit that bills the customers. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company&#x2019;s primary business operations were in North America.</div></div></div> 1641000 1519000 91000 218000 125 1.40 114584 0 114584 1.40 12000 103412 147221 3.99 2.04 70650 4.55 0 0.856 0.013 128641 16.10 161.18 6910 1.10 5000 237214 230304 14.64 10.24 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(</div></div><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">k</div></div><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">) </div></div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Share-Based Compensation</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Costs resulting from all share-based payment transactions are recognized in the consolidated financial statements at their fair values. The aggregate share-based compensation expense recorded in the consolidated statements of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million, respectively. The following table summarizes share-based compensation related to the Company&#x2019;s share-based plans by expense category for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016:</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended July 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Product development</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">53 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Selling, general and administratvie</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">78 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">165 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total share-based compensation expense</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">218 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 2.75 1.30 P5Y182D 4000 P6Y109D 100323 P7Y219D P9Y73D 6313996 -48065 12621205 -70081 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>)&nbsp;Summary of Significant Accounting Policies</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(a)&nbsp;Consolidation</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 2pt">&nbsp;</div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(b) Use of Estimates</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The current economic environment, particularly the macroeconomic pressures in certain European countries, has increased the degree of uncertainty inherent in those estimates and assumptions.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(c) Revenue Recognition</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of zero. The Company&#x2019;s share of the costs is recorded as product development expense.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Generally, revenue under fixed price or cost plus contracts is recognized using the cost to cost percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In addition, recognition of revenue (and the related costs) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unbilled receivables represent expenditures on contracts, plus applicable profit margin, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet billed. Unbilled receivables are normally billed and collected within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(d)&nbsp;Cash, Cash Equivalents, Restricted Cash and Security Agreements</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Cash and Cash Equivalents</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company considers all highly liquid investments with a maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> of the bank&#x2019;s total obligations under the agreement.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Checking and savings accounts</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,400 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,241 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Overnight repurchase account</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,014 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,180 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,414 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,421 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">&nbsp;Restricted Cash and </div><div style="display: inline; font-style: italic;">Security Agreements</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A portion of the Company&#x2019;s cash is restricted under the terms of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> security agreements.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 26.4pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility is approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;0.3</div> million (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million) and carries a fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1%</div> per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have an expiration date, but is cancelable at the discretion of the bank. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;0.3</div> million (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million) in letters of credit outstanding under this agreement.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> agreement is between the Company and Santander Bank. Under this agreement, the cash is on deposit at Santander Bank and serves as security for letter of credit issued by Santander Bank for the lease of new warehouse/office space in Monroe Township, New Jersey. The agreement cannot be extended beyond <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 31, 2025, </div>and is cancelable at the discretion of the bank. Restricted cash includes the following:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Barclay's Bank Agreement</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">361 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">334 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Santander Bank</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">515 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">488 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash and cash equivalents</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,414 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,421 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Restricted cash- short term</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">361 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">334 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Restricted cash- long term</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,929 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,909 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(e) Marketable Securities</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Marketable securities with original maturities longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months but that mature in less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017, </div>all of the Company&#x2019;s investments were classified as held-to-maturity.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(f)&nbsp;Foreign Exchange Gains and Losses</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in &#x201c;Foreign exchange gain/(loss)&#x201d;&nbsp;in the accompanying consolidated statements of operations.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(g)&nbsp;Property and Equipment</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(h)&nbsp;Concentration of Credit Risk</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company's consolidated revenues for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the periods indicated:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 42.9pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended July 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Customer </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Mitsui Engineering &amp; Shipbuilding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; MARGIN-TOP: 0px; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt"> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">U.S. Department of Defense Office of&nbsp; Naval Research</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">- </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require its customers to maintain collateral.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(i) Warrant Liabilities</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within &#x201c;Change in fair value of warrant liabilities.&#x201d; The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to &#x201c;Additional paid-in capital&#x201d;, a component of &#x201c;Stockholders' equity&#x201d; on the consolidated balance sheets.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(j)&nbsp;Net Loss per Common Share</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">701,977</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">711,453</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2016, </div>were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.<div style="display: inline; font-weight: bold;"> &nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(</div></div><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">k</div></div><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">) </div></div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Share-Based Compensation</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Costs resulting from all share-based payment transactions are recognized in the consolidated financial statements at their fair values. The aggregate share-based compensation expense recorded in the consolidated statements of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.2</div> million, respectively. The following table summarizes share-based compensation related to the Company&#x2019;s share-based plans by expense category for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016:</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three months ended July 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Product development</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">53 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Selling, general and administratvie</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">78 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">165 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total share-based compensation expense</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">218 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: 36pt">&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(l) Recently Issued Accounting Standards</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>).&#x201d;</div> ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The FASB subsequently issued additional clarifying standards to address issues arising from implementation of the new revenue standard, including a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-year deferral of the effective date for the new revenue standard. Public companies should now apply the guidance in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> to annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and interim periods within those annual periods. Earlier application is permitted only as of annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> including interim periods within that annual period. As such, the Company is required to adopt this standard effective in fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> which begins <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2018. </div>Companies <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>use either a full retrospective or a modified retrospective approach to adopt ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet completed its final review of the impact of this guidance; however the Company anticipates applying the modified retrospective method upon adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2018.</div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> The impact to the Company could be affected by the nature and terms of potential future contracts with customers, as those contracts <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>have terms that differ from the Company&#x2019;s current contracts. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 7.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.5pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2014, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">&#x201c;Disclosure of Uncertainties about an Entity&#x2019;s Ability</div> <div style="display: inline; font-style: italic;">to Continue as a Going Concern&#x201d;,</div> which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> annual period ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>and interim periods thereafter. Early application is permitted. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> for the fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> The Company&#x2019;s addition of the standard did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on its disclosures.</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> See section (c) &#x201c;Liquidity/Going Concern&#x201d; within Note (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>)&nbsp;&#x201c;Background and Liquidity&#x201d; of the consolidated financial statements included in this Quarterly Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q for further discussion on the Company&#x2019;s ability to continue as a going concern.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div><div style="display: inline; font-style: italic;"> &#x201c;Recognition and Measurement of Financial Assets and Financial Liabilities&#x201d;,</div> which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>including interim periods within those fiscal years. The Company will evaluate the effect of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01</div> for future periods as applicable.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: 21.6pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">&#x201c;Leases (Topic&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div></div>).&#x201d; The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div>&nbsp;months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will have on its consolidated financial statements and disclosures and has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet determined the effect of the standard on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">&#x201c;Compensation - Stock Compensation (Topic</div> <div style="display: inline; font-style: italic;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>)</div><div style="display: inline; font-style: italic;">.</div><div style="display: inline; font-style: italic;">&#x201d;</div> The amendments of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including accounting for forfeitures, income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>and interim periods within those annual periods. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2017. </div>Certain of the amendments are applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2017, </div>while other amendments are applied retrospectively, prospectively or using either a prospective or a retrospective transition method. Upon adoption, the Company is beginning to account for forfeitures as they occur rather than estimate a forfeiture rate and has recorded a cumulative-effect adjustment in equity of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10,000</div> on the date of initial adoption. In periods subsequent to adoption, a higher expense will be recognized earlier during the respective vesting periods of stock-based awards that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> forfeited. The Company expects that the income tax amendments within ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> will have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on its results of operations or cash flows because it is in a net operating loss position with a full valuation allowance. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">&#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Classification</div> <div style="display: inline; font-style: italic;">of Certain Cash Receipts and Cash Payments&#x201d;,</div> providing additional guidance on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within those fiscal years and early adoption is permitted. The Company has evaluated the effect ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> will have on its consolidated financial statements and disclosures and has determined the standard will have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on its ongoing financial reporting at this time.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> <div style="display: inline; font-style: italic;">&#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Restricted</div> <div style="display: inline; font-style: italic;">Cash&#x201d;,</div> which amends guidance and presentation related to restricted cash in the statement of cash flows, including stating that amounts generally described as restricted cash and restricted cash equivalents should be included within cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. An entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within those fiscal years and early adoption is permitted. The Company has early adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 1, 2017. </div>In connection with the adoption of the standard the Company has used a retrospective transition method for each period presented in the statement of cash flows. The Company reclassified <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$488,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$300,000</div> of restricted cash to cash, cash equivalents and restricted cash, beginning of period for the period <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2016 </div>in the statement of cash flows. The Company reclassified <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$266,000</div> of restricted cash to cash, cash equivalents and restricted cash, end of period for the period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2016 </div>in the statement of cash flows.</div></div></div> 417000 595000 2760000 360000 6192750 807750 6192750 114459 7000 7214000 7221000 10086000 5447000 6000 -263000 193234000 -187370000 -160000 13000 -295000 200549000 -190043000 -138000 10 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;<div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>)&nbsp;Accrued Expenses</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued expenses consist of the following at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2017.</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">July 31, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">April 30, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="6"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</td> </tr> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Project costs </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">898 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contract loss reserve</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">298 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">238 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Employee incentive payments</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">142 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">643 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued salary and benefits</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">420 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">484 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Legal and accounting fees</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">358 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">478 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued taxes payable</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Other</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">134 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">186 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,530 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,059 </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 70081 48065 22016 447 295000 263000 32000 32000 163000 296000 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(b) Use of Estimates</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The current economic environment, particularly the macroeconomic pressures in certain European countries, has increased the degree of uncertainty inherent in those estimates and assumptions.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div> 12268683000 2228585000 xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares iso4217:EUR utr:T utr:Rate 0001378140 us-gaap:ForeignCountryMember us-gaap:TaxAuthoritySpainMember 2012-06-01 2012-06-30 0001378140 optt:ReverseStockSplitMember 2015-10-22 2015-10-22 0001378140 2016-05-01 2016-07-31 0001378140 us-gaap:EmployeeStockOptionMember 2016-05-01 2016-07-31 0001378140 us-gaap:RestrictedStockMember 2016-05-01 2016-07-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-05-01 2016-07-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:MitsuiEngineeringAndShipBuildingMember 2016-05-01 2016-07-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:USDepartmentOfDefenseOfficeOfNavalResearchMember 2016-05-01 2016-07-31 0001378140 us-gaap:FairValueMeasurementsNonrecurringMember 2016-05-01 2016-07-31 0001378140 us-gaap:WarrantMember 2016-05-01 2016-07-31 0001378140 us-gaap:WarrantMember us-gaap:MaximumMember 2016-05-01 2016-07-31 0001378140 us-gaap:WarrantMember us-gaap:MinimumMember 2016-05-01 2016-07-31 0001378140 optt:ProductDevelopmentMember 2016-05-01 2016-07-31 0001378140 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-05-01 2016-07-31 0001378140 us-gaap:TreasuryStockMember 2016-05-01 2016-07-31 0001378140 2016-05-01 2017-04-30 0001378140 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignCountryMember us-gaap:TaxAuthoritySpainMember 2016-05-01 2017-04-30 0001378140 us-gaap:WarrantMember 2016-05-01 2017-04-30 0001378140 optt:PlacementAgentsMember optt:PlacementAgentFeesMember optt:PurchaseAgreementMember 2016-06-02 2016-06-02 0001378140 optt:PlacementAgentsMember optt:ReimbursementOfOutOfPocketAndLegalExpensesMember optt:PurchaseAgreementMember 2016-06-02 2016-06-02 0001378140 optt:PurchaseAgreementMember 2016-06-02 2016-06-02 0001378140 optt:PurchaseAgreementMember 2016-07-22 2016-07-22 0001378140 optt:OfferingAgreementMember 2016-10-19 2016-10-19 0001378140 us-gaap:OverAllotmentOptionMember 2016-10-19 2016-10-19 0001378140 2017-05-01 2017-07-31 0001378140 optt:BarclaysBankMember 2017-05-01 2017-07-31 0001378140 us-gaap:EmployeeStockOptionMember 2017-05-01 2017-07-31 0001378140 optt:NonVestedRestrictedStockMember 2017-05-01 2017-07-31 0001378140 us-gaap:RestrictedStockMember 2017-05-01 2017-07-31 0001378140 us-gaap:RestrictedStockMember optt:PerformanceBasedVestingMember 2017-05-01 2017-07-31 0001378140 us-gaap:RestrictedStockMember optt:ServiceBasedVestingMember 2017-05-01 2017-07-31 0001378140 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignCountryMember us-gaap:TaxAuthoritySpainMember 2017-05-01 2017-07-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-05-01 2017-07-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:MitsuiEngineeringAndShipBuildingMember 2017-05-01 2017-07-31 0001378140 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember optt:USDepartmentOfDefenseOfficeOfNavalResearchMember 2017-05-01 2017-07-31 0001378140 us-gaap:FairValueMeasurementsNonrecurringMember 2017-05-01 2017-07-31 0001378140 us-gaap:WarrantMember 2017-05-01 2017-07-31 0001378140 us-gaap:WarrantMember us-gaap:MaximumMember 2017-05-01 2017-07-31 0001378140 us-gaap:WarrantMember us-gaap:MinimumMember 2017-05-01 2017-07-31 0001378140 optt:ProductDevelopmentMember 2017-05-01 2017-07-31 0001378140 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-05-01 2017-07-31 0001378140 optt:CurrentMember 2017-05-01 2017-07-31 0001378140 us-gaap:MaximumMember 2017-05-01 2017-07-31 0001378140 us-gaap:MinimumMember 2017-05-01 2017-07-31 0001378140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-05-01 2017-07-31 0001378140 us-gaap:AdditionalPaidInCapitalMember 2017-05-01 2017-07-31 0001378140 us-gaap:CommonStockMember 2017-05-01 2017-07-31 0001378140 us-gaap:RetainedEarningsMember 2017-05-01 2017-07-31 0001378140 us-gaap:TreasuryStockMember 2017-05-01 2017-07-31 0001378140 optt:OfferingAgreementMember 2017-05-02 2017-05-02 0001378140 us-gaap:OverAllotmentOptionMember 2017-05-02 2017-05-02 0001378140 optt:StipulationMember 2017-08-01 2017-08-31 0001378140 2001-04-30 0001378140 us-gaap:ForeignCountryMember us-gaap:TaxAuthoritySpainMember 2012-06-30 0001378140 2016-04-30 0001378140 us-gaap:AccountingStandardsUpdate201618Member us-gaap:RestatementAdjustmentMember 2016-04-30 0001378140 us-gaap:WarrantMember 2016-04-30 0001378140 optt:PurchaseAgreementMember 2016-06-02 0001378140 optt:PurchaseAgreementMember 2016-07-22 0001378140 2016-07-31 0001378140 us-gaap:AccountingStandardsUpdate201618Member us-gaap:RestatementAdjustmentMember 2016-07-31 0001378140 optt:OfferingAgreementMember 2016-10-19 0001378140 us-gaap:ForeignCountryMember us-gaap:TaxAuthoritySpainMember 2017-01-31 0001378140 2017-04-30 0001378140 us-gaap:AccountingStandardsUpdate201618Member us-gaap:RestatementAdjustmentMember 2017-04-30 0001378140 optt:NonVestedRestrictedStockMember 2017-04-30 0001378140 optt:CheckingAndSavingsAccountsMember 2017-04-30 0001378140 optt:OvernightRepurchaseAccountMember 2017-04-30 0001378140 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-04-30 0001378140 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-04-30 0001378140 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-04-30 0001378140 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-04-30 0001378140 us-gaap:WarrantMember 2017-04-30 0001378140 optt:BarclaysBankAgreementMember 2017-04-30 0001378140 optt:SantanderBankMember 2017-04-30 0001378140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-04-30 0001378140 us-gaap:AdditionalPaidInCapitalMember 2017-04-30 0001378140 us-gaap:CommonStockMember 2017-04-30 0001378140 us-gaap:RetainedEarningsMember 2017-04-30 0001378140 us-gaap:TreasuryStockMember 2017-04-30 0001378140 us-gaap:AccountingStandardsUpdate201609Member us-gaap:RetainedEarningsMember 2017-05-01 0001378140 optt:OfferingAgreementMember 2017-05-02 0001378140 2017-07-31 0001378140 optt:BarclaysBankMember 2017-07-31 0001378140 us-gaap:EmployeeStockOptionMember 2017-07-31 0001378140 optt:NonVestedRestrictedStockMember 2017-07-31 0001378140 us-gaap:RestrictedStockMember 2017-07-31 0001378140 us-gaap:RestrictedStockMember optt:PerformanceBasedVestingMember 2017-07-31 0001378140 optt:CheckingAndSavingsAccountsMember 2017-07-31 0001378140 optt:OvernightRepurchaseAccountMember 2017-07-31 0001378140 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-07-31 0001378140 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-07-31 0001378140 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-07-31 0001378140 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-07-31 0001378140 us-gaap:WarrantMember 2017-07-31 0001378140 optt:StipulationMember 2017-07-31 0001378140 optt:BarclaysBankAgreementMember 2017-07-31 0001378140 optt:SantanderBankMember 2017-07-31 0001378140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-07-31 0001378140 us-gaap:AdditionalPaidInCapitalMember 2017-07-31 0001378140 us-gaap:CommonStockMember 2017-07-31 0001378140 us-gaap:RetainedEarningsMember 2017-07-31 0001378140 us-gaap:TreasuryStockMember 2017-07-31 0001378140 2017-08-30 EX-101.SCH 7 optt-20170731.xsd EXHIBIT 101.SCH 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Unaudited Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Unaudited Consolidated Statements of Comprehensive Loss link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Unaudited Consolidated Statements of Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Unaudited Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 1 - Background, Basis of Presentation and Liquidity link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 3 - Marketable Securities link:calculationLink link:definitionLink link:presentationLink 010 - Document - Note 4 - Accrued Expenses link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 5 - Deferred Credits Payable link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 6 - Warrants link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 7 - Stock-based Compensation link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 8 - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 9 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 10 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 11 - Operating Segments and Geographic Information link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 3 - Marketable Securities (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 4 - Accrued Expenses (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 6 - Warrants (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 7 - Stock-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 8 - Fair Value Measurements (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 1 - Background, Basis of Presentation and Liquidity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Cash Restricted Under Security Agreements (Details) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Revenues by Major Customers (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Share-based Compensation (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 3 - Marketable Securities - Marketable Securities That Mature Within One Year (Details) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 4 - Accrued Expenses - Accrued Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 5 - Deferred Credits Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 6 - Warrants (Details Textual) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 6 - Warrants - Fair Value Assumptions for Warrants (Details) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 7 - Stock-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 7 - Stock-based Compensation - Fair Value Assumptions for Options (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 7 - Share-based Compensation Plans - Stock Options Under the Plans (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 7 - Share-based Compensation Plans - Non-vested Restricted Stock Under the Plans (Details) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 8 - Fair Value Measurements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 8 - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 8 - Fair Value Measurements - Changes on Value of Warrant Liability (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 9 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 10 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 11 - Operating Segments and Geographic Information (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 optt-20170731_cal.xml EXHIBIT 101.CAL EX-101.DEF 9 optt-20170731_def.xml EXHIBIT 101.DEF EX-101.LAB 10 optt-20170731_lab.xml EXHIBIT 101.LAB Document And Entity Information Note To Financial Statement Details Textual statementsignificantaccountingpoliciespolicies statementnote2summaryofsignificantaccountingpoliciestables statementnote3marketablesecuritiestables us-gaap_PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs statementnote4accruedexpensestables Type of Adoption [Domain] statementnote6warrantstables Adjustments for New Accounting Pronouncements [Axis] statementnote7stockbasedcompensationtables statementnote8fairvaluemeasurementstables Operating expenses: statementnote2summaryofsignificantaccountingpoliciescashandcashequivalentsdetails statementnote2summaryofsignificantaccountingpoliciescashrestrictedundersecurityagreementsdetails statementnote2summaryofsignificantaccountingpoliciesreconciliationofcashcashequivalentsandrestrictedcashdetails statementnote2summaryofsignificantaccountingpoliciesrevenuesbymajorcustomersdetails statementnote2summaryofsignificantaccountingpoliciessharebasedcompensationdetails Revenues Revenues statementnote3marketablesecuritiesmarketablesecuritiesthatmaturewithinoneyeardetails statementnote4accruedexpensesaccruedexpensesdetails statementnote6warrantsfairvalueassumptionsforwarrantsdetails Financial Instruments [Domain] statementnote7stockbasedcompensationfairvalueassumptionsforoptionsdetails statementnote7sharebasedcompensationplansstockoptionsundertheplansdetails statementnote7sharebasedcompensationplansnonvestedrestrictedstockundertheplansdetails statementnote8fairvaluemeasurementsfinancialassetsandliabilitiesmeasuredatfairvalueonarecurringbasisdetails statementnote8fairvaluemeasurementschangesonvalueofwarrantliabilitydetails Purchase Agreement [Member] Represents the securities purchase agreement. Financial Instrument [Axis] Notes To Financial Statements Notes To Financial Statements [Abstract] optt_ClassOfWarrantOrRightExpirationPeriod Class of Warrant or Right, Expiration Period Period from date of issuance that the warrant or right expires. Reimbursement of Out of Pocket and Legal Expenses [Member] Represents the amount reimbursed to the placement agents for their out of pocket and legal expenses in connection with the offering. Proceeds from issuance of common stock and related warrants, net of costs Proceeds from Issuance or Sale of Equity us-gaap_PaymentsForRepurchaseOfCommonStock Acquisition of treasury stock Placement Agents [Member] Represents the persons in connection with the securities purchase agreement. Adoption of accounting standard update related to stock compensation accounting (ASU 2016-09) Cumulative Effect of New Accounting Principle in Period of Adoption Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 1 [Member] Placement Agent Fees [Member] Represents the fees associated with the placement agents in the securities purchase agreement. optt_LitigationSettlementAmountPaidByInsurer Litigation Settlement, Amount Paid by Insurer Amount of judgment or settlement paid by the entity's insurer in respect of litigation. Retained Earnings [Member] Stipulation [Member] Represents the Stipulation and Agreement of Class Settlement. Fair Value, Inputs, Level 3 [Member] Santander Bank [Member] Cash on deposit at Santander Bank which serves as security for letter of credit. us-gaap_LineOfCredit Long-term Line of Credit Additional Paid-in Capital [Member] Treasury Stock [Member] us-gaap_MarketableSecuritiesCurrent Marketable securities Fair Value Hierarchy [Domain] Cash flows from investing activities: Fair Value, Hierarchy [Axis] Interim Period, Costs Not Allocable [Domain] Proceeds from issuance of common stock, net of costs Nature of Expense [Axis] Reported Value Measurement [Member] Marketable Securities, Policy [Policy Text Block] Equity Component [Domain] Concentration Risk, Credit Risk, Policy [Policy Text Block] Common Stock [Member] Equity Components [Axis] Accounts Payable and Accrued Liabilities [Member] Cash and Cash Equivalents [Domain] Unearned revenues Cash and Cash Equivalents [Axis] us-gaap_LineOfCreditFacilityCommitmentFeePercentage Line of Credit Facility, Commitment Fee Percentage Supplemental Balance Sheet Disclosures [Text Block] us-gaap_IncreaseDecreaseInAccruedLiabilities Accrued expenses Restrictions on Cash and Cash Equivalents [Table Text Block] optt_PricePerCommonStockAndWarrant Price Per Common Stock and Warrant Per unit amount of common stock and warrant issued. Restricted Cash and Cash Equivalents [Axis] us-gaap_TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired Acquisition of treasury stock (in shares) Preferred stock, shares outstanding (in shares) Use of Estimates, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Cash and Cash Equivalents [Table Text Block] Product Development [Member] Primary financial statement caption encompassing product development. us-gaap_SharesOutstanding Balance (in shares) Balance (in shares) us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable Weighted average shares used to compute basic and diluted net loss per share (in shares) Basic and diluted net loss per share (in dollars per share) us-gaap_SharePrice Share Price us-gaap_IncomeTaxExaminationPenaltiesExpense Income Tax Examination, Penalties Expense Restricted cash Consolidation, Policy [Policy Text Block] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Offering Agreement [Member] Offering-agreement. Tax Authority, Spain [Member] us-gaap_RepaymentsOfLongTermCapitalLeaseObligations Payment of capital lease obligations Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block] Tabular disclosure of the components of cash, cash equivalents, and restricted cash. Restatement Adjustment [Member] Checking and Savings Accounts [Member] Checking and savings accounts [member] Barclays Bank Agreement [Member] Barclays bank agreement [member] U.S. Department of Defense Office of Naval Research [Member] Related to the customer U.S. Department of Defense Office of Naval Research. Balance Sheet Location [Domain] Balance Sheet Location [Axis] Scenario, Unspecified [Domain] Selling, General and Administrative Expenses [Member] Mitsui Engineering and Ship Building [Member] Related to the customer Mitsui Engineering and Ship Building. Scenario [Axis] Income Tax Authority, Name [Domain] Nonmonetary Transaction Type [Domain] Current [Member] Current [member] Nonmonetary Transaction Type [Axis] Foreign Tax Authority [Member] us-gaap_FairValueAssumptionsExpectedVolatilityRate Expected volatility Stock based compensation Income Tax Authority, Name [Axis] Customer Advances and Deposits Disclosure [Text Block] Customer Advances And Deposits Disclosure optt_DeferredCreditsPayableOptionDetails Deferred Credits Payable Option Details Deferred credits payable option details optt_DeferredCreditsPayableMarketDiscountRate Deferred Credits Payable Market Discount Rate Deferred Credits Payable Market Discount Rate Income Tax Authority [Domain] optt_DeferredCreditsPayableMarketLiquidatedDamagesRate Deferred Credits Payable Market Liquidated Damages Rate Deferred Credits Payable Market Liquidated Damages Rate Income Tax Authority [Axis] Performance-based vesting [Member] Represents the performance-based vesting requirements. Revenues, percentage Income Statement Location [Domain] Income Statement Location [Axis] us-gaap_TreasuryStockValueAcquiredCostMethod Acquisition of treasury stock Maximum [Member] Customer Concentration Risk [Member] Basis of Accounting, Policy [Policy Text Block] Range [Domain] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Minimum [Member] us-gaap_TreasuryStockValue Treasury stock, at cost; 70,081 and 48,065 shares, respectively Customer [Axis] us-gaap_StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio us-gaap_IncreaseDecreaseInOtherOperatingAssets Other assets Concentration Risk Type [Domain] Significant Accounting Policies [Text Block] Range [Axis] us-gaap_UnrecognizedTaxBenefits Unrecognized Tax Benefits Accounting Policies [Abstract] Customer [Domain] us-gaap_LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party Statement of Financial Position [Abstract] Concentration Risk Type [Axis] optt_InputTax Input Tax Input tax. Sales Revenue, Net [Member] Statement of Cash Flows [Abstract] Statement of Stockholders' Equity [Abstract] us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Axis] Issuance of restricted stock, net (in shares) Legal Entity Type of Counterparty [Domain] us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Exercised (in shares) Issuance of restricted stock, net us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Total comprehensive loss Legal Entity of Counterparty, Type [Axis] us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Change in fair value Net loss Net loss us-gaap_IncreaseDecreaseInUnbilledReceivables Unbilled receivable us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Cancelled/forfeited (in shares) Granted (in shares) Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] us-gaap_RepaymentsOfDebt Payment of debt Sale of stock, net of financing costs (in shares) Stock Issued During Period, Shares, New Issues Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Sale of stock, net of financing costs us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders’ equity us-gaap_IncomeTaxExpenseBenefit Income Tax Expense (Benefit) Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss us-gaap_CustomerAdvancesOrDepositsNoncurrent Customer Advances or Deposits, Noncurrent us-gaap_PolicyTextBlockAbstract Accounting Policies Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair value Fair value Marketable Securities [Table Text Block] Major Types of Debt and Equity Securities [Domain] Transfers Statement [Table] Major Types of Debt and Equity Securities [Axis] Issuance Foreign exchange gain Foreign exchange gain Cash flows from financing activities: Income Statement [Abstract] Long-term portion of capital lease obligations Contract loss reserve us-gaap_NumberOfOperatingSegments Number of Operating Segments Class of Stock [Axis] Award Type [Axis] Equity Award [Domain] Interest income, net Segment Reporting Disclosure [Text Block] us-gaap_FairValueAssumptionsExpectedDividendRate Dividend rate us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements us-gaap_FairValueAssumptionsRiskFreeInterestRate Risk-free rate Foreign Currency Transactions and Translations Policy [Policy Text Block] Deferred credits payable current Customer Advances and Deposits, Current Reverse Stock Split [Member] The conversion of a reverse stock split where there is a reduction in the shares outstanding us-gaap_LiabilitiesCurrent Total current liabilities us-gaap_FairValueAssumptionsExpectedTerm Expected life (years) (Year) Fair Value, Measurements, Nonrecurring [Member] Earnings Per Share, Policy [Policy Text Block] Fair Value, Measurements, Recurring [Member] Schedule of Other Assets and Other Liabilities [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block] Share-based Compensation, Activity [Table Text Block] us-gaap_OperatingExpenses Total operating expenses Fair Value, Measurement Frequency [Domain] Measurement Frequency [Axis] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Changes in operating assets and liabilities: Litigation payable Estimated Litigation Liability, Current Restricted cash- long-term Restricted cash- long term Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Expected dividend yield us-gaap_DerivativeLiabilitiesCurrent Derivative Liability, Current us-gaap_LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Risk-free interest rate us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Expected volatility us-gaap_OperatingIncomeLoss Operating loss Cost of revenues us-gaap_GrossProfit Gross profit (loss) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 Expected life (in years) (Year) Litigation Case [Domain] Current portion of capital lease obligations Treasury stock (in shares) Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Amendment Flag Warrant Liability, Policy [Policy Text Block] Disclosure of accounting policy for warrant liability. Litigation Case [Axis] Warrant Disclosure [Text Block] The entire disclosure for warrants. Common stock, $0.001 par value; authorized 50,000,000 shares, issued 12,621,205 and 6,313,996 shares, respectively Change in fair value of warrant liabilities Fair Value Adjustment of Warrants Change in fair value of warrant liabilities Commitments and Contingencies Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Cancelled/forfeited (in dollars per share) Common stock, shares authorized (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Vested (in dollars per share) Changes on Value of Warrant Liability [Table Text Block] Tabular disclosure of pertinent information about the changes on the value of the warrant liability. Common stock, shares issued (in shares) Other noncurrent assets us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Beginning Balance, issued and unvested (in dollars per share) Ending Balance, issued and unvested (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Beginning Balance, issued and unvested (in shares) Ending Balance, issued and unvested (in shares) Common stock, par value (in dollars per share) Income Tax Disclosure [Text Block] us-gaap_GainLossOnSaleOfPropertyPlantEquipment Loss on disposal of property, plant and equipment Compensation expense related to stock option grants and restricted stock us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Granted (in dollars per share) us-gaap_InsuranceSettlementsReceivable Insurance Settlements Receivable us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Cancelled/forfeited (in shares) Current Fiscal Year End Date us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Vested (in shares) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Document Fiscal Period Focus Document Fiscal Year Focus Warrant liabilities The current portion of warrant liability. us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Litigation receivable Exercisable, weighted average remaining contractual term (Year) Document Period End Date Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding Preferred stock, shares issued (in shares) Overnight Repurchase Account [Member] Represents overnight repurchase account. Exercisable, weighted average exercise price (in dollars per share) Document Type Exercisable, shares underlying options (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Accrued taxes payable Depreciation and amortization us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 Balance, weighted average remaining contractual term (Year) Preferred stock, shares authorized (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Accounts payable Document Information [Line Items] Document Information [Table] Preferred stock par value (in dollars per share) us-gaap_AssetsCurrent Total current assets us-gaap_AccruedLiabilitiesCurrent Accrued expenses Accrued expenses total Estimate of Fair Value Measurement [Member] Entity Filer Category Employee incentive payments Entity Current Reporting Status Counterparty Name [Domain] Entity Voluntary Filers Counterparty Name [Axis] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares Entity Well-known Seasoned Issuer Measurement Basis [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Beginning Balance, weighted average exercise price (in dollars per share) Ending Balance, weighted average exercise price (in dollars per share) Portion at Fair Value Measurement [Member] optt_NumberOfFinancingAgreementsClosed Number of Financing Agreements Closed Refers to the number of financing agreements closed by the company. Accrued salary and benefits us-gaap_PaymentsToAcquireMarketableSecurities Purchases of marketable securities Cancelled/forfeited (in dollars per share) Granted (in dollars per share) Adjustments to reconcile net loss to net cash used in operating activities: us-gaap_OtherAccruedLiabilitiesCurrent Other Exercised (in dollars per share) Legal and accounting fees Entity Central Index Key Entity Registrant Name us-gaap_AssetsFairValueAdjustment Assets, Fair Value Adjustment Entity [Domain] Legal Entity [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Beginning Balance, shares underlying options (in shares) Ending Balance, shares underlying options (in shares) us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Barclays Bank [Member] The entity of Barclays bank. Project costs Other current assets Entity Common Stock, Shares Outstanding (in shares) Cash paid for interest LIABILITIES AND STOCKHOLDERS' EQUITY us-gaap_Assets Total assets Additional paid-in capital optt_ForeignTaxExaminationRefund Foreign Tax Examination Refund The amount of tax refund due to the result of a foreign tax examination. Ocean Power Technologies, Inc. stockholders’ equity: Revenue Recognition, Policy [Policy Text Block] Trading Symbol us-gaap_LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount Non-vested Restricted Stock [Member] Business Description and Basis of Presentation [Text Block] us-gaap_PaymentsToAcquireMachineryAndEquipment Purchases of equipment Liquidity, Policy [Policy Text Block] Disclosure of liquidity accounting policy. Vesting [Domain] Selling, general and administrative costs Vesting [Axis] Commitments and contingencies Service-based Vesting [Member] Shares which will vest based on service. us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options us-gaap_Liabilities Total liabilities us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Restricted Stock [Member] Warrant [Member] Cash flows from operating activities: Employee Stock Option [Member] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Accounts Receivable Statement [Line Items] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Statement of Comprehensive Income [Abstract] Product development costs Supplemental schedule of cash flows information: AOCI Attributable to Parent [Member] us-gaap_PropertyPlantAndEquipmentUsefulLife Property, Plant and Equipment, Useful Life Fair Value Disclosures [Text Block] Restricted cash- short-term Restricted cash- short term Property and equipment, net us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period ASSETS Accounting Standards Update 2016-09 [Member] Effect of exchange rate changes on cash and cash equivalents us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net increase in cash, cash equivalents and restricted cash us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities Foreign currency translation adjustment Over-Allotment Option [Member] us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities Sale of Stock [Domain] us-gaap_TableTextBlock Notes Tables Sale of Stock [Axis] Other comprehensive loss Property, Plant and Equipment, Policy [Policy Text Block] Accounting Standards Update 2016-18 [Member] us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Total stockholders' equity Balance Balance Unbilled receivables EX-101.PRE 11 optt-20170731_pre.xml EXHIBIT 101.PRE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document And Entity Information - shares
3 Months Ended
Jul. 31, 2017
Aug. 30, 2017
Document Information [Line Items]    
Entity Registrant Name Ocean Power Technologies, Inc.  
Entity Central Index Key 0001378140  
Trading Symbol optt  
Current Fiscal Year End Date --04-30  
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Entity Common Stock, Shares Outstanding (in shares)   12,526,124
Document Type 10-Q  
Document Period End Date Jul. 31, 2017  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q1  
Amendment Flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jul. 31, 2017
Apr. 30, 2017
ASSETS    
Cash and cash equivalents $ 11,414 $ 8,421
Marketable securities 25 25
Restricted cash- short-term 361 334
Accounts Receivable 86 48
Unbilled receivables 163 296
Litigation receivable 350
Other current assets 383 622
Total current assets 12,782 9,746
Property and equipment, net 146 170
Restricted cash- long-term 154 154
Other noncurrent assets 3 3
Total assets 13,085 10,073
LIABILITIES AND STOCKHOLDERS' EQUITY    
Accounts payable 183 586
Accrued expenses 1,530 3,059
Litigation payable 350
Warrant liabilities 286 323
Current portion of capital lease obligations 36 35
Deferred credits payable current 600 600
Total current liabilities 2,985 4,603
Long-term portion of capital lease obligations 14 23
Total liabilities 2,999 4,626
Commitments and contingencies
Ocean Power Technologies, Inc. stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding
Common stock, $0.001 par value; authorized 50,000,000 shares, issued 12,621,205 and 6,313,996 shares, respectively 13 6
Treasury stock, at cost; 70,081 and 48,065 shares, respectively (295) (263)
Additional paid-in capital 200,549 193,234
Accumulated deficit (190,043) (187,370)
Accumulated other comprehensive loss (138) (160)
Total stockholders' equity 10,086 5,447
Total liabilities and stockholders’ equity $ 13,085 $ 10,073
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
Jul. 31, 2017
Apr. 30, 2017
Preferred stock par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 12,621,205 6,313,996
Treasury stock (in shares) 70,081 48,065
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Unaudited Consolidated Statements of Operations - USD ($)
shares in Thousands
3 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Revenues $ 195,000 $ 202,000
Cost of revenues 217,000 127,000
Gross profit (loss) (22,000) 75,000
Operating expenses:    
Product development costs 1,102,000 1,636,000
Selling, general and administrative costs 1,641,000 1,519,000
Total operating expenses 2,743,000 3,155,000
Operating loss (2,765,000) (3,080,000)
Change in fair value of warrant liabilities 37,000 (752,000)
Interest income, net 3,000
Foreign exchange gain 62,000 5,000
Net loss $ (2,663,000) $ (3,827,000)
Basic and diluted net loss per share (in dollars per share) $ (0.22) $ (1.72)
Weighted average shares used to compute basic and diluted net loss per share (in shares) 12,268,683 2,228,585
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Unaudited Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Net loss $ (2,663) $ (3,827)
Foreign currency translation adjustment 22 (31)
Total comprehensive loss $ (2,641) $ (3,858)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Unaudited Consolidated Statements of Stockholders' Equity - 3 months ended Jul. 31, 2017 - USD ($)
$ in Thousands
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Apr. 30, 2017 6,313,996 (48,065)        
Balance at Apr. 30, 2017 $ 6 $ (263) $ 193,234 $ (187,370) $ (160) $ 5,447
Net loss (2,663) (2,663)
Stock based compensation 91 91
Issuance of restricted stock, net (in shares) 114,459        
Issuance of restricted stock, net
Sale of stock, net of financing costs (in shares) 6,192,750        
Sale of stock, net of financing costs $ 7 7,214 7,221
Acquisition of treasury stock (in shares) (22,016)        
Acquisition of treasury stock $ (32) (32)
Other comprehensive loss 22 22
Balance (in shares) at Jul. 31, 2017 12,621,205 (70,081)        
Balance at Jul. 31, 2017 $ 13 $ (295) 200,549 (190,043) (138) 10,086
Adoption of accounting standard update related to stock compensation accounting (ASU 2016-09) $ 10 $ (10)
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Unaudited Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Cash flows from operating activities:    
Net loss $ (2,663,000) $ (3,827,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Foreign exchange gain (62,000) (5,000)
Depreciation and amortization 31,000 34,000
Loss on disposal of property, plant and equipment 4,000
Compensation expense related to stock option grants and restricted stock 91,000 218,000
Change in fair value of warrant liabilities (37,000) 752,000
Changes in operating assets and liabilities:    
Accounts receivable (38,000) (150,000)
Unbilled receivable 133,000 (13,000)
Other assets 239,000 (370,000)
Accounts payable (405,000) 264,000
Accrued expenses (1,531,000) 215,000
Unearned revenues (39,000)
Net cash used in operating activities (4,238,000) (2,921,000)
Cash flows from investing activities:    
Purchases of marketable securities (25,000)
Purchases of equipment (12,000) (5,000)
Net cash used in investing activities (12,000) (30,000)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of costs 7,221,000
Proceeds from issuance of common stock and related warrants, net of costs 5,261,000
Payment of capital lease obligations (9,000)
Payment of debt (32,000)
Acquisition of treasury stock (32,000) (4,000)
Net cash provided by financing activities 7,180,000 5,225,000
Effect of exchange rate changes on cash and cash equivalents 90,000 (13,000)
Net increase in cash, cash equivalents and restricted cash 3,020,000 2,261,000
Cash, cash equivalents and restricted cash, beginning of period 8,909,000 7,030,000
Cash, cash equivalents and restricted cash, end of period 11,929,000 9,291,000
Supplemental schedule of cash flows information:    
Cash paid for interest $ 1,000 $ 2,000
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Background, Basis of Presentation and Liquidity
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Business Description and Basis of Presentation [Text Block]
(
1
) Background, Basis of Presentation and Liquidity
 
a)
Background
 
Ocean Power Technologies, Inc. (the “Company”) was founded in
1984
in New Jersey, commenced business operations in
1994
and re-incorporated in Delaware in
2007.
The Company is developing and commercializing its proprietary systems that generate electricity by harnessing the renewable energy of ocean waves. The Company uses proprietary technologies that convert the mechanical energy created by the heaving motion of ocean waves into electricity. The Company has designed and continues to develop the PowerBuoy product line which is based on modular, ocean-going buoys, which the Company has been periodically ocean testing since
1997.
The Company markets its PowerBuoys in the United States and internationally. Since fiscal
2002,
government agencies have accounted for a significant portion of the Company’s revenues.  These revenues were largely for the support of product development efforts. The Company’s goal is that an increased portion of its revenues be from the sale or lease of products and maintenance services, as compared to revenue to support its product development efforts. As the Company continues to advance its proprietary technologies, it expects to continue to have a net decrease in cash from operating activities unless and until it achieves positive cash flow from the planned commercialization of products and services.
 
b)
Basis of Presentation
 
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form
10
-Q and Article 
10
of Regulation S-
X.
Accordingly, they do
not
include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are
not
necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form
10
-K for the year ended
April 30, 2017
filed with the Securities and Exchange Commission (“SEC”) and elsewhere in this Form
10
-Q.
 
c)
Liquidity/Going Concern
 
The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of
$190.0
million as of
July 31, 2017.
As of
July 31, 2017,
the Company had approximately
$11.4
million in cash and cash equivalents on hand. The Company generated revenues of
$0.2
million during each of the
three
months ended
July 31, 2017
and
2016.
Based on the Company’s cash and cash equivalents and marketable securities as of
July 31, 2017,
the Company believes that it will be able to finance its capital requirements and operations into the quarter ending
July 31, 2018.
The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
 
The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do
not
include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
 
Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies
may
include, but are
not
limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company’s equity or debt securities; partnerships and/or collaborations. There can be
no
assurance that any of these future-funding efforts will be successful.
 
In fiscal
2017
and the
three
months ended
July 31, 2017,
the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company’s future results of operations involve significant risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are
not
limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys,
its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed
four
equity financing arrangements during the year ended
April 30, 2017
and
three
months ended
July 31, 2017.
The Company does
not
currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is
not
obtained when needed, the Company
may
be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and
may
cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.
 
On
June 2, 2016,
the Company entered into a securities purchase agreement, which was amended on
June 7, 2016 (
as amended, the “Purchase Agreement”) with certain institutional purchasers (the
“June
Purchasers”). Pursuant to the terms of the
June
Purchase Agreement, the Company sold an aggregate of
417,000
shares of Common Stock together with warrants to purchase up to an aggregate of
145,952
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.35
of a share of Common Stock at a combined purchase price of
$4.60.
The net proceeds to the Company from the offering were approximately
$1.7
million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of
$6.08
per share, became exercisable on
December 3, 2016 (
“Initial Exercise Date”), and will expire
five
years following the Initial Exercise Date. 
The Company paid the placement agents approximately
$0.1
million as placement agent fees in connection with the sale of securities in the offering. The Company also reimbursed the placement agents
$35,000
for their out of pocket and legal expenses in connection with the offering.  
 
On
July 22, 2016,
the Company entered into the Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain purchasers (the
“July
Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of
595,000
shares of Common Stock together with warrants to purchase up to an aggregate of
178,500
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.30
of a share of Common Stock at a combined purchase price of
$6.75.
The net proceeds to the Company from the offering were approximately
$3.6
million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of
$9.36
per share. The Warrants will expire on the
fifth
(
5th
) anniversary of the initial date of issuance.
 
On
October 19, 2016,
the Company sold
2,760,000
shares of common stock at a price of
$2.75
per share, which includes the sale of
360,000
shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately
$6.9
million, after deducting underwriter fees and offering expenses payable by the Company.
 
On
May 2, 2017,
the Company sold
6,192,750
shares of common stock at a price of
$1.30
per share, which includes the sale of
807,750
shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately
$7.2
million, after deducting underwriter fees and offering expenses payable by the Company.
 
The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company’s Common Stock and could contain covenants that would restrict its operations. Financing
may
not
be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it
may
be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it
may
be forced to cease operations.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
(
2
) Summary of Significant Accounting Policies
 
(a) Consolidation
 
The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
 
 
(b) Use of Estimates
 
The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates.
The current economic environment, particularly the macroeconomic pressures in certain European countries, has increased the degree of uncertainty inherent in those estimates and assumptions.
 
(c) Revenue Recognition
 
The Company’s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.
 
The Company has
two
types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of zero. The Company’s share of the costs is recorded as product development expense.
 
Generally, revenue under fixed price or cost plus contracts is recognized using the cost to cost percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria
may
be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.
 
In addition, recognition of revenue (and the related costs)
may
be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management
may
make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects
may
have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.
 
Unbilled receivables represent expenditures on contracts, plus applicable profit margin,
not
yet billed. Unbilled receivables are normally billed and collected within
one
year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.
  
(d) Cash, Cash Equivalents, Restricted Cash and Security Agreements
 
Cash and Cash Equivalents
 
The Company considers all highly liquid investments with a maturity of
three
months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does
not
take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least
100%
of the bank’s total obligations under the agreement.
 
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Checking and savings accounts
  $
4,400
    $
4,241
 
Overnight repurchase account
   
7,014
     
4,180
 
    $
11,414
    $
8,421
 
 
 Restricted Cash and
Security Agreements
 
A portion of the Company’s cash is restricted under the terms of
two
security agreements.
 
One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD,
one
of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility is approximately
€0.3
million (
$0.3
million) and carries a fee of
1%
per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does
not
have an expiration date, but is cancelable at the discretion of the bank. As of
July 31, 2017,
there was
€0.3
million (
$0.3
million) in letters of credit outstanding under this agreement.
 
The
second
agreement is between the Company and Santander Bank. Under this agreement, the cash is on deposit at Santander Bank and serves as security for letter of credit issued by Santander Bank for the lease of new warehouse/office space in Monroe Township, New Jersey. The agreement cannot be extended beyond
January 31, 2025,
and is cancelable at the discretion of the bank. Restricted cash includes the following:
 
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Barclay's Bank Agreement
  $
361
    $
334
 
Santander Bank
   
154
     
154
 
    $
515
    $
488
 
 
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.
 
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Cash and cash equivalents
  $
11,414
    $
8,421
 
Restricted cash- short term
   
361
     
334
 
Restricted cash- long term
   
154
     
154
 
    $
11,929
    $
8,909
 
 
(e) Marketable Securities
 
Marketable securities with original maturities longer than
three
months but that mature in less than
one
year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of
July 31, 2017
and
April 30, 2017,
all of the Company’s investments were classified as held-to-maturity.
 
 
(f) Foreign Exchange Gains and Losses
 
The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions
may
result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in “Foreign exchange gain/(loss)” in the accompanying consolidated statements of operations.
 
(g) Property and Equipment
 
Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives (
three
to
seven
years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset
may
not
be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.
 
(h) Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does
not
believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.
 
The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least
10%
of the Company's consolidated revenues for at least
one
of the periods indicated:
 
 
 
Three months ended July 31,
 
Customer
 
2017
 
 
2016
 
                 
Mitsui Engineering & Shipbuilding
   
67
%    
100
%
U.S. Department of Defense Office of  Naval Research
   
33
%    
-
 
     
100
%    
100
%
 
The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does
not
require its customers to maintain collateral.
 
(i) Warrant Liabilities
 
The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within “Change in fair value of warrant liabilities.” The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to “Additional paid-in capital”, a component of “Stockholders' equity” on the consolidated balance sheets.
 
(j) Net Loss per Common Share
 
Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.
 
In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling
701,977
for the
three
months ended
July 31, 2017
and
711,453
for the
three
months ended
July 31, 2016,
were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.
 
 
(
k
)
Share-Based Compensation
 
Costs resulting from all share-based payment transactions are recognized in the consolidated financial statements at their fair values. The aggregate share-based compensation expense recorded in the consolidated statements of operations for the
three
months ended
July 31, 2017
and
2016
was approximately
$0.1
million and
$0.2
million, respectively. The following table summarizes share-based compensation related to the Company’s share-based plans by expense category for the
three
months ended
July 31, 2017
and
2016:
 
 
 
Three months ended July 31,
 
 
 
2017
 
 
2016
 
   
(in thousands)
 
                 
Product development
  $
13
    $
53
 
Selling, general and administratvie
   
78
     
165
 
Total share-based compensation expense
  $
91
    $
218
 
 
(l) Recently Issued Accounting Standards
 
In
May 2014,
the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
No.
 
2014
-
09,
Revenue from Contracts with Customers (Topic
606
).”
ASU
2014
-
09
outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a
five
-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The FASB subsequently issued additional clarifying standards to address issues arising from implementation of the new revenue standard, including a
one
-year deferral of the effective date for the new revenue standard. Public companies should now apply the guidance in ASU
2014
-
09
to annual reporting periods beginning after
December 
15,
2017
and interim periods within those annual periods. Earlier application is permitted only as of annual reporting periods beginning after
December 
15,
2016,
including interim periods within that annual period. As such, the Company is required to adopt this standard effective in fiscal
2019,
which begins
May 1, 2018.
Companies
may
use either a full retrospective or a modified retrospective approach to adopt ASU
2014
-
09.
The Company has
not
yet completed its final review of the impact of this guidance; however the Company anticipates applying the modified retrospective method upon adoption of ASU
2014
-
09
on
May 1, 2018.
The impact to the Company could be affected by the nature and terms of potential future contracts with customers, as those contracts
may
have terms that differ from the Company’s current contracts.
 
In
August 2014,
the FASB issued ASU
2014
-
15,
“Disclosure of Uncertainties about an Entity’s Ability
to Continue as a Going Concern”,
which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the
first
annual period ending after
December 15, 2016,
and interim periods thereafter. Early application is permitted. The Company adopted ASU
2014
-
15
for the fiscal year
2017.
The Company’s addition of the standard did
not
have a material impact on its disclosures.
See section (c) “Liquidity/Going Concern” within Note (
1
) “Background and Liquidity” of the consolidated financial statements included in this Quarterly Report on Form
10
-Q for further discussion on the Company’s ability to continue as a going concern.
 
In
January 2016,
the FASB issued ASU
No.
2016
-
01,
“Recognition and Measurement of Financial Assets and Financial Liabilities”,
which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after
December 15, 2017,
including interim periods within those fiscal years. The Company will evaluate the effect of ASU
2016
-
01
for future periods as applicable.
 
In
February 2016,
the FASB issued ASU
No.
2016
-
02,
“Leases (Topic 
842
).” The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than
12
 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU
2016
-
02
is effective for annual periods beginning after
December 
15,
2018,
including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU
2016
-
02
will have on its consolidated financial statements and disclosures and has
not
yet determined the effect of the standard on its ongoing financial reporting at this time.
 
In
March 2016,
the FASB issued ASU
No.
2016
-
09,
“Compensation - Stock Compensation (Topic
718
)
.
The amendments of ASU
No.
2016
-
09
were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity
may
be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including accounting for forfeitures, income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU
No.
2016
-
09
is effective for fiscal years beginning after
December 15, 2016,
and interim periods within those annual periods. The Company adopted ASU
2016
-
09
on
May 1, 2017.
Certain of the amendments are applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of
May 1, 2017,
while other amendments are applied retrospectively, prospectively or using either a prospective or a retrospective transition method. Upon adoption, the Company is beginning to account for forfeitures as they occur rather than estimate a forfeiture rate and has recorded a cumulative-effect adjustment in equity of approximately
$10,000
on the date of initial adoption. In periods subsequent to adoption, a higher expense will be recognized earlier during the respective vesting periods of stock-based awards that are
not
forfeited. The Company expects that the income tax amendments within ASU
2016
-
09
will have
no
impact on its results of operations or cash flows because it is in a net operating loss position with a full valuation allowance.
 
In
August 2016,
the FASB issued ASU
2016
-
15,
“Statement of Cash Flows (Topic
230
): Classification
of Certain Cash Receipts and Cash Payments”,
providing additional guidance on
eight
specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for
fiscal years beginning after
December 15, 2017,
and interim periods within those fiscal years and early adoption is permitted. The Company has evaluated the effect ASU
2016
-
13
will have on its consolidated financial statements and disclosures and has determined the standard will have
no
impact on its ongoing financial reporting at this time.
 
In
November 2016,
the FASB issued ASU
2016
-
18,
“Statement of Cash Flows (Topic
230
): Restricted
Cash”,
which amends guidance and presentation related to restricted cash in the statement of cash flows, including stating that amounts generally described as restricted cash and restricted cash equivalents should be included within cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. An entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for
fiscal years beginning after
December 15, 2017,
and interim periods within those fiscal years and early adoption is permitted. The Company has early adopted ASU
2016
-
18
effective
May 1, 2017.
In connection with the adoption of the standard the Company has used a retrospective transition method for each period presented in the statement of cash flows. The Company reclassified
$488,000
and
$300,000
of restricted cash to cash, cash equivalents and restricted cash, beginning of period for the period
April 30, 2017
and
April 30, 2016
in the statement of cash flows. The Company reclassified
$266,000
of restricted cash to cash, cash equivalents and restricted cash, end of period for the period ended
July 31, 2016
in the statement of cash flows.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Marketable Securities
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
(
3
) Marketable Securities
 
Marketable securities with initial maturities greater than
three
months but that mature within
one
year from the balance sheet date are classified as current assets and are summarized as follows:
 
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Certificate of Deposit
  $
25
    $
25
 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Accrued Expenses
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Supplemental Balance Sheet Disclosures [Text Block]
  
(
4
) Accrued Expenses
 
Accrued expenses consist of the following at
July 31, 2017
and
April 30, 2017.
 
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Project costs
  $
46
    $
898
 
Contract loss reserve
   
298
     
238
 
Employee incentive payments
   
142
     
643
 
Accrued salary and benefits
   
420
     
484
 
Legal and accounting fees
   
358
     
478
 
Accrued taxes payable
   
132
     
132
 
Other
   
134
     
186
 
    $
1,530
    $
3,059
 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Deferred Credits Payable
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Customer Advances and Deposits Disclosure [Text Block]
 
(
5
) Deferred Credits Payable
 
During the year ended
April 
30,
2001,
in connection with the sale of common stock to an investor, the Company received
$0.6
million from the investor in exchange for an option to purchase up to
500,000
metric tons of carbon emissions credits generated by the Company during the years
2008
through
2012,
at a
30%
discount from the then-prevailing market rate. If the Company received emission credits under applicable laws and failed to sell to the investor the credits up to the full amount of emission credits covered by the option, the investor was entitled to liquidated damages equal to
30%
of the aggregate market value of the shortfall in emission credits (subject to a limit on the market price of emission credits).  Under the terms of the agreement, if the Company did
not
become entitled under applicable laws to the full amount of emission credits covered by the option by
December 
31,
2012,
the Company was obligated to return the option fee of
$0.6
million, less the aggregate discount on any emission credits sold to the investor prior to such date. In
December 2012,
the Company and the investor agreed to extend the period for the sale of emission credits until
December 31, 2017.
As of
July 31, 2017,
the Company has
not
generated any emissions credits eligible for purchase under the agreement. As a result, the Company anticipates returning the option fee of
$0.6
million. Therefore, the
$0.6
million is reflected in the consolidated balance sheets within “Deferred credits payable current” as of
July 31, 2017
and
April 30, 2017,
respectively.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Warrants
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Warrant Disclosure [Text Block]
(
6
) Warrants
 
On
June 2, 2016,
the Company entered into a securities purchase agreement, which was amended on
June 7, 2016 (
as amended, the
“June
Purchase Agreement”) with certain institutional purchasers (the
“June
Purchasers”). Pursuant to the terms of the
June
Purchase Agreement, the Company sold an aggregate of
417,000
shares of Common Stock together with warrants to purchase up to an aggregate of
145,952
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.35
of a share of Common Stock at a combined purchase price of
$4.60.
The warrants have an exercise price of
$6.08
per share, became exercisable on
December 3, 2016 (
“Initial Exercise Date”), and will expire
five
years following the Initial Exercise Date. 
 
On
July 22, 2016,
the Company entered into a Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain institutional purchasers (the
“July
Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of
595,000
shares of Common Stock together with warrants to purchase up to an aggregate of
178,500
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.30
of a share of Common Stock at a combined purchase price of
$6.75.
The Warrants were exercisable immediately at an exercise price of
$9.36
per share. The Warrants will expire on the
fifth
(
5th
) anniversary of the initial date of issuance.
  
Both sets of warrants contain a feature whereby they could require the transfer of assets and therefore are classified as a liability in accordance with ASC
480.
As such, the warrants with a value of
$0.3
million and
$0.3
million at
July 31, 2017
and
April 30, 2017,
respectively, are reflected within “Warrant liabilities” in the unaudited consolidated balance sheets.
 
An unrealized gain and unrealized loss of approximately
$37,000
and
$752,000,
respectively, were included within “Change in fair value of warrant liability” in the consolidated statements of operations for the
three
months ended
July 31, 2017
and
2016,
respectively. The Company determined the fair value using the Black-Scholes option pricing model with the following assumptions:
 
 
 
July 31, 2017
 
 
July 31, 2016
 
                     
Dividend rate
 
 
0.0%
 
   
 
0.0%
 
 
Risk-free rate
 
 
1.68%
 
   
 
1.00%
 
 
Expected life (years)
 
4.0
-
4.4
   
5.0
-
5.4
 
Expected volatility
 
 
140.3%
 
   
 
125.4%
 
 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Stock-based Compensation
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(
7
) Stock-Based Compensation
 
(a) Stock Options
 
Valuation Assumptions for Options Granted during the
three
months ended
July 31, 2017
and
2016
 
The fair value of each stock option granted, for both service-based and performance-based vesting requirements during the
three
months ended
July 31, 2017
and
2016,
was estimated at the date of grant using the Black-Scholes option pricing model, assuming
no
dividends, and using the weighted average valuation assumptions noted in the following table. The risk-free rate is based on the US Treasury yield curve in effect at the time of grant. The expected life (estimated period of time outstanding) of the stock options granted was estimated using the "simplified" method as permitted by the SEC's Staff Accounting Bulletin
No.
 
110,
Share-Based Payment.
Expected volatility was based on the Company’s historical volatility during the
three
months ended
July 31, 2017
and
2016.
The below assumptions were used to determine the weighted average per share fair value of
$1.10
for stock options granted during the
three
months ended
July 31, 2016.
No
options were granted during the
three
months ended
July 31, 2017.
 
 
 
Three months ended July 31,
 
 
 
2017
 
 
2016
 
                 
Risk-free interest rate
   
N/A
     
1.3
%
Expected dividend yield
   
N/A
     
0.0
%
Expected life (in years)
   
N/A
     
5.5
 
Expected volatility
   
N/A
     
85.6
%
   
 
A summary of stock options under our stock incentive plans is detailed in the following table. 
 
 
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
Weighted
 
 
Remaining
 
 
 
Shares
 
 
Average
 
 
Contractual
 
 
 
Underlying
 
 
Exercise
 
 
Term
 
 
 
Options
 
 
Price
 
 
(In Years)
 
Outstanding as of April 30, 2017
   
237,214
    $
14.64
     
7.6
 
Granted
   
-
    $
-
     
 
 
Exercised
   
-
    $
-
     
 
 
Cancelled/forfeited
   
(6,910
)   $
161.18
     
 
 
Outstanding as of July 31, 2017
   
230,304
    $
10.24
     
7.6
 
Exercisable as of July 31, 2017
   
128,641
    $
16.10
     
6.3
 
 
As of
July 31, 2017,
the total intrinsic value of outstanding and exercisable options was approximately
$5,000
and
$4,000,
respectively. As of
July 31, 2017,
approximately
100,323
additional options were unvested, which had
no
intrinsic value and a weighted average remaining contractual term of
9.2
years. There was approximately
$69,000
and
$83,000
 of total recognized compensation cost related to stock options during each of the
three
months ended
July 31, 2017
and
2016,
respectively. As of
July 31, 2017,
there was approximately
$0.1
million of total unrecognized compensation cost related to non-vested stock options granted under the plans. This cost is expected to be recognized over a weighted-average period of
0.4
years. The Company typically issues newly authorized but unissued shares to satisfy option exercises under these plans.
 
(b) Restricted Stock
 
Compensation expense for non-vested restricted stock is generally recorded based on its market value on the date of grant and recognized ratably over the associated service and performance period. During the
three
months ended
July 31, 2017,
the Company granted
114,584
shares subject to service-based vesting requirements and
no
shares subject to performance-based vesting requirements. The achievement or vesting requirement of the performance-based grants is tied to the Company’s total shareholder return (“TSR”) relative to the total shareholder return of
three
alternative energy Exchange Traded Funds as measured over a specific performance period.
No
vesting of the relevant shares will occur in instances where the Company’s TSR for the relevant period is below
80%
of the peer group. However, additional opportunities to vest some or all of a portion of the shares in a subsequent period
may
occur. Compensation expense for these awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.
 
Restricted stock issued and unvested as of
July 31, 2017
included
12,000
shares of unvested restricted stock subjected to performance-based vesting requirements.
 
A summary of non-vested restricted stock under our stock incentive plans is as follows:
 
 
 
 
 
 
 
Weighted
 
 
 
Number
 
 
Average Price per
 
 
 
of Shares
 
 
Share
 
                 
Issued and unvested at April 30, 2017
   
103,412
    $
3.99
 
Granted
   
114,584
    $
1.40
 
Vested
   
(70,650
)   $
4.55
 
Cancelled/forfeited
   
(125
)   $
1.40
 
Issued and unvested at July 31, 2017
   
147,221
    $
2.04
 
 
There was approximately
$22,000
and
$0.1
million of total recognized compensation cost related to restricted stock for the
three
months ended
July 31, 2017
and
2016,
respectively. As of
July 31, 2017,
there was approximately
$0.2
million of total unrecognized compensation cost related to unvested restricted stock granted under our plans. This cost is expected to be recognized over a weighted average period of
1.5
 years.
 
 
 
(c) Treasury Stock
 
During the
three
months ended
July 31, 2017
and
2016,
22,016
and
447
shares, respectively, of common stock were purchased by the Company from employees to pay taxes related to the vesting of restricted stock.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value Measurements
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
(
8
) Fair Value Measurements
 
The Company measures and reports certain financial and non-financial assets and liabilities on a fair value basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP specifies a
three
-level hierarchy that is used when measuring and disclosing fair value. The fair value hierarchy gives the highest priority to quoted prices available in active markets (i.e., observable inputs) and the lowest priority to data lacking transparency (i.e., unobservable inputs). An instrument’s categorization within the fair value hierarchy is based on the lowest level of significant input to its valuation. The following is a description of the
three
hierarchy levels.
 
Level
1
Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Active markets are considered to be those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.
 
 
Level
2
Quoted prices in markets that are
not
active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in inactive markets.
 
 
Level
3
   
Unobservable inputs are
not
corroborated by market data. This category is comprised of financial and non-financial assets and liabilities whose fair value is estimated based on internally developed models or methodologies using significant inputs that are generally less readily observable from objective sources.
 
Transfers into or out of any hierarchy level are recognized at the end of the reporting period in which the transfers occurred. There were
no
transfers between any levels during the
three
months ended
July 
31,
2017
and
2016.
 
The following information is provided to help readers gain an understanding of the relationship between amounts reported in the accompanying consolidated financial statements and the related market or fair value. The disclosures include financial instruments and derivative financial instruments, other than investment in affiliates.
 
Following are descriptions of the valuation methodologies used to measure material assets and liabilities at fair value and details of the valuation models, key inputs to those models and significant assumptions utilized.
 
Warrant Liabilities
 
The fair value of the Company's warrant liabilities (refer to Note 
6
) recorded in the Company's financial statements is determined using the Black-Scholes option pricing model and the quoted price of the Company's common stock in an active market, volatility and expected life, is a Level 
3
measurement. Volatility is based on the actual market activity of the Company's stock. The expected life is based on the remaining contractual term of the warrants and the risk free interest rate is based on the implied yield available on U.S. Treasury Securities with a maturity equivalent to the warrants' expected life.  
 
The following table presents financial assets and liabilities measured at fair value on a recurring basis as of
July 
31,
2017.
 
 
 
Total Carrying Value in Consolidated Balance Sheet
 
 
Quoted prices in active markets for identical assts or liabilities
(Level 1)
 
 
Significant other observable inputs
(Level 2)
 
 
Significant unobservable inputs
(Level 3)
 
   
(in thousands)
 
                                 
Warrant liabilities
  $
286
    $
-
    $
-
    $
286
 
 
 The following table presents financial assets and liabilities measured at fair value on a recurring basis as of
April 
30,
2017.
 
 
 
Total Carrying Value in Consolidated Balance Sheet
 
 
Quoted prices in active markets for identical assts or liabilities
(Level 1)
 
 
Significant other observable inputs
(Level 2)
 
 
Significant unobservable inputs
(Level 3)
 
   
(in thousands)
 
                                 
Warrant liabilities
  $
323
    $
-
    $
-
    $
323
 
 
The following table provides a summary of changes in fair value of the Company’s warrant liabilities held at
July 31, 2017.
 
 
Fair Value Measurement Using Significant Unobservable Inputs ( Level 3)  
       
   
Total
 
   
Warrant
 
   
Liability
 
   
(in thousands)
 
         
Fair value – April 30, 2016
  $
-
 
Issuance
   
1,814
 
Transfers
   
-
 
Change in fair value
   
(1,491
)
Fair value – April 30, 2017
  $
323
 
         
Change in fair value
   
(37
)
Fair value – July 31, 2017
  $
286
 
 
There were
no
re-measured assets or liabilities at fair value on a non-recurring basis during the
three
months ended
July 31, 2017
and
2016,
respectively.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Commitments and Contingencies
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
(
9
) Commitments and Contingencies
 
(a) Litigation
 
Shareholder Litigation and Demands 
 
The Company and certain of its current and former directors and officers are defendants in a derivative lawsuit filed on
March 18, 2015
in the United States District Court for the District of New Jersey captioned
Labare v. Dunleavy, et. al.,
Case
No.
3:15
-cv-
01980
-FLW-LHG. The derivative complaint alleges claims for breach of fiduciary duty, abuse of control, gross mismanagement and unjust enrichment relating to the now terminated agreement between Victorian Wave Partners Pty. Ltd. (VWP) and the Australian Renewable Energy Agency (ARENA) for the development of a wave power station. The derivative complaint seeks unspecified monetary damages and other relief.
 
On
July 10, 2015,
a
second
derivative lawsuit, captioned
Rywolt v. Dunleavy, et al.,
Case
No.
3:15
-cv-
05469,
was filed by another shareholder against the same defendants in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, gross mismanagement, abuse of control, and unjust enrichment relating to the now terminated agreement between VWP and ARENA. The
Rywolt
complaint also seeks unspecified monetary damages and other relief.
On
February 8, 2016,
the Court issued an order consolidating the
Labare
and
Rywolt
actions, appointing co-lead plaintiffs and lead counsel, and ordering a consolidated amended complaint to be filed within
30
days of the order. On
March 9, 2016,
the co-lead plaintiffs filed an amended complaint consolidating their claims and seeking unspecified monetary damages and other relief.
 
On
April 21, 2016,
a
third
derivative lawsuit, captioned
LaCalamito v. Dunleavy, et al.,
Case
No.
3:16
-cv-
02249,
was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty relating to the now terminated agreement between VWP and ARENA. The
LaCalamito
complaint seeks unspecified monetary damages and other relief.
The Company has
not
been formally served and has
not
yet responded to the complaint.
 
On
June 9, 2016,
a
fourth
derivative lawsuit, captioned
Pucillo v. Dunleavy, et al.,
was filed by another shareholder against certain current and former directors and officers of the Company in the United States District Court for the District of New Jersey alleging similar claims for breach of fiduciary duty, unjust enrichment, and abuse of control relating to the now terminated agreement between VWP and ARENA. The
Pucillo
complaint seeks unspecified monetary damages and other relief.
On
August 2, 2016,
the parties in the
Pucillo
lawsuit filed a Stipulation and Proposed Order pursuant to which: (i) the defendants agreed to accept service of the
Pucillo
complaint; (ii) the parties agreed to stay the
Pucillo
action pending the filing and resolution of a motion to consolidate the
Pucillo
action with the
Labar
e and
Rywolt
actions; and (iii) the parties agreed that the defendants shall
not
be required to respond to the
Pucillo
complaint during the pendency of the stay. The Court approved the Stipulation on
August 3, 2016.
 
On
October 25, 2016,
the Court approved and entered a Stipulation and Order that, among other things, (i) consolidated the
four
derivative actions; (ii) identified plaintiff
Pucillo
as the lead plaintiff in the consolidated actions; and (iii) stayed the consolidated actions pending the settlement hearing scheduled for
November 14, 2016
in the securities class action and further order of the Court. During the month of
August, 2017,
the Company tentatively reached a settlement with the plaintiff subject to final documentation. The settlement, once finalized and if approved by the court, provides, among other things, for a settlement payment by or on behalf of the Company of
$350,000,
of which the Company’s insurer would pay the complete amount of
$350,000.
As a result, the Company has accrued
$350,000
related to this matter as a probable and reasonably estimable loss contingency during the
three
months ended
July 31, 2017.
The Company also recorded a receivable of
$350,000
from its insurance carrier with the offset to the statement of operations.
 
On
May 26, 2017,
an attorney claiming to represent
two
stockholders sent the Company’s Board of Directors a Stockholder Litigation Demand letter (“Stockholder Demand”). The Stockholder Demand alleges that the voting of shares for the
1
-for-
10
reverse stock split at the
2015
annual meeting of stockholders held on
October 22, 2015
was
not
properly counted, and further alleges that, although the Company reported the reverse stock split as having been passed, if the vote was properly counted the reverse stock split would
not
have been approved. The Stockholder Demand requests the Board of Directors either to deem the reverse stock split as ineffective and disclose the same or to seek a proper and effective stockholder ratification of the reverse stock split. In addition, the Stockholder Demand requests the Board of Directors to adopt and implement adequate internal controls and systems to prevent the alleged improper voting from recurring. On
June 23, 2017,
the Company responded to the Stockholder Demand, explained the procedures that were followed for the
2015
annual meeting of stockholders and provided the Oath of the Inspector of Elections and the Certificate of the Inspector of Elections that certified as accurate the results of the voting at the meeting including voting on the reverse stock split proposal. On
June 26, 2017,
the attorney representing the alleged stockholders replied to the Company’s response, further alleged that the proxy statement underlying the
2015
annual meeting provided voting instructions that misled the stockholders regarding whether their brokers could vote on the reverse stock split proposal, and renewed their requests of the Board. On
July 24, 2017,
the Company provided an additional response to the Stockholders Demand, denied the allegations, and declined to take any of the actions requested.
 
Employment Litigation 
 
On
June 10, 2014,
the Company announced that it had terminated Charles Dunleavy as its Chief Executive Officer and as an employee of the Company for cause, effective
June 9, 2014,
and that Mr. Dunleavy had also been removed from his position as Chairman of the Board of Directors. On
June 17, 2014,
Mr. Dunleavy wrote to the Company stating that he had retained counsel to represent him in connection with an alleged wrongful termination of his employment. On
July 28, 2014,
Mr. Dunleavy resigned from the Board and the boards of directors of the Company's subsidiaries. The Company and Mr. Dunleavy have agreed to suspend his alleged employment claims pending resolution of the shareholder litigation, and have since agreed to continue to the suspension pending resolution of the derivatives litigation.
 
Except for the pending settlement noted previously, we have
not
established any provision for losses relating to these claims and pending litigation. Due to the stages of these proceedings, and considering the inherent uncertainty of these claims and litigation, at this time we are
not
able to predict or reasonably estimate whether we have any possible loss exposure or the ultimate outcome of these claims.
 
(b) Regulatory Matters
 
SEC Investigation
 
On
February 4, 2015,
the Company received a subpoena from the SEC requesting information related to the VWP Project. The Company has provided information to the SEC in response to that subpoena. As part of the same investigation, on
July 12, 2016,
the SEC issued
second
subpoena requesting information related to the Company’s
April 4, 2014
public offering. The Company has provided information to the SEC in response to that subpoena. The SEC investigation is ongoing and the Company continues to cooperate with the SEC in its investigation. We are unable to predict what action, if any, might be taken by the SEC or its staff as a result of this investigation or what impact, if any, the cost of responding to the SEC’s investigation or its ultimate outcome might have on our financial position, results of operations or liquidity. We have
not
established any provision for losses relating to this matter.
 
Spain IVA (sales tax)
 
In
June 2012,
the Company received notice that the Spanish tax authorities are inquiring into its
2010
IVA (value-added tax) filing for which the Company benefitted from the offset of approximately
$0.3
million of input tax. The Company believes that the inquiry will find that the tax credit was properly claimed and, therefore,
no
liability has been recorded. The Company issued
two
letters of credit totaling
€0.3
million (
$0.3
million) at the request of the Spanish tax authorities. On
January 31, 2017
the Company has received
$0.2
million from the Spanish tax authorities as a result of the conclusion of the inquiry. In addition, during
February 2017,
the Spanish tax authorities approved of the release of the
two
outstanding letters of credit.
    
Spain Income Tax Audit
 
The Company is currently undergoing an income tax audit in Spain for the period from
2008
to
2014,
when its Spanish branch was closed. The branch reported net operating losses for each of the years reported.
It is anticipated that the Company will be assessed a penalty relating to these tax years for these losses. The Company has estimated this penalty to be
$132,000
,
and as such, for the period ended
April 30, 2017
and
July 31, 2017,
the Company has recorded
$132,000
for this penalty to Accrued expenses in its balance sheet.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Income Taxes
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
(
10
) Income Taxes
 
 The Company did
not
recognize any consolidated income tax benefit (expense) during the
three
month periods ended
July 31, 2017
and
2016.
The Company has recorded a valuation allowance to reduce its net deferred tax asset to an amount that is more likely than
not
to be realized in future years. Accordingly, the benefit of the net operating loss that would have been recognized was offset by changes in the valuation allowance.
 
The Company applies the guidance issued by the FASB for the accounting and reporting of uncertain tax positions. The guidance requires the Company to recognize in its consolidated financial statements the impact of a tax position if that position is more likely than
not
to be sustained upon examination, based on the technical merits of the position. We are currently undergoing an income tax audit in Spain for the period from
2008
to
2014,
when our Spanish branch was closed. The branch reported net operating losses for each of the years reported. It is anticipated that we will be assessed a penalty relating to these tax years for these losses. We have estimated this penalty to be
$132,000
,
and as such, for the period ended
April 30, 2017
and
July 31, 2017,
we have recorded
$132,000
for this penalty to Accrued expenses in the Balance Sheet. At
July 
31,
2017
the Company had
no
other unrecognized tax positions. The Company does
not
expect any material increase or decrease in its income tax expense in the next
twelve
months, related to examinations or uncertain tax positions. U.S. federal and state income tax returns were audited through fiscal
2014
and fiscal
2010
respectively. Net operating loss and credit carry forwards since inception remain open to examination by taxing authorities, and will continue to remain open for a period of time after utilization.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Operating Segments and Geographic Information
3 Months Ended
Jul. 31, 2017
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
 (
11
) Operating Segments and Geographic Information
 
The Company's business consists of
one
segment as this represents management's view of the Company's operations. The Company operates on a worldwide basis with
one
operating company in the US and operating subsidiaries in the UK and in Australia. Revenues and expenses are generally attributed to the operating unit that bills the customers. During the
three
months ended
July 31, 2017
and
2016,
the Company’s primary business operations were in North America.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Significant Accounting Policies (Policies)
3 Months Ended
Jul. 31, 2017
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]
b)
Basis of Presentation
 
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form
10
-Q and Article 
10
of Regulation S-
X.
Accordingly, they do
not
include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The interim operating results are
not
necessarily indicative of the results for a full year or for any other interim period. Further information on potential factors that could affect the Company's financial results can be found in the Company's Annual Report on Form
10
-K for the year ended
April 30, 2017
filed with the Securities and Exchange Commission (“SEC”) and elsewhere in this Form
10
-Q.
Liquidity, Policy [Policy Text Block]
c)
Liquidity/Going Concern
 
The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced substantial and recurring losses from operations, which have contributed to an accumulated deficit of
$190.0
million as of
July 31, 2017.
As of
July 31, 2017,
the Company had approximately
$11.4
million in cash and cash equivalents on hand. The Company generated revenues of
$0.2
million during each of the
three
months ended
July 31, 2017
and
2016.
Based on the Company’s cash and cash equivalents and marketable securities as of
July 31, 2017,
the Company believes that it will be able to finance its capital requirements and operations into the quarter ending
July 31, 2018.
The Company will require additional equity and/or debt financing to continue its operations. The Company cannot provide assurances that it will be able to secure additional funding when needed or at all, or, if secured, that such funding would be on favorable terms. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
 
The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do
not
include any adjustments relating to the recoverability and classification of recorded assets amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
 
Management is evaluating different strategies to obtain the required additional funding for future operations. These strategies
may
include, but are
not
limited to, additional funding from current or new investors, officers and directors; borrowings of debt; a public offering of the Company’s equity or debt securities; partnerships and/or collaborations. There can be
no
assurance that any of these future-funding efforts will be successful.
 
In fiscal
2017
and the
three
months ended
July 31, 2017,
the Company has continued to make investments in ongoing product development efforts in anticipation of future growth. The Company’s future results of operations involve significant risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are
not
limited to, risks from lack of available financing and insufficient capital, performance of PowerBuoys,
its inability to market and commercialize its PowerBuoys, technology development, scalability of technology and production, dependence on skills of key personnel, concentration of customers and suppliers, deployment risks and laws, regulations and permitting. In order to continue to implement its business strategy, the Company requires additional equity and/or debt financing. The Company closed
four
equity financing arrangements during the year ended
April 30, 2017
and
three
months ended
July 31, 2017.
The Company does
not
currently have any committed sources of debt or equity financing, and the Company cannot assure that additional equity and/or debt financing will be available to the Company as needed on acceptable terms, or at all. Historically, the Company has raised capital through securities sales in the public capital markets. If sufficient additional financing is
not
obtained when needed, the Company
may
be required to further curtail or limit operations, product development costs, and/or selling, general and administrative activities in order to reduce its cash expenditures. This could cause the Company to be unable to execute its business plan, take advantage of future opportunities and
may
cause it to scale back, delay or eliminate some or all of its product development activities and/or reduce the scope of or cease its operations.
 
On
June 2, 2016,
the Company entered into a securities purchase agreement, which was amended on
June 7, 2016 (
as amended, the “Purchase Agreement”) with certain institutional purchasers (the
“June
Purchasers”). Pursuant to the terms of the
June
Purchase Agreement, the Company sold an aggregate of
417,000
shares of Common Stock together with warrants to purchase up to an aggregate of
145,952
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.35
of a share of Common Stock at a combined purchase price of
$4.60.
The net proceeds to the Company from the offering were approximately
$1.7
million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The warrants have an exercise price of
$6.08
per share, became exercisable on
December 3, 2016 (
“Initial Exercise Date”), and will expire
five
years following the Initial Exercise Date. 
The Company paid the placement agents approximately
$0.1
million as placement agent fees in connection with the sale of securities in the offering. The Company also reimbursed the placement agents
$35,000
for their out of pocket and legal expenses in connection with the offering.  
 
On
July 22, 2016,
the Company entered into the Second Amendment to the Purchase Agreement (the “Second Amended Purchase Agreement”) with certain purchasers (the
“July
Purchasers”). Pursuant to the terms of the Second Amended Purchase Agreement, the Company sold an aggregate of
595,000
shares of Common Stock together with warrants to purchase up to an aggregate of
178,500
shares of Common Stock. Each share of Common Stock was sold together with a warrant to purchase
0.30
of a share of Common Stock at a combined purchase price of
$6.75.
The net proceeds to the Company from the offering were approximately
$3.6
million, after deducting placement agent fees and estimated offering expenses payable by the Company, but excluding the proceeds, if any, from the exercise of the warrants issued in the offering. The Warrants were exercisable immediately at an exercise price of
$9.36
per share. The Warrants will expire on the
fifth
(
5th
) anniversary of the initial date of issuance.
 
On
October 19, 2016,
the Company sold
2,760,000
shares of common stock at a price of
$2.75
per share, which includes the sale of
360,000
shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately
$6.9
million, after deducting underwriter fees and offering expenses payable by the Company.
 
On
May 2, 2017,
the Company sold
6,192,750
shares of common stock at a price of
$1.30
per share, which includes the sale of
807,750
shares of the Company’s common stock sold by the Company pursuant to the exercise, in full, of the over-allotment option by the underwriters in a public offering. The net proceeds to the Company from the offering were approximately
$7.2
million, after deducting underwriter fees and offering expenses payable by the Company.
 
The sale of additional equity or convertible securities could result in dilution to stockholders. If additional funds are raised through the issuance of debt securities, these securities could have rights senior to those associated with the Company’s Common Stock and could contain covenants that would restrict its operations. Financing
may
not
be available in amounts or on terms acceptable to the Company, or at all. If the Company is unable to obtain required financing, it
may
be required to reduce the scope of its operations, including its planned product development and marketing efforts, which could materially and adversely harm its financial condition and operating results. If the Company is unable to secure additional financing, it
may
be forced to cease operations.
Consolidation, Policy [Policy Text Block]
(a) Consolidation
 
The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]
(b) Use of Estimates
 
The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the recoverability of the carrying amount of property and equipment; fair value of warrant liabilities, valuation allowances for receivables and deferred income tax assets; estimated costs to complete projects; and percentage of completion of customer contracts for purposes of revenue recognition. Actual results could differ from those estimates.
The current economic environment, particularly the macroeconomic pressures in certain European countries, has increased the degree of uncertainty inherent in those estimates and assumptions.
Revenue Recognition, Policy [Policy Text Block]
(c) Revenue Recognition
 
The Company’s contracts are either cost plus or fixed price contracts. Under cost plus contracts, customers are billed for actual expenses incurred plus an agreed-upon fee. Under cost plus contracts, a profit or loss on a project is recognized depending on whether actual costs are more or less than the agreed upon amount.
 
The Company has
two
types of fixed price contracts, firm fixed price and cost-sharing. Under firm fixed price contracts, the Company receives an agreed-upon amount for providing products and services specified in the contract, a profit or loss is recognized depending on whether actual costs are more or less than the agreed upon amount. Under cost-sharing contracts, the fixed amount agreed upon with the customer is only intended to fund a portion of the costs on a specific project. Under cost sharing contracts, an amount corresponding to the revenue is recorded in cost of revenues, resulting in gross profit on these contracts of zero. The Company’s share of the costs is recorded as product development expense.
 
Generally, revenue under fixed price or cost plus contracts is recognized using the cost to cost percentage-of-completion method, measured by the ratio of costs incurred to total estimated costs at completion. In certain circumstances, revenue under contracts that have specified milestones or other performance criteria
may
be recognized only when the customer acknowledges that such criteria have been satisfied. If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis. Amounts allocated to each element are based on its objectively determined fair value, such as the sales price for the product or service when it is sold separately or competitor prices for similar products or services.
 
In addition, recognition of revenue (and the related costs)
may
be deferred for fixed price contracts until contract completion if the Company is unable to reasonably estimate the total costs of the project prior to completion. These contracts are subject to interpretation and management
may
make a judgment as to the amount of revenue earned and recorded. Because the Company has a small number of contracts, revisions to the percentage-of-completion determination, management interpretation or delays in meeting performance and contractual criteria or in completing projects
may
have a significant effect on revenue for the periods involved. Upon anticipating a loss on a contract, the Company recognizes the full amount of the anticipated loss in the current period.
 
Unbilled receivables represent expenditures on contracts, plus applicable profit margin,
not
yet billed. Unbilled receivables are normally billed and collected within
one
year. Billings made on contracts are recorded as a reduction of unbilled receivables, and to the extent that such billings and cash collections exceed costs incurred plus applicable profit margin, they are recorded as unearned revenues.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
(d) Cash, Cash Equivalents, Restricted Cash and Security Agreements
 
Cash and Cash Equivalents
 
The Company considers all highly liquid investments with a maturity of
three
months or less when purchased to be cash equivalents. The Company invests excess cash in an overnight U.S. government securities repurchase bank account and a money market account. In accordance with the terms of the repurchase agreement, the Company does
not
take possession of the related securities. The agreement contains provisions to ensure that the market value of the underlying assets remain sufficient to protect the Company in the event of default by the bank by requiring that the underlying securities have a total market value of at least
100%
of the bank’s total obligations under the agreement.
 
 
 
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Checking and savings accounts
  $
4,400
    $
4,241
 
Overnight repurchase account
   
7,014
     
4,180
 
    $
11,414
    $
8,421
 
 
 Restricted Cash and
Security Agreements
 
A portion of the Company’s cash is restricted under the terms of
two
security agreements.
 
One agreement is between the Company and Barclays Bank. Under this agreement, the cash is on deposit at Barclays Bank and serves as security for letters of credit and bank guarantees that are expected to be issued by Barclays Bank on behalf of OPT LTD,
one
of the Company's subsidiaries, under a credit facility established by Barclays Bank for OPT LTD. The credit facility is approximately
€0.3
million (
$0.3
million) and carries a fee of
1%
per annum of the amount of any such obligations issued by Barclays Bank. The credit facility does
not
have an expiration date, but is cancelable at the discretion of the bank. As of
July 31, 2017,
there was
€0.3
million (
$0.3
million) in letters of credit outstanding under this agreement.
 
The
second
agreement is between the Company and Santander Bank. Under this agreement, the cash is on deposit at Santander Bank and serves as security for letter of credit issued by Santander Bank for the lease of new warehouse/office space in Monroe Township, New Jersey. The agreement cannot be extended beyond
January 31, 2025,
and is cancelable at the discretion of the bank. Restricted cash includes the following:
 
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Barclay's Bank Agreement
  $
361
    $
334
 
Santander Bank
   
154
     
154
 
    $
515
    $
488
 
 
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the statement of cash flows.
 
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Cash and cash equivalents
  $
11,414
    $
8,421
 
Restricted cash- short term
   
361
     
334
 
Restricted cash- long term
   
154
     
154
 
    $
11,929
    $
8,909
 
Marketable Securities, Policy [Policy Text Block]
(e) Marketable Securities
 
Marketable securities with original maturities longer than
three
months but that mature in less than
one
year from the balance sheet date are classified as current assets. Marketable securities that the Company has the intent and ability to hold to maturity are classified as investments held-to-maturity and are reported at amortized cost. The difference between the acquisition cost and face values of held-to-maturity investments is amortized over the remaining term of the investments and added to or subtracted from the acquisition cost and interest income. As of
July 31, 2017
and
April 30, 2017,
all of the Company’s investments were classified as held-to-maturity.
Foreign Currency Transactions and Translations Policy [Policy Text Block]
(f) Foreign Exchange Gains and Losses
 
The Company has invested in certain certificates of deposit and has maintained cash accounts that are denominated in British pounds sterling, Euros and Australian dollars. These amounts are included in cash, cash equivalents, restricted cash and marketable securities on the accompanying consolidated balance sheets. Such positions
may
result in realized and unrealized foreign exchange gains or losses from exchange rate fluctuations, which are included in “Foreign exchange gain/(loss)” in the accompanying consolidated statements of operations.
Property, Plant and Equipment, Policy [Policy Text Block]
(g) Property and Equipment
 
Property and equipment is stated at cost, less accumulated depreciation and amortization. Depreciation and amortization is calculated using the straight-line method over the estimated useful lives (
three
to
seven
years) of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the remaining lease term. Expenses for maintenance and repairs are charged to operations as incurred. Property and equipment is also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset
may
not
be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, then an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Concentration Risk, Credit Risk, Policy [Policy Text Block]
(h) Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, bank certificates of deposit and trade receivables. The Company invests its excess cash in highly liquid investments (principally, short-term bank deposits, Treasury bills, Treasury notes and money market funds) and does
not
believe that it is exposed to any significant risks related to its cash accounts, money market funds or certificates of deposit.
 
The table below shows the percentage of the Company's revenues derived from customers whose revenues accounted for at least
10%
of the Company's consolidated revenues for at least
one
of the periods indicated:
 
 
 
Three months ended July 31,
 
Customer
 
2017
 
 
2016
 
                 
Mitsui Engineering & Shipbuilding
   
67
%    
100
%
U.S. Department of Defense Office of  Naval Research
   
33
%    
-
 
     
100
%    
100
%
 
The loss of, or a significant reduction in revenues from a current customer could significantly impact the Company's financial position or results of operations. The Company does
not
require its customers to maintain collateral.
Warrant Liability, Policy [Policy Text Block]
(i) Warrant Liabilities
 
The Company's warrants to purchase shares of its common stock are classified as warrant liabilities and are recorded at fair value. The warrant liabilities are subject to re-measurement at each balance sheet date and the Company recognizes any change in fair value in its consolidated statements of operations within “Change in fair value of warrant liabilities.” The Company will continue to adjust the carrying value of the warrants for changes in the estimated fair value until such time as these instruments are exercised or expire. At that time, the liabilities will be reclassified to “Additional paid-in capital”, a component of “Stockholders' equity” on the consolidated balance sheets.
Earnings Per Share, Policy [Policy Text Block]
(j) Net Loss per Common Share
 
Basic and diluted net loss per share for all periods presented is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Due to the Company's net losses, potentially dilutive securities, consisting of outstanding stock options and non-vested performance-based shares, were excluded from the diluted loss per share calculation due to their anti-dilutive effect.
 
In computing diluted net loss per share, options to purchase shares of common stock, warrants on common stock and non-vested restricted stock issued to employees and non-employee directors, totaling
701,977
for the
three
months ended
July 31, 2017
and
711,453
for the
three
months ended
July 31, 2016,
were excluded from each of the computations as the effect would be anti-dilutive due to the Company's losses.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
(
k
)
Share-Based Compensation
 
Costs resulting from all share-based payment transactions are recognized in the consolidated financial statements at their fair values. The aggregate share-based compensation expense recorded in the consolidated statements of operations for the
three
months ended
July 31, 2017
and
2016
was approximately
$0.1
million and
$0.2
million, respectively. The following table summarizes share-based compensation related to the Company’s share-based plans by expense category for the
three
months ended
July 31, 2017
and
2016:
 
 
 
Three months ended July 31,
 
 
 
2017
 
 
2016
 
   
(in thousands)
 
                 
Product development
  $
13
    $
53
 
Selling, general and administratvie
   
78
     
165
 
Total share-based compensation expense
  $
91
    $
218
 
New Accounting Pronouncements, Policy [Policy Text Block]
(l) Recently Issued Accounting Standards
 
In
May 2014,
the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
No.
 
2014
-
09,
Revenue from Contracts with Customers (Topic
606
).”
ASU
2014
-
09
outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a
five
-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The FASB subsequently issued additional clarifying standards to address issues arising from implementation of the new revenue standard, including a
one
-year deferral of the effective date for the new revenue standard. Public companies should now apply the guidance in ASU
2014
-
09
to annual reporting periods beginning after
December 
15,
2017
and interim periods within those annual periods. Earlier application is permitted only as of annual reporting periods beginning after
December 
15,
2016,
including interim periods within that annual period. As such, the Company is required to adopt this standard effective in fiscal
2019,
which begins
May 1, 2018.
Companies
may
use either a full retrospective or a modified retrospective approach to adopt ASU
2014
-
09.
The Company has
not
yet completed its final review of the impact of this guidance; however the Company anticipates applying the modified retrospective method upon adoption of ASU
2014
-
09
on
May 1, 2018.
The impact to the Company could be affected by the nature and terms of potential future contracts with customers, as those contracts
may
have terms that differ from the Company’s current contracts.
 
In
August 2014,
the FASB issued ASU
2014
-
15,
“Disclosure of Uncertainties about an Entity’s Ability
to Continue as a Going Concern”,
which describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides accounting guidance that will be used along with existing auditing standards. The new standard applies to all entities for the
first
annual period ending after
December 15, 2016,
and interim periods thereafter. Early application is permitted. The Company adopted ASU
2014
-
15
for the fiscal year
2017.
The Company’s addition of the standard did
not
have a material impact on its disclosures.
See section (c) “Liquidity/Going Concern” within Note (
1
) “Background and Liquidity” of the consolidated financial statements included in this Quarterly Report on Form
10
-Q for further discussion on the Company’s ability to continue as a going concern.
 
In
January 2016,
the FASB issued ASU
No.
2016
-
01,
“Recognition and Measurement of Financial Assets and Financial Liabilities”,
which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The update significantly revises an entity's accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. The update will take effect for public companies for fiscal years beginning after
December 15, 2017,
including interim periods within those fiscal years. The Company will evaluate the effect of ASU
2016
-
01
for future periods as applicable.
 
In
February 2016,
the FASB issued ASU
No.
2016
-
02,
“Leases (Topic 
842
).” The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than
12
 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU
2016
-
02
is effective for annual periods beginning after
December 
15,
2018,
including interim periods within those annual periods, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the effect ASU
2016
-
02
will have on its consolidated financial statements and disclosures and has
not
yet determined the effect of the standard on its ongoing financial reporting at this time.
 
In
March 2016,
the FASB issued ASU
No.
2016
-
09,
“Compensation - Stock Compensation (Topic
718
)
.
The amendments of ASU
No.
2016
-
09
were issued as part of the FASB's Simplification initiative focused on improving areas of GAAP for which cost and complexity
may
be reduced while maintaining or improving the usefulness of information disclosed within the financial statements. The amendments focused on simplification specifically with regard to share-based payment transactions, including accounting for forfeitures, income tax consequences, classification of awards as equity or liabilities and classification on the statement of cash flows. The guidance in ASU
No.
2016
-
09
is effective for fiscal years beginning after
December 15, 2016,
and interim periods within those annual periods. The Company adopted ASU
2016
-
09
on
May 1, 2017.
Certain of the amendments are applied using a modified retrospective transition method by means of a cumulative-effect adjustment to equity as of
May 1, 2017,
while other amendments are applied retrospectively, prospectively or using either a prospective or a retrospective transition method. Upon adoption, the Company is beginning to account for forfeitures as they occur rather than estimate a forfeiture rate and has recorded a cumulative-effect adjustment in equity of approximately
$10,000
on the date of initial adoption. In periods subsequent to adoption, a higher expense will be recognized earlier during the respective vesting periods of stock-based awards that are
not
forfeited. The Company expects that the income tax amendments within ASU
2016
-
09
will have
no
impact on its results of operations or cash flows because it is in a net operating loss position with a full valuation allowance.
 
In
August 2016,
the FASB issued ASU
2016
-
15,
“Statement of Cash Flows (Topic
230
): Classification
of Certain Cash Receipts and Cash Payments”,
providing additional guidance on
eight
specific cash flow classification issues. The goal of the ASU is to reduce diversity in practice of classifying certain items. The amendments in the ASU are effective for
fiscal years beginning after
December 15, 2017,
and interim periods within those fiscal years and early adoption is permitted. The Company has evaluated the effect ASU
2016
-
13
will have on its consolidated financial statements and disclosures and has determined the standard will have
no
impact on its ongoing financial reporting at this time.
 
In
November 2016,
the FASB issued ASU
2016
-
18,
“Statement of Cash Flows (Topic
230
): Restricted
Cash”,
which amends guidance and presentation related to restricted cash in the statement of cash flows, including stating that amounts generally described as restricted cash and restricted cash equivalents should be included within cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. An entity is required to provide a disclosure indicating the reconciliation of all cash accounts. The amendments in the ASU are effective for
fiscal years beginning after
December 15, 2017,
and interim periods within those fiscal years and early adoption is permitted. The Company has early adopted ASU
2016
-
18
effective
May 1, 2017.
In connection with the adoption of the standard the Company has used a retrospective transition method for each period presented in the statement of cash flows. The Company reclassified
$488,000
and
$300,000
of restricted cash to cash, cash equivalents and restricted cash, beginning of period for the period
April 30, 2017
and
April 30, 2016
in the statement of cash flows. The Company reclassified
$266,000
of restricted cash to cash, cash equivalents and restricted cash, end of period for the period ended
July 31, 2016
in the statement of cash flows.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies (Tables)
3 Months Ended
Jul. 31, 2017
Notes Tables  
Schedule of Cash and Cash Equivalents [Table Text Block]
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Checking and savings accounts
  $
4,400
    $
4,241
 
Overnight repurchase account
   
7,014
     
4,180
 
    $
11,414
    $
8,421
 
Restrictions on Cash and Cash Equivalents [Table Text Block]
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Barclay's Bank Agreement
  $
361
    $
334
 
Santander Bank
   
154
     
154
 
    $
515
    $
488
 
Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Cash and cash equivalents
  $
11,414
    $
8,421
 
Restricted cash- short term
   
361
     
334
 
Restricted cash- long term
   
154
     
154
 
    $
11,929
    $
8,909
 
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
 
 
Three months ended July 31,
 
Customer
 
2017
 
 
2016
 
                 
Mitsui Engineering & Shipbuilding
   
67
%    
100
%
U.S. Department of Defense Office of  Naval Research
   
33
%    
-
 
     
100
%    
100
%
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
 
 
Three months ended July 31,
 
 
 
2017
 
 
2016
 
   
(in thousands)
 
                 
Product development
  $
13
    $
53
 
Selling, general and administratvie
   
78
     
165
 
Total share-based compensation expense
  $
91
    $
218
 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Marketable Securities (Tables)
3 Months Ended
Jul. 31, 2017
Current [Member]  
Notes Tables  
Marketable Securities [Table Text Block]
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Certificate of Deposit
  $
25
    $
25
 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Accrued Expenses (Tables)
3 Months Ended
Jul. 31, 2017
Notes Tables  
Schedule of Other Assets and Other Liabilities [Table Text Block]
 
 
July 31, 2017
 
 
April 30, 2017
 
   
(in thousands)
 
                 
Project costs
  $
46
    $
898
 
Contract loss reserve
   
298
     
238
 
Employee incentive payments
   
142
     
643
 
Accrued salary and benefits
   
420
     
484
 
Legal and accounting fees
   
358
     
478
 
Accrued taxes payable
   
132
     
132
 
Other
   
134
     
186
 
    $
1,530
    $
3,059
 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Warrants (Tables)
3 Months Ended
Jul. 31, 2017
Notes Tables  
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]
 
 
July 31, 2017
 
 
July 31, 2016
 
                     
Dividend rate
 
 
0.0%
 
   
 
0.0%
 
 
Risk-free rate
 
 
1.68%
 
   
 
1.00%
 
 
Expected life (years)
 
4.0
-
4.4
   
5.0
-
5.4
 
Expected volatility
 
 
140.3%
 
   
 
125.4%
 
 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Stock-based Compensation (Tables)
3 Months Ended
Jul. 31, 2017
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
 
 
Three months ended July 31,
 
 
 
2017
 
 
2016
 
                 
Risk-free interest rate
   
N/A
     
1.3
%
Expected dividend yield
   
N/A
     
0.0
%
Expected life (in years)
   
N/A
     
5.5
 
Expected volatility
   
N/A
     
85.6
%
Share-based Compensation, Activity [Table Text Block]
 
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
Weighted
 
 
Remaining
 
 
 
Shares
 
 
Average
 
 
Contractual
 
 
 
Underlying
 
 
Exercise
 
 
Term
 
 
 
Options
 
 
Price
 
 
(In Years)
 
Outstanding as of April 30, 2017
   
237,214
    $
14.64
     
7.6
 
Granted
   
-
    $
-
     
 
 
Exercised
   
-
    $
-
     
 
 
Cancelled/forfeited
   
(6,910
)   $
161.18
     
 
 
Outstanding as of July 31, 2017
   
230,304
    $
10.24
     
7.6
 
Exercisable as of July 31, 2017
   
128,641
    $
16.10
     
6.3
 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
 
 
 
 
 
 
Weighted
 
 
 
Number
 
 
Average Price per
 
 
 
of Shares
 
 
Share
 
                 
Issued and unvested at April 30, 2017
   
103,412
    $
3.99
 
Granted
   
114,584
    $
1.40
 
Vested
   
(70,650
)   $
4.55
 
Cancelled/forfeited
   
(125
)   $
1.40
 
Issued and unvested at July 31, 2017
   
147,221
    $
2.04
 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value Measurements (Tables)
3 Months Ended
Jul. 31, 2017
Notes Tables  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
 
 
Total Carrying Value in Consolidated Balance Sheet
 
 
Quoted prices in active markets for identical assts or liabilities
(Level 1)
 
 
Significant other observable inputs
(Level 2)
 
 
Significant unobservable inputs
(Level 3)
 
   
(in thousands)
 
                                 
Warrant liabilities
  $
286
    $
-
    $
-
    $
286
 
 
 
Total Carrying Value in Consolidated Balance Sheet
 
 
Quoted prices in active markets for identical assts or liabilities
(Level 1)
 
 
Significant other observable inputs
(Level 2)
 
 
Significant unobservable inputs
(Level 3)
 
   
(in thousands)
 
                                 
Warrant liabilities
  $
323
    $
-
    $
-
    $
323
 
Changes on Value of Warrant Liability [Table Text Block]
Fair Value Measurement Using Significant Unobservable Inputs ( Level 3)  
       
   
Total
 
   
Warrant
 
   
Liability
 
   
(in thousands)
 
         
Fair value – April 30, 2016
  $
-
 
Issuance
   
1,814
 
Transfers
   
-
 
Change in fair value
   
(1,491
)
Fair value – April 30, 2017
  $
323
 
         
Change in fair value
   
(37
)
Fair value – July 31, 2017
  $
286
 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Background, Basis of Presentation and Liquidity (Details Textual)
3 Months Ended 12 Months Ended
May 02, 2017
USD ($)
$ / shares
shares
Oct. 19, 2016
USD ($)
$ / shares
shares
Jul. 22, 2016
USD ($)
$ / shares
shares
Jun. 02, 2016
USD ($)
$ / shares
shares
Jul. 31, 2017
USD ($)
Jul. 31, 2016
USD ($)
Apr. 30, 2017
USD ($)
Retained Earnings (Accumulated Deficit)         $ (190,043,000)   $ (187,370,000)
Cash and Cash Equivalents, at Carrying Value         11,414,000   $ 8,421,000
Proceeds from Issuance or Sale of Equity         $ 5,261,000  
Revenues         $ 195,000 $ 202,000  
Number of Financing Agreements Closed         4   4
Purchase Agreement [Member]              
Proceeds from Issuance or Sale of Equity     $ 3,600,000 $ 1,700,000      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 9.36 $ 6.08      
Class of Warrant or Right, Expiration Period     5 years 5 years      
Stock Issued During Period, Shares, New Issues | shares     595,000 417,000      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares     178,500 145,952      
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares     0.3 0.35      
Price Per Common Stock and Warrant | $ / shares     $ 6.75 $ 4.60      
Purchase Agreement [Member] | Placement Agents [Member] | Placement Agent Fees [Member]              
Payments of Stock Issuance Costs       $ 100,000      
Purchase Agreement [Member] | Placement Agents [Member] | Reimbursement of Out of Pocket and Legal Expenses [Member]              
Payments of Stock Issuance Costs       $ 35,000      
Offering Agreement [Member]              
Share Price | $ / shares $ 1.30 $ 2.75          
Stock Issued During Period, Shares, New Issues | shares 6,192,750 2,760,000          
Over-Allotment Option [Member]              
Proceeds from Issuance or Sale of Equity $ 7.20 $ 6,900,000          
Stock Issued During Period, Shares, New Issues | shares 807,750 360,000          
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies (Details Textual)
€ in Millions
3 Months Ended
Jul. 31, 2017
USD ($)
shares
Jul. 31, 2016
USD ($)
shares
Jul. 31, 2017
EUR (€)
May 01, 2017
USD ($)
Apr. 30, 2017
USD ($)
Apr. 30, 2016
USD ($)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares 701,977 711,453        
Allocated Share-based Compensation Expense $ 91,000 $ 218,000        
Cumulative Effect of New Accounting Principle in Period of Adoption          
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11,929,000 9,291,000     $ 8,909,000 $ 7,030,000
Accounting Standards Update 2016-18 [Member] | Restatement Adjustment [Member]            
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents   $ 266,000     $ 488,000 $ 300,000
Retained Earnings [Member]            
Cumulative Effect of New Accounting Principle in Period of Adoption $ (10,000)          
Retained Earnings [Member] | Accounting Standards Update 2016-09 [Member]            
Cumulative Effect of New Accounting Principle in Period of Adoption       $ (10,000)    
Minimum [Member]            
Property, Plant and Equipment, Useful Life 3 years          
Maximum [Member]            
Property, Plant and Equipment, Useful Life 7 years          
Barclays Bank [Member]            
Line of Credit Facility, Commitment Fee Percentage 1.00%          
Long-term Line of Credit $ 300,000   € 0.3      
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Jul. 31, 2017
Apr. 30, 2017
Cash and cash equivalents $ 11,414 $ 8,421
Checking and Savings Accounts [Member]    
Cash and cash equivalents 4,400 4,241
Overnight Repurchase Account [Member]    
Cash and cash equivalents $ 7,014 $ 4,180
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies - Cash Restricted Under Security Agreements (Details) - USD ($)
$ in Thousands
Jul. 31, 2017
Apr. 30, 2017
Restricted cash $ 515 $ 488
Barclays Bank Agreement [Member]    
Restricted cash 361 334
Santander Bank [Member]    
Restricted cash $ 154 $ 154
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Jul. 31, 2017
Apr. 30, 2017
Jul. 31, 2016
Apr. 30, 2016
Cash and Cash Equivalents, at Carrying Value $ 11,414 $ 8,421    
Restricted cash- short term 361 334    
Restricted cash- long term 154 154    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 11,929 $ 8,909 $ 9,291 $ 7,030
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies - Revenues by Major Customers (Details) - Customer Concentration Risk [Member] - Sales Revenue, Net [Member]
3 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Revenues, percentage 100.00% 100.00%
Mitsui Engineering and Ship Building [Member]    
Revenues, percentage 67.00% 100.00%
U.S. Department of Defense Office of Naval Research [Member]    
Revenues, percentage 33.00%
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Summary of Significant Accounting Policies - Share-based Compensation (Details) - USD ($)
$ in Thousands
3 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Allocated Share-based Compensation Expense $ 91 $ 218
Product Development [Member]    
Allocated Share-based Compensation Expense 13 53
Selling, General and Administrative Expenses [Member]    
Allocated Share-based Compensation Expense $ 78 $ 165
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Marketable Securities - Marketable Securities That Mature Within One Year (Details) - USD ($)
$ in Thousands
Jul. 31, 2017
Apr. 30, 2017
Apr. 30, 2016
Marketable securities $ 25 $ 25 $ 25
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Accrued Expenses - Accrued Expenses (Details) - USD ($)
$ in Thousands
Jul. 31, 2017
Apr. 30, 2017
Project costs $ 46 $ 898
Contract loss reserve 298 238
Employee incentive payments 142 643
Accrued salary and benefits 420 484
Legal and accounting fees 358 478
Accrued taxes payable 132 132
Other 134 186
Accrued expenses total $ 1,530 $ 3,059
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Deferred Credits Payable (Details Textual)
$ in Thousands
Jul. 31, 2017
USD ($)
Apr. 30, 2017
USD ($)
Apr. 30, 2001
USD ($)
T
Rate
Customer Advances or Deposits, Noncurrent | $     $ 600
Deferred Credits Payable Option Details | T     500,000
Deferred Credits Payable Market Discount Rate | Rate     30.00%
Deferred Credits Payable Market Liquidated Damages Rate | Rate     30.00%
Customer Advances and Deposits, Current | $ $ 600 $ 600  
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Warrants (Details Textual) - USD ($)
3 Months Ended
Jul. 22, 2016
Jun. 02, 2016
Jul. 31, 2017
Jul. 31, 2016
Apr. 30, 2017
Fair Value Adjustment of Warrants     $ (37,000) $ 752,000  
Warrant [Member]          
Derivative Liability, Current     $ 300,000   $ 300,000
Purchase Agreement [Member]          
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 9.36 $ 6.08      
Class of Warrant or Right, Expiration Period 5 years 5 years      
Stock Issued During Period, Shares, New Issues 595,000 417,000      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 178,500 145,952      
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 0.3 0.35      
Price Per Common Stock and Warrant $ 6.75 $ 4.60      
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Warrants - Fair Value Assumptions for Warrants (Details) - Warrant [Member]
3 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Dividend rate 0.00% 0.00%
Risk-free rate 1.68% 1.00%
Expected life (years) (Year)  
Expected volatility 140.30% 125.40%
Minimum [Member]    
Dividend rate  
Risk-free rate  
Expected life (years) (Year) 4 years 5 years
Expected volatility
Maximum [Member]    
Dividend rate  
Risk-free rate  
Expected life (years) (Year) 4 years 146 days 5 years 146 days
Expected volatility
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Stock-based Compensation (Details Textual) - USD ($)
3 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 1.10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $ 5,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 4,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares 100,323  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term 9 years 73 days  
Allocated Share-based Compensation Expense $ 91,000 $ 218,000
Treasury Stock [Member]    
Treasury Stock, Shares, Acquired 22,016 447
Employee Stock Option [Member]    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 146 days  
Allocated Share-based Compensation Expense $ 69,000 $ 83,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options 100,000  
Restricted Stock [Member]    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options $ 200,000  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 1 year 182 days  
Allocated Share-based Compensation Expense $ 22,000 $ 100,000
Restricted Stock [Member] | Service-based Vesting [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 114,584  
Restricted Stock [Member] | Performance-based vesting [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 12,000  
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Stock-based Compensation - Fair Value Assumptions for Options (Details) - Employee Stock Option [Member]
3 Months Ended
Jul. 31, 2016
Risk-free interest rate 1.30%
Expected dividend yield 0.00%
Expected life (in years) (Year) 5 years 182 days
Expected volatility 85.60%
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Share-based Compensation Plans - Stock Options Under the Plans (Details)
3 Months Ended
Jul. 31, 2017
$ / shares
shares
Beginning Balance, shares underlying options (in shares) | shares 237,214
Beginning Balance, weighted average exercise price (in dollars per share) | $ / shares $ 14.64
Ending Balance, weighted average exercise price (in dollars per share) | $ / shares $ 10.24
Balance, weighted average remaining contractual term (Year) 7 years 219 days
Granted (in shares) | shares
Granted (in dollars per share) | $ / shares
Exercised (in shares) | shares
Exercised (in dollars per share) | $ / shares
Cancelled/forfeited (in shares) | shares (6,910)
Cancelled/forfeited (in dollars per share) | $ / shares $ 161.18
Ending Balance, shares underlying options (in shares) | shares 230,304
Exercisable, shares underlying options (in shares) | shares 128,641
Exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 16.10
Exercisable, weighted average remaining contractual term (Year) 6 years 109 days
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Share-based Compensation Plans - Non-vested Restricted Stock Under the Plans (Details) - Non-vested Restricted Stock [Member]
3 Months Ended
Jul. 31, 2017
$ / shares
shares
Beginning Balance, issued and unvested (in shares) | shares 103,412
Beginning Balance, issued and unvested (in dollars per share) | $ / shares $ 3.99
Ending Balance, issued and unvested (in dollars per share) | $ / shares $ 2.04
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 114,584
Granted (in dollars per share) | $ / shares $ 1.40
Vested (in shares) | shares (70,650)
Vested (in dollars per share) | $ / shares $ 4.55
Cancelled/forfeited (in shares) | shares (125)
Cancelled/forfeited (in dollars per share) | $ / shares $ 1.40
Ending Balance, issued and unvested (in shares) | shares 147,221
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value Measurements (Details Textual) - Fair Value, Measurements, Nonrecurring [Member] - USD ($)
$ in Thousands
3 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Liabilities, Fair Value Adjustment $ 0 $ 0
Assets, Fair Value Adjustment $ 0 $ 0
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Jul. 31, 2017
Apr. 30, 2017
Warrant liabilities $ 286 $ 323
Warrant [Member] | Fair Value, Measurements, Recurring [Member] | Reported Value Measurement [Member]    
Warrant liabilities 286 323
Warrant [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]    
Warrant liabilities
Warrant [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member]    
Warrant liabilities
Warrant [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]    
Warrant liabilities $ 286 $ 323
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value Measurements - Changes on Value of Warrant Liability (Details) - Warrant [Member] - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jul. 31, 2017
Apr. 30, 2017
Fair value $ 323
Issuance   1,814
Transfers  
Change in fair value (37) (1,491)
Fair value $ 286 $ 323
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Commitments and Contingencies (Details Textual)
€ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Oct. 22, 2015
Aug. 31, 2017
USD ($)
Jun. 30, 2012
USD ($)
Jul. 31, 2017
USD ($)
Apr. 30, 2017
USD ($)
Jan. 31, 2017
USD ($)
Jun. 30, 2012
EUR (€)
Estimated Litigation Liability, Current       $ 350,000    
Tax Authority, Spain [Member] | Foreign Tax Authority [Member]              
Input Tax     $ 300,000        
Letters of Credit Outstanding, Amount     $ 300,000       € 0.3
Foreign Tax Examination Refund           $ (200,000)  
Tax Authority, Spain [Member] | Foreign Tax Authority [Member] | Accounts Payable and Accrued Liabilities [Member]              
Income Tax Examination, Penalties Expense       132,000 $ 132,000    
Reverse Stock Split [Member]              
Stockholders' Equity Note, Stock Split, Conversion Ratio 10            
Stipulation [Member]              
Litigation Settlement, Amount Awarded to Other Party   $ 350,000          
Litigation Settlement, Amount Paid by Insurer   $ 350,000          
Estimated Litigation Liability, Current       350,000      
Insurance Settlements Receivable       $ 350,000      
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Income Taxes (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Apr. 30, 2017
Unrecognized Tax Benefits $ 0    
Income Tax Expense (Benefit) 0 $ 0  
Tax Authority, Spain [Member] | Foreign Tax Authority [Member] | Accounts Payable and Accrued Liabilities [Member]      
Income Tax Examination, Penalties Expense $ 132,000   $ 132,000
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Operating Segments and Geographic Information (Details Textual)
3 Months Ended
Jul. 31, 2017
Number of Operating Segments 1
EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 61 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 63 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 104 218 1 false 46 0 false 7 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-consolidated-balance-sheets-current-period-unaudited Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-consolidated-balance-sheets-current-period-unaudited-parentheticals Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Unaudited Consolidated Statements of Operations Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-unaudited-consolidated-statements-of-operations Unaudited Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Unaudited Consolidated Statements of Comprehensive Loss Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-unaudited-consolidated-statements-of-comprehensive-loss Unaudited Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 005 - Statement - Unaudited Consolidated Statements of Stockholders' Equity Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-unaudited-consolidated-statements-of-stockholders-equity Unaudited Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 006 - Statement - Unaudited Consolidated Statements of Cash Flows Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-unaudited-consolidated-statements-of-cash-flows Unaudited Consolidated Statements of Cash Flows Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Background, Basis of Presentation and Liquidity Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-1-background-basis-of-presentation-and-liquidity Note 1 - Background, Basis of Presentation and Liquidity Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Marketable Securities Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-3-marketable-securities Note 3 - Marketable Securities Notes 10 false false R11.htm 010 - Document - Note 4 - Accrued Expenses Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-4-accrued-expenses Note 4 - Accrued Expenses Uncategorized 11 false false R12.htm 011 - Disclosure - Note 5 - Deferred Credits Payable Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-5-deferred-credits-payable Note 5 - Deferred Credits Payable Uncategorized 12 false false R13.htm 012 - Disclosure - Note 6 - Warrants Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-6-warrants Note 6 - Warrants Uncategorized 13 false false R14.htm 013 - Disclosure - Note 7 - Stock-based Compensation Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-7-stockbased-compensation Note 7 - Stock-based Compensation Uncategorized 14 false false R15.htm 014 - Disclosure - Note 8 - Fair Value Measurements Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-8-fair-value-measurements Note 8 - Fair Value Measurements Uncategorized 15 false false R16.htm 015 - Disclosure - Note 9 - Commitments and Contingencies Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-9-commitments-and-contingencies Note 9 - Commitments and Contingencies Uncategorized 16 false false R17.htm 016 - Disclosure - Note 10 - Income Taxes Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-10-income-taxes Note 10 - Income Taxes Uncategorized 17 false false R18.htm 017 - Disclosure - Note 11 - Operating Segments and Geographic Information Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-11-operating-segments-and-geographic-information Note 11 - Operating Segments and Geographic Information Uncategorized 18 false false R19.htm 018 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 19 false false R20.htm 019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Uncategorized 20 false false R21.htm 020 - Disclosure - Note 3 - Marketable Securities (Tables) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-3-marketable-securities-tables Note 3 - Marketable Securities (Tables) Uncategorized 21 false false R22.htm 021 - Disclosure - Note 4 - Accrued Expenses (Tables) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-4-accrued-expenses-tables Note 4 - Accrued Expenses (Tables) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 6 - Warrants (Tables) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-6-warrants-tables Note 6 - Warrants (Tables) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 7 - Stock-based Compensation (Tables) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-7-stockbased-compensation-tables Note 7 - Stock-based Compensation (Tables) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 8 - Fair Value Measurements (Tables) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-8-fair-value-measurements-tables Note 8 - Fair Value Measurements (Tables) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 1 - Background, Basis of Presentation and Liquidity (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-1-background-basis-of-presentation-and-liquidity-details-textual Note 1 - Background, Basis of Presentation and Liquidity (Details Textual) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-2-summary-of-significant-accounting-policies-cash-and-cash-equivalents-details Note 2 - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Cash Restricted Under Security Agreements (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-2-summary-of-significant-accounting-policies-cash-restricted-under-security-agreements-details Note 2 - Summary of Significant Accounting Policies - Cash Restricted Under Security Agreements (Details) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-2-summary-of-significant-accounting-policies-reconciliation-of-cash-cash-equivalents-and-restricted-cash-details Note 2 - Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Revenues by Major Customers (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-2-summary-of-significant-accounting-policies-revenues-by-major-customers-details Note 2 - Summary of Significant Accounting Policies - Revenues by Major Customers (Details) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Share-based Compensation (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-2-summary-of-significant-accounting-policies-sharebased-compensation-details Note 2 - Summary of Significant Accounting Policies - Share-based Compensation (Details) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 3 - Marketable Securities - Marketable Securities That Mature Within One Year (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-3-marketable-securities-marketable-securities-that-mature-within-one-year-details Note 3 - Marketable Securities - Marketable Securities That Mature Within One Year (Details) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 4 - Accrued Expenses - Accrued Expenses (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-4-accrued-expenses-accrued-expenses-details Note 4 - Accrued Expenses - Accrued Expenses (Details) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 5 - Deferred Credits Payable (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-5-deferred-credits-payable-details-textual Note 5 - Deferred Credits Payable (Details Textual) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 6 - Warrants (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-6-warrants-details-textual Note 6 - Warrants (Details Textual) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 6 - Warrants - Fair Value Assumptions for Warrants (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-6-warrants-fair-value-assumptions-for-warrants-details Note 6 - Warrants - Fair Value Assumptions for Warrants (Details) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 7 - Stock-based Compensation (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-7-stockbased-compensation-details-textual Note 7 - Stock-based Compensation (Details Textual) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 7 - Stock-based Compensation - Fair Value Assumptions for Options (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-7-stockbased-compensation-fair-value-assumptions-for-options-details Note 7 - Stock-based Compensation - Fair Value Assumptions for Options (Details) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 7 - Share-based Compensation Plans - Stock Options Under the Plans (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-7-sharebased-compensation-plans-stock-options-under-the-plans-details Note 7 - Share-based Compensation Plans - Stock Options Under the Plans (Details) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 7 - Share-based Compensation Plans - Non-vested Restricted Stock Under the Plans (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-7-sharebased-compensation-plans-nonvested-restricted-stock-under-the-plans-details Note 7 - Share-based Compensation Plans - Non-vested Restricted Stock Under the Plans (Details) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 8 - Fair Value Measurements (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-8-fair-value-measurements-details-textual Note 8 - Fair Value Measurements (Details Textual) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 8 - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-8-fair-value-measurements-financial-assets-and-liabilities-measured-at-fair-value-on-a-recurring-basis-details Note 8 - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 8 - Fair Value Measurements - Changes on Value of Warrant Liability (Details) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-8-fair-value-measurements-changes-on-value-of-warrant-liability-details Note 8 - Fair Value Measurements - Changes on Value of Warrant Liability (Details) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 9 - Commitments and Contingencies (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-9-commitments-and-contingencies-details-textual Note 9 - Commitments and Contingencies (Details Textual) Uncategorized 45 false false R46.htm 045 - Disclosure - Note 10 - Income Taxes (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-10-income-taxes-details-textual Note 10 - Income Taxes (Details Textual) Uncategorized 46 false false R47.htm 046 - Disclosure - Note 11 - Operating Segments and Geographic Information (Details Textual) Sheet http://www.oceanpowertechnologies.com/20170731/role/statement-note-11-operating-segments-and-geographic-information-details-textual Note 11 - Operating Segments and Geographic Information (Details Textual) Uncategorized 47 false false All Reports Book All Reports optt-20170731.xml optt-20170731.xsd optt-20170731_cal.xml optt-20170731_def.xml optt-20170731_lab.xml optt-20170731_pre.xml true true ZIP 65 0001437749-17-015699-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-17-015699-xbrl.zip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�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